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ABSTRACT 
 This thesis presents the development of new catalyst for the coupling of alkene 
hydroacylation and enantioselective α-arylation to form heterocyclic ketones containing α-chiral 
quarternary stereocenters, the N-heterocyclic carbene-catalyzed intramolecular hydroacylation to 
form basic nitrogen-containing heterocycles, and the first examples of nickel-catalyzed alkene 
carboacylation triggered by amide C-N bond activation. 
 Chapter II discusses a strategy that combines alkene hydroacylation and enantioselective 
α-arylation to form a wide variety of nitrogen-containing heterocyclic ketones bearing α-chiral 
quarternary stereogenic centers. Exo-selective, intramolecular Ni-catalyzed hydroacylations of N-
homoallylindole- and N-homoallylpyrrole-2-carboxaldehydes form α-substituted six-membered 
heterocyclic ketones in up to 95% yield, while N-heterocyclic carbene (NHC) catalyzed 
hydroacylations of N-allylindole- and N-allylpyrrole-2-carboxaldehydes form α-substituted five-
membered heterocyclic ketones in up to 99% yield.  The racemic five- and six-membered products 
of Ni- and NHC-catalyzed hydroacylation reactions are readily transformed into heterocyclic 
ketones containing an α-chiral quarternary stereogenic center by enantioselective Ni-catalyzed α-
arylation and α-(hetero)arylation reactions.  The chiral, nonracemic products formed through a 
combination of alkene hydroacylation and α-(hetero)arylation reactions are formed in moderate to 
high yields (44-99%) with excellent enantioselectivities (typically >95% ee).  The identity of the 
precatalyst for Ni-catalyzed α-(hetero)arylation is dictated by the identity of the α-substituted 
heterocyclic ketone starting material.  α-(Hetero)arylations of six-membered heterocyclic ketones 
occur at 65-85 °C in the presence of a catalyst generated in situ from Ni(COD)2 and (R)-BINAP 
or (R)-DIFLUORPHOS.  α-(Hetero)arylation of five-membered heterocyclic ketones must be 
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conducted at room temperature in the presence of an [((R)-BINAP)Ni(η2-NC-Ph)] precatalyst or a 
catalyst generated in situ from Ni(COD)2, (R)-DIFLUORPHOS, and benzonitrile. 
 Chapter III describes the intramolecular hydroacylations of N-allylimidazole- 2-
carboxaldehydes and N-allylbenzimidazole-2-carboxaldehydes. These exo-selective 
hydroacylations occur in the presence of a N-heterocyclic carbene catalyst to generate 5,6-dihydro- 
7H-pyrrolo[1,2-α]imidazol-7-ones and 1,2-dihydro-3H-benzo[d] pyrrolo[1,2-α]imidazol-2-ones 
in high yields (66–99%). In addition, hydroacylations of N-allylimidazole-2-carboxaldehydes in 
the presence of a chiral, non-racemic NHC catalyst occur, forming 5,6- dihydro-7H-pyrrolo[1,2-
α]imidazol-7-ones in moderate-to-high yields (39–98%) with modest enantioselectivities (56–79% 
ee). 
 Chapter IV discusses nickel-catalyzed formal carboacylation of ortho-allylbenzamides 
with arylboronic acid pinacol esters. These carboacylation reactions are triggered by the oxidative 
addition of an activated amide C-N bond to a nickel(0) catalyst and proceed via alkene insertion 
into a nickel(II)-acyl bond. The exo-selective carboacylation reactions generate 2-benzyl-2,3-
dihydro-1H-inden-1-ones in moderate-to-high yields (46-99%) from a variety of arylboronic acid 
pinacol esters and substituted ortho-allylbenzamides. These results demonstrate that amides are 
practical substrates for alkene carboacylation via activation of an amide C-N bond, and this 
approach bypasses challenges associated with alkene carboacylation triggered by C-C bond 
activation. 
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CHAPTER I 
 INTRODUCTION 
Transition-metal catalyzed olefin functionalizations has been an important and essential 
component of modern synthetic organic chemistry.1-6  This broad area of research encompasses 
reactions such as hydroacylation, carboacylation, polymerizations, metathesis, among many 
others.1-6  In this thesis, fundamental principles of transition-metal catalysts and organocatalysts 
will be applied to the development of processes for the endo- and exo-selective hydroacylation of 
nitrogen-containing heterocycles and sequential enantioselective α-arylation, N-heterocylcic 
carbene catalyzed hydroacylation or N-allylimidazolecarboxaldehydes and N-
allylbenzimidazolecarboxaldehyes and a new method for the formal carboacylation of ortho-
allylbenzamides triggered by nickel-catalyzed activation of amide C-N bonds. 
Nitrogen-containing heterocycles possessing quarternary stereogenic centers are common 
structural motifs present in biologically active natural products and small molecules.7-18  Despite 
many advances over the past decades, enantioselective synthesis of quarternary stereogenic centers 
remain a significant synthetic challenge.19-27  In 2011, 12% of the top 200 prescription drugs sole 
in the United States contained quarternary stereogenic centers.27-28  However, the majority of these 
compounds are synthesized from naturally occurring compounds (steroids, opioids, taxane, and 
diterpenoids) with the natural product precursor providing the quarternary stereogenic centers.27,29   
To address this issue we have developed a strategy to generate racemic five- and six-
membered products of Ni- and NHC-catalyzed hydroacylation reactions.  The generated products 
are readily transformed into heterocyclic ketones containing an α-chiral quarternary stereogenic 
center by enantioselective Ni-catalyzed α-arylation and α-(hetero)arylation reactions (Figure 1.)  
This thesis presents a method of  sequential hydroacylation and α-arylation to generate nitrogen-
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containing heterocycle containing all-carbon quaternary stereocenters in high yields (up to 99%) 
and enantioselectivities (typically >95% ee). 
 
Figure 1. Coupling catalytic alkene hydroacylation and α-arylation reactions. 
 Intramolecular hydroacylation of alkenes in the presence of transition-metal catalysts are 
well-known processes to generate a variety of valuable cyclic ketones.30-35 Transition metal-
catalysed alkene hydroacylations to form and functionalize nitrogen-containing heterocycles, in 
many cases with high yields and enantioselectivities, have been the focus of recent studies to 
improve the synthetic utility of these important C-C bond forming processes.36-40  However, alkene 
hydroacylations to form nitrogen heterocycles containing a basic nitrogen atom often do not occur 
in the presence of rhodium, cobalt, and nickel complexes that are excellent catalysts for alkene 
hydroacylation due to inhibition of the catalyst in the presence of basic nitrogen atoms.36   
 N-Heterocyclic carbenes (NHCs)41-45 are a widely utilized class of organocatalysts and 
offer a promising alternative to transition-metal catalsyts for alkene hydroacylation reactions.46-49 
Key to our studies, NHCs have been shown to tolerate additives containing basic nitrogen atoms.50 
Building on reports from Glorius and co-workers (Figure 2.)50-53 and a recent study from our 
laboratory54 on NHC-catalyzed intramolecular hydroacylations of unactivated alkenes, this thesis 
describes the exo-selective intramolecular hydroacylation of basic nitrogen-containing 
3 
 
heterocycles. This NHC-catalyzed process generates 5,6-dihydro-7H-pyrrolo[1,2-α]imidazol-2-
ones in high yields (66-99%).  Additionally, hydroacylations of N-allylimidazole-2-
carboxaldehydes in the presence of a chiral, non-racemic NHC catalyst occur, forming 5,6-
dihydro-7H-pyrrolo[1,2-α]imidazol-7-ones in moderate-to-high yields (39-98%) with modest 
enantioselectivities (56-79% ee). 
 
Figure 2. (a) NHC-catalyzed enantioselective intramolecular hydroacylations of unactivated 
alkenes and (b) NHC-catalyzed, exo-selective hydroacylation of N-allylimidazole and N-
allylbenzimidazole-2-carboxaldehydes. 
 
Carboacylation of alkenes in the presence of a transition-metal catalyst is an emerging 
reaction that enables the difunctionalization of an alkene with formation of two C-C σ-bonds.55-70   
Among the most studies and developed approaches to alkene carboacylation are reactions initiated 
by activation of a C-C σ-bond of a ketone.  However, current methods are limited by the 
requirement of substrates containing either a quinolone directing group56-57, 59, 61, 65 or a strained 
cyclic ketone.60, 63-64, 66-69 The ability to perform alkene carboacylation reactions without a 
requirement for strained ketone substrates or substrates containing directing groups has the 
potential to expand the utility of these reactions with readily accessible substrates.55, 58, 62, 70-75 
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Scheme 1. Synthesis of Ketones via Transition Metal-Catalyzed Activation of Amide C-N 
Bonds 
 
Recently, studies by a number of groups have demonstrated Suzuki-Miyaura coupling of 
benzamides with arylboron compounds to generate a variety of aromatic ketones.76-87  The Suzuki-
Miyaura-Type coupling reactions involve C-N activation of an activated benzamide via oxidative 
addition and transmetalation with an arylboron compound to generate acyl-metal-aryl intermediate 
A (Scheme 1a.). Subsequent reductive elimination forms a diary ketone. The ability to intercept 
acyl-metal intermediates with an alkene offers the potential to develop a new class of alkene 
functionalization reactions.  During the course of our studies, Garg and co-workers reported 
Mizoroki-Heck cyclizations of ortho-allylbenzamides that involve insertation of an alkene into an 
acyl-nickel(II)-amido intermediate B (Scheme 1b).88 Subsequent β-hydride elimination forms 2-
vinylindanones containing a quarternary carbon center.  This thesis describes carboacylation 
5 
 
reactions triggered by the oxidative addition of an activated amide C-N bond76-87, 89-94 to a nickel 
(0) catalyst that proceed via alkene insertions into a nickel(II)-acyl bond (Scheme 1c).  The exo-
selective carboacylation reactions generate 2-benzyl-2,3-dihydro-1H-1-ones in moderate-to-high 
yields (46-99%) from a variety of arylboronic acid pinacol esters and substituted ortho-
allylbenzamides.  These results demonstrate that amides are practical substrates for alkene 
carbazcylaion via activation of an amide C-N bond, and this approach bypasses challenges 
associated with alkene carboacylation triggered by C-C bond activation. 
Thesis Organization 
 This thesis is comprised of five chapters that contain work that has been published in peer-
reviewed journals.  Chapter I serves to introduce transition metal-catalyzed and organo catalytic 
methods development in the context of hydroacylation and carboacylation reactions.  Chapter II is 
adapted from a paper published in ACS catalysis.  Chapter III is adapted from a paper published in 
Organic & Biomolecular Chemistry. Chapter IV is adapted from a paper published in the Journal 
of the American Chemical Society.  Chapter V serves as a general summary and conclusion of the 
presented research and proposes strategies to address the limitations that remain in some of the 
research projects described. 
 Chapter II describes the exo-selective, intramolecular nickel-catalyzed hydroacylation of 
N-homoallylindole- and N-homoallylpyrrole-2-carboxaldehydes and N-heterocyclic carbene-
catalyzed hydroacylations of N-allylindole- and N-allylpyrrole-2-carboxaldehydes. In addition, the 
racemic five- and six-membered products of Ni- and NHC-catalyzed hydroacylation reactions 
were readily transformed into heterocyclic ketones containing an α-chiral quarternary stereogenic 
center by enantioselective Ni-catalyzed α-arylation and α-(hetero)arylation reactions. Chapter II is 
adapted from a paper published in ACS Catalysis in 2016.  This work was accomplished in 
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collaboration with Avipsa Ghosh, also of the Stanley group.  The author of this thiesis is 
responsible for the synthesis of indole substrates 1a, 1c, 1e, 1h, and pyrrole substrates 1m-p. 
Additionally, the development of reaction conditions and scope of NHC-catalyzed hydroacylation 
of N-allylindole-2-carboxaldehyde and N-allylpyrrole-2-carboxaldehyde was completed by the 
author of this thesis.  The screening of reaction conditions for the α-arylation of 
dihydropyrroloindolones and evaluation of the scope was completed by the author of this thesis. 
Avipsa Ghosh was responsible for the screening of reaction conditions for the nickel-catalyzed of 
hydroacylation N-homoallylindole-2-carboxaldehyde to generate dihydropyridoindolones, and the 
synthesis of compounds of 1b, 1d, 1f-g, 1i-l, and scope of the nickel-catalyzed hydroacylation. 
Additionally, Avipsa Ghosh was responsible for the screening of reaction conditions for Ni-
catalyzed α-arylation of dihydropyridoindolones and the scope of the reactions.  Lastly, Avipsa 
Ghosh screened reaction conditions for the α-heteroarylation of dihydropyrroloindolone, 
dihydropyridoindolone, dihydropyrrolizinone, and dihydroindolizinone, and the corresponding 
scope of the reaction. 
 Chapter III describes the NHC-catalyzed hydroacylation of N-allylimidazole-2-
carboxaldehydes and N-allylbenzimidazole-2-carboxaldehydes, and is adapted from a paper 
published in Organic and Biomolecular Chemistry in 2016.  This details the development of a 
intramolecular hydroacylation of basic nitrogen-containing heterocycles N-allylimidazole and N-
allylbenzimidazole to generate 5,6-dihydro-7H-pyrrolo[1,2-α]imidazol-7-ones and 1,2-dihydro-
3H-pyrrolo[1,2-α]imidazol-2-ones in high yields.  Additionally, hydroacylations of N-
allylimidazole-2-carboxaldehydes in the presence of a chiral, non-racemic NHC catalyst occur, 
forming 5,6-dihydro-7H-pyrrolo[1,2-α]imidazol-7-ones in moderate-to-high yields with modest 
enantioselectivities. The author of this thesis is responsible for all work reported in this chapter. 
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 Chapter IV details the development of nickel-catalyzed formal carboacylation of ortho-
allylbenzamides triggered by activation of amide C-N bond.  The chapter is adapted from a paper 
published in the Journal of the American Chemical Society in 2017.  This chapter demonstrates a 
new utility of amides for use in formal carboacylation reactions.  Additionally, this demonstrates 
how this new method bypasses the limitations of traditional carboacylation reactions.  We also 
propose a mechanistic cycle for the new reaction that is well supported by experimental data 
detailed in the manuscript.  This work was accomplished in collaboration with Kevin Vickerman, 
a graduate student of the Stanley group, and Jenna Humke, an undergraduate researcher.  Kevin 
Vickerman is responsible for the synthesis of arylboronate esters, and the carboacylation scope 
involving the arylboron compounds and characterization of products formed.  Jenna Humke is 
responsible for assisting in the initial development of reaction conditions, and development of 
procedures to synthesize ortho-allylbenzamides.  The author of this thesis is responsible for the 
synthesis and characterization of all ortho-allylbenzamides, development of reaction conditions, 
scope of ortho-allylbenzamides and characterization of products.  The author of the thesis and 
Kevin Vickerman contributed equally to this published paper. 
 Chapter V discusses general conclusions from the work presented and proposes new 
directions for the continuation of this research in the Stanley lab. 
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 CHAPTER II   
COUPLING CATALYTIC ALKENE HYDROACYLATION AND α-ARYLATION: 
ENANTIOSELECTIVE SYNTHESIS OF HETEROCYCLIC KETONES WITH α-
CHIRAL QUARTERNARY STEREOCENTERS 
Modified from ACS Catalysis 2016, 6, 2673-2680. Copyright ©2016 American Chemical 
Society 
Avipsa Ghosh, James A. Walker Jr., Arkady Ellern, and Levi M. Stanley 
Abstract 
 We report a strategy that combines alkene hydroacylation and enantioselective α-
(hetero)arylation reactions to form a wide variety of nitrogen-containing heterocyclic ketones 
bearing α-chiral quarternary stereogenic centers.  Exo-selective, intramolecular Ni-catalyzed 
hydroacylation of N-homoallylindole- and N-homoallylpyrrole-2-carboxaldehydes from α-
substituted six-membered heterocyclic ketones in up to 95% yield, while N-heterocyclic carbene 
(NHC) catalyzed hydroacylations of N-allylindole- and N-allylpyrrole-2-carboxaldehydes form α-
substituted five-membered heterocyclic ketones in up to 99% yield.  The racemic five- and six-
membered products of Ni- and NHC-catalyzed hydroacylation reactions are readily transformed 
into heterocyclic ketones containing an α-chiral quarternary stereogenic center by enantioselective 
Ni-catalyzed α-arylation and α-(hetero)arylation reactions.  The chiral, nonracemic products 
formed through a combination of alkene hydroacylation and α-(hetero)arylation reactions are 
formed in moderate to high yields (44-99%) with excellent enantioselectivities (typically >95% 
ee).  The identity of the precatalyst for Ni-catalyzed α-(hetero)arylation is dictated by the identity 
of the α-substituted heterocyclic ketone starting material.  α-(Hetero)arylations of six-membered 
heterocyclic ketones occur at 65-85 °C in the presence of a catalyst generated in situ from 
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Ni(COD)2 and (R)-BINAP or (R)-DIFLUORPHOS.  α-(Hetero)arylation of five-membered 
heterocyclic ketones must be conducted at room temperature in the presence of an [((R)-
BINAP)Ni(η2-NC-Ph)] precatalyst or a catalyst generated in situ from Ni(COD)2, (R)-
DIFLUORPHOS, and benzonitrile. 
Introduction 
 Nitrogen-containing heterocycles possessing quarternary stereogenic centers are common 
structural motifs present in biologically active natural products and small molecules.1-12  Despite 
many advances over the past decades, enantioselective synthesis of quarternary stereogenic centers 
remains a significant synthetic challenge.13-21 The composition of current pharmaceutical agents 
provides a snapshot into this challenge. In 2011, 12% of the top 200 prescription drugs sold in the 
United States contained quaternary stereogenic centers.21-22  However, the majority of these 
compounds are synthesized from naturally occurring compounds (steroids, opioids, taxane, and 
diterpenoids) with the natural product precursor providing the quaternary stereogenic centers.21, 23 
Thus, approaches to molecular scaffolds, particularly heterocyclic scaffolds, containing quaternary 
stereogenic centers offer the potential to create and provide access to new classes of biologically 
active compounds. 
 Extensive development over the past decade has rendered palladium- and nickel-catalyzed 
α-arylation of carbonyl enolates a practical strategy to form benzylic quaternary stereogenic 
centers α to a carbonyl group.24  However, the majority of the metal-catalyzed, enantioselective α-
arylation studies have focused on reactions of ketones with carbocyclic backbones25-31 or 
lactones.31-32  Enantioselective α-arylation of nitrogen-containing heterocycles to form benzylic 
quaternary stereogenic centers has been studied to a much lesser extent and is largely limited to 
reactions of oxindoles.33-36  We focused our studies on developing strategies to synthesize indole 
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and pyrrole derivatives containing benzylic quaternary stereogenic centers due to the presence of 
this structural feature in the indole alkaloid haplophytine37-41 and polycyclic indoles with 
antiandrogenic,42 antiarrhythmic,43 and antihypertensive44-45 activities (Figure 1). 
 
Figure 1. Biologically active indole derivatives containing benzylic quarternary stereogenic 
centers 
 
Glorius et al. recently reported a direct method to form cyclic ketones containing α-
quaternary stereogenic centers by chiral N-heterocyclic carbene (NHC)-catalyzed intramolecular 
hydroacylation.46 They reported the formation of chiral, nonracemic five- and six-membered 
carbocyclic ketones and two five-membered nitrogen-containing heterocyclic ketones. However, 
a general strategy that encompasses formation of both five- and six-membered nitrogen-containing 
heterocyclic ketones with α-chiral quaternary stereogenic centers has not been reported. We sought 
to develop a versatile strategy combining intramolecular alkene hydroacylation with 
enantioselective α-arylation to provide access to a wide variety of indole and pyrrole derivatives 
containing benzylic quaternary stereogenic centers. 
Intramolecular hydroacylation of alkenes has emerged as a promising, atom-economical 
transformation to generate a wide variety of carbocyclic and heterocyclic ketones.47-50 These 
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transformations generally occur in the presence of transition-metal or NHC catalysts, and the 
selection of the specific catalyst type determines the regiochemical outcome of the reaction. In 
2014, we reported enantioselective Rh-catalyzed hydroacylations of N-vinylindole-2-
carboxaldehydes to form β-substituted dihydropyrroloindolones51 and N-allylindole- and N-
allylpyrrole-2-carboxaldehydes to form β-substituted dihydropyridoindolones and 
dihydroindolizinones that occur exclusively with endo selectivity.52 We envisioned forming α- 
substituted dihydropyrroloindolones and dihydropyridoindolones by exo-selective Ni- or NHC-
catalyzed intramolecular hydroacylations of N-allyl- and N-homoallylindole-2-carboxaldehydes 
due to the complementary regioselectivity often observed with these types of catalysts.53-65 We 
further hypothesized that these five- and six-membered α-substituted ketones could serve as 
substrates for enantioselective α-arylation reactions to access heterocyclic ketones bearing α- 
chiral quaternary stereocenters. Due to the wide range of carbonyl functionalization reactions, this 
sequence of alkene hydroacylation and α-arylation reactions is poised to serve as a strategic 
approach to the synthesis of chiral heterocycles possessing benzylic quaternary stereocenters.66 
Herein, we report a strategy that combines catalytic alkene hydroacylation and α-arylation 
to generate five- and six-membered nitrogen-containing heterocyclic ketones bearing α-chiral 
quaternary stereocenters (Figure 2). We have identified a Ni(0)-NHC complex that catalyzes exo-
selective hydroacylations of N-homoallylindole-2-carboxaldehydes to form six-membered 
heterocyclic ketones in high yields. This reactivity increases the scope of Ni-catalyzed 
hydroacylation beyond the formation of carbocyclic ketones and is complementary to NHC-
catalyzed hydroacylations which are known to form five-membered nitrogen-containing, α-
substituted heterocyclic ketones in excellent yields.46, 64 Our studies reveal that nitrogen-containing 
five- and six-membered heterocyclic ketones exhibit significantly different reactivity toward Ni-
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catalyzed, enantioselective α-arylations in comparison to previously studied carbocyclic ketones.29 
Finally, we have successfully demonstrated a sequential “one-pot” synthesis of a 
dihydropyridoindolone by exo-selective alkene hydroacylation and enantioselective α-arylation 
reactions using two distinct nickel catalysts. 
 
Figure 2. Coupling catalytic alkene hydroacylation and α-arylation reactions. 
Results and Discussion 
 Exo-Selective Intramolecular Hydroacylation. Initial studies to develop intramolecular, 
exo-selective Ni-catalyzed hydroacylations of N-allylindole-2-carboxaldehydes were guided by 
hydroacylations of 2-allylbenzaldehyde catalyzed by Ni(0) complexes of NHC ligands.60 To test 
whether hydroacylation of N-allylindole-2-carboxaldehyde (1a) could occur under reaction 
conditions similar to those reported for carbocyclic ketone formation, we studied the reaction of 
1a in the presence of catalysts generated in situ from Ni(COD)2 and various NHC ligands at 130 
°C (Table 1, entries 1−4). We found that exo-selective hydroacylation of 1a occurs to form 
dihydropyrroloindolone 2a in low yields (8−34%), with the reaction catalyzed by a Ni complex 
containing the N-adamantylcarbene (IAd) ligand L4 forming the desired product in the highest 
yield. The yield of the model hydroacylation of 1a improved to 60% when the reaction was 
conducted at 165 °C and further to 72% when the reaction occurred in the presence of 15 mol % 
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of the catalyst (Table 1, entries 5 and 6). In contrast, an NHC catalyst, generated in situ from 10 
mol % of 3 and 20 mol % of 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU), led to the formation of 
2a in 97% yield when the reaction was conducted at 60 °C (Table 1, entry 7).67 
Table 1. Identification of Catalysts for Exo-Selective Hydroacylation of N-allyl- and N-
Homoallylindole-2-carboxaldehydea,b 
 
entry 1 precatalyst precatalyst (mol %) ligand temp (°C) Yield (%)c 
1 1a Ni(COD)2 10 L1 130 16 
2 1a Ni(COD)2 10 L2 130 8 
3 1a Ni(COD)2 10 L3 130 9 
4 1a Ni(COD)2 10 L4 130 34(30) 
5 1a Ni(COD)2 10 L4 165 60(60) 
6 1a Ni(COD)2 15 L4 165 72(70) 
7 1a 3 10  60 99(97) 
8 1b Ni(COD)2 5 L4 165 99(95) 
9 1b 3 10  60 30 
aReaction conditions for Ni-catalyzed hydroacylation: 1a,b (0.200 mmol), Ni(COD)2 
(0.010=0.030 mmol), ligand L1-L4 (0.012-0.036 mmol), and mesitylne (1.0 mL). bReaction 
conditions for NHC0catalyzed hydroacylations 1a,b (0.200 mmol), 3 (0.020 mmol), DBU (0.040 
mmol), and 1,4 dioxane (1.0 mL). cYield of 2a or 2b determined by 1H NMR spectroscopy using 
dibromomethane as the internal standard; the isolated yield of 2a or 2b is shown in parentheses. 
 
 In general, the formation of six-membered rings by transition-metal-catalyzed 
intramolecular hydroacylation reactions is challenging in comparison to the formation of five-
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membered rings.68-73 Surprisingly, the Ni-catalyzed hydroacylation of N-homoallylindole-2-
carboxaldehyde (1b) forms the six-membered heterocyclic ketone 2b in 95% yield with only 5 
mol % of Ni catalyst (Table 1, entry 8). However, a catalyst generated in situ from 10 mol % of 3 
and 20 mol % of DBU at 60 °C forms 2b in only 30% yield (Table 1, entry 9). 
Scheme 1. Intramolecular Exo-Selective Ni-Catalyzed Hydroacylationa 
 
aReaction conditions: 1a-l (0.100 mmol), Ni(COD)2 (0.005-0.015 mmol), ligand L4 (0.006-0.018 
mmol), and mesitylene (0.5 mL). Yields of 2 are isolated yields after column chromatography. 
bReaction run in the presence of 15 mol % of Ni(COD)2 and 18 mol % of ligand L4. 
 
With a practical Ni catalyst system in hand, we evaluated the hydroacylations of various 
N-homoallylindole-2-carboxaldehydes containing substitution at the 4-, 5-, and 6-positions on the 
indole backbone (Scheme 1). A variety of N-homoallylindole-2-carboxaldehydes containing 
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electron-donating and electron-withdrawing substituents are excellent substrates for the Ni-
catalyzed exo-selective intramolecular hydroacylations. Hydroacylations of electron-rich 4-MeO-
, 5-Me-, 5-MeO-, and 6-MeO-substituted N-homoallylindole-2-carboxaldehydes occur with 5 mol 
% of Ni catalyst and form dihydropyridoindolones 2c−e,g in 88−92% yields. Hydroacylations of 
electron-deficient 5-F- and 6-CF3-substituted N-homoallylindole-2-carboxaldehydes also form 
dihydropyridoindolones 2f,h in 96% and 75% yields. Intramolecular hydroacylation of N-
homoallylpyrrole-2- carboxaldehyde (1i) forms the product 2i in 80% yield with 15 mol % of Ni 
catalyst. 
 Although substitution at the 4-, 5-, and 6-positions of the indole core is well-tolerated, 
substitution on the double bond of the N-homoallyl moiety had a detrimental effect on Ni-catalyzed 
intramolecular hydroacylation. The hydroacylation of 1-(3-methylbut-3-en-1-yl)-1H-indole-2-
carboxaldehyde (1j) requires 15 mol % of Ni catalyst to form 2j in 75% yield, while the 
hydroacylation of 1-(hex-3-en-1-yl)-1H-indole-2-carboxaldehyde (1k) affords 2k in only 15% 
yield. The hydroacylation of 1-(3-methylbut-3-en-1-yl)-1H-pyrrole-2-carboxaldehyde (1l) 
generated 2l in 20% yield. The formation of six-membered ketones by an exo-selective pathway 
was exclusive; formation of seven-membered ketone products by an endo-selective pathway was 
not observed.  
The results of NHC-catalyzed intramolecular hydroacylations of N-allylindole-2-
carboxaldehyde and N-allylpyrrole-2-carboxaldehydes containing a range of 1-substituted allyl 
units are shown in Scheme 2. Hydroacylations of 1m−p containing phenyl, 4-methoxyphenyl, and 
4-chlorophenyl substituents at the terminal carbon of the allyl unit forms the hydroacylation 
products 2m−p in excellent yields (80−99%). 
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Scheme 2. Intramolecular Exo-Selective NHC-Catalyzed Hydroacylationa 
 
aReaction conditions: 1a,m-p (0.200 mmol), 3 (0.020 mmol), DBU (0.040 mmol), and 1,4-dioxane 
(1.0 mL). Yields of 2 are isolated yields after column chromatography. b24 h reaction time. 
 
α-Arylation of Nitrogen-Containing Six-Membered Heterocyclic Ketones. Initial 
studies to develop catalytic, enantioselective α-arylations of α-methyl dihydropyridoindolones 
were guided by α-arylations of 2-methyl-1-indanones and 2-methyl-1-tetralones catalyzed by a 
Ni(0) complex of BINAP.29 To test the feasibility of nitrogen-containing heterocyclic ketones as 
substrates for α-arylations, we evaluated the reaction of 8-methyl-7,8-dihydropyrido[1,2-a]indol-
9(6H)- one (2b) with 1-chloro-4-(trifluoromethyl)benzene (4a) catalyzed by complexes prepared 
in situ from Ni(COD)2 and a selection of aromatic bisphosphine ligands L5−L8 containing axial 
chiral backbones (Table 2, entries 1−4). At 80 °C, complexes generated in situ from Ni(COD)2 
and ligands L5−L8 catalyzed the formation of α-arylated product 5a in yields ranging from 45 to 
77% with 95−97% ee. However, we found that subtle changes in temperature had a marked 
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influence on the yield of 5a. For example, the yield of 5a increased from 60% to 72% and 99% as 
the temperature of the reaction decreased from 80 to 70 and 65 °C (compare entries 4−6; see the 
Experimental section for additional entries) when the α-arylation of 2b was run in the presence of 
Ni(COD)2 and L8. Lower reaction temperatures likely minimize catalyst inactivation through 
thermal decomposition of the Ni(II) complex formed after oxidative addition of aryl chloride 4a 
(see the Experimental section), which leads to the pronounced influence of temperature on the 
yield of 5a.29, 74  
 
Scheme 3 summarizes the results of α-arylations of 2b with a range of aryl chlorides 
catalyzed by the complex generated in situ from Ni(COD)2 and (R)-BINAP. A variety of electron-
rich, electron-neutral, and electron-deficient aryl chlorides react to generate α-arylated products 
with high yields (75−99%) and excellent enantioselectivities (97−99% ee). Reactions of aryl 
chlorides containing electron-withdrawing groups at the para position and electron-donating 
groups at the meta position form 5a−d in high yields when the reactions are performed at 65 °C. 
The reaction of 2b with methyl 4-chlorobenzoate (4c) is notable, as it generated the tert-butyl ester 
5c as the only α-arylated product, presumably due to complete transesterification in the presence 
of NaOtBu. Reactions of electron-neutral aryl chlorides and aryl chlorides with electron-donating 
groups at the para position and electron-withdrawing groups at the meta position require a reaction 
temperature of 70 °C to form products 5e−i,k in high yields. 2-Chloronaphthalene (4j) also reacted 
with 2b at 70 °C to generate 5j in 95% yield and 99% ee. Although the α-arylation of 2b tolerates 
a range of functional groups on the aryl chloride partners, ortho-substituted aryl chlorides do not 
react under our standard reaction conditions. The α-arylation of dihydroindolizinone 2k with 1-
chloro-3-methoxybenzene formed 5l in 70% yield and 91% ee. 
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The absolute configuration of the quaternary stereocenter in 5d was unambiguously 
determined by X-ray crystallographic analysis to be R (see the Experimental section for details). 
Thus, the catalyst generated from (R)-BINAP leads to the formation of (R)-5d (Figure 3). 
Table 2. Identification of Catalyst for Ni-Catalyzed α-Arylation of Dihydropyridoindolone 
and Dihydroindolizinone with Aryl Chloridesa,b 
 
entry ligand temp (°C) time (h) conversionb (%) yieldc (%) eed (%) 
1 L5 80 48 99 77 95 
2 L6 80 48 99 72 97 
3 L7 80 48 80 45 97 
4 L8 80 48 99 60 97 
5 L8 70 48 99 72 98 
6 L8 65 48 99 99 99 
7 L8 65 24 75 60 98 
aReaction conditions: 2b (0.200 mmol), 4a (0.400 mmol), NaOtBu (0.400 mmol), Ni(COD)2 
(0.020 mol), ligdand L5-L8 (0.024 mmol), and toluene (1.0 mL). bThe conversion of 2b was 
determined by 1H NMR spectroscopy. cIsolated yield after column chromatography. dDetermined 
by chiral HPLC analysis. 
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Scheme 3. Ni-Catalyzed Enantioselective α-Arylation of Dihydropyridoindolone and 
Dihydroindolizinone with Aryl Chloridesa,b 
 
aReaction conditions: 2b,k (0.100 mmol), 4a-k (0.200 mmol), NaOtBu (0.200 mmol), Ni(COD)2 
(0.010 mmol), ligand L8 (0.012 mmol), and toluene (0.5 mL). 
 
α-Heteroarylation of Nitrogen-Containing Six-Membered Heterocyclic Ketones. 
Encouraged by the ability to form α-arylated heterocyclic ketones with indole and pyrrole 
backbones in high yields and enantioselectivities, we evaluated the enantioselective Ni-catalyzed 
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α-heteroarylation of 2b with 2-chloropyridine (6a). The catalyst generated in situ from Ni(COD)2 
and (R)-BINAP (L8) did not yield any α-heteroarylated product, with >95% recovery of 2b after 
48 h. However, the complex generated in situ from Ni(COD)2 and (R)-DIFLUORPHOS (L7) at 
80 °C catalyzed the formation of α-heteroarylated product 7a in 72% isolated yield and 99% ee 
(Scheme 4). 
 
Figure 3. Determination of the absolute stereochemistry of 5d by X-ray crystallographic analysis. 
 
 Scheme 4 summarizes the results of α-heteroarylation reactions of 2b with a range 
of 2-chloropyridines containing electron-donating and electron-withdrawing substituents at the 4-
, 5-, and 6-positions of the pyridine ring, as well as with 5- chloro-2-(trifluoromethyl)pyridine and 
3-chlorothiophene. Ni-catalyzed α-heteroarylation of 2b with 2-chloro-5-fluoropyridine forms the 
heteroarylated ketone 7b in 82% yield with 98% ee. α-Heteroarylation of 2b with electron-
deficient heteroaryl chlorides, 6-chloronicotinonitrile (6c) and 2-chloro-5- 
(trifluoromethyl)pyridine (6d) generated the heteroarylated products 7c,d in 93% and 55% yield, 
but the enantioselectivities were poor (29−65% ee). The decrease in enantioselectivity results from 
uncatalyzed nucleophilic aromatic substitution of these electron-deficient heteroaryl chlorides by 
the sodium enolate of 2b. Additions of 2b to 6c,d at 85 °C in the absence of catalyst formed the α-
arylated products 7c,d in 42% and 22% yields by 1H NMR analysis. 
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Scheme 4. Ni-Catalyzed Enantioselective α-Heteroarylation of Dihydropyridoindolone with 
Heteroaryl Chloridesa,b 
 
aReaction conditions: 2b (0.100 mmol), 6a-I (0.200 mmol), NaOtBu (0.200 mmol), Ni(COD)2 
(0.010 mmol), ligand L7 (0.012 mmol), and toluene (0.5 mL). bYields of 7 are isolated yields after 
column chromatography; enantiomeric excesses of 7 were determined by chiral HPLC analysis. 
cReaction run at 80 °C. 
 
 α-Heteroarylation of 2b with the electron-rich heteroaryl chlorides 2-chloro-4-
methoxypyridine, 2-chloro-6-methylpyridine, and 2-chloro-6-methoxypyridine formed the α-
heteroarylated ketones 7e−g in moderate to good yields (50−75%) with moderate to high 
enantioselectivities (75−95%). 5-Chloro-2-(trifluoromethyl)pyridine and 3-chlorothiophene 
proved to be excellent substrates for α-heteroarylation of 2b. Reactions of these heteroaryl 
chlorides formed 7h,i in high yields (80−92%) with excellent enantioselectivities (94−99%). 
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α-Arylation of Nitrogen-Containing Five-Membered Heterocyclic Ketones. The ability 
to form a range of dihydropyridoindolones with α-chiral quaternary stereocenters in high yield 
with excellent stereocontrol led us to investigate Ni-catalyzed α-arylation reactions of five-
membered heterocyclic ketones. Surprisingly, α-arylation of 2a with chlorobenzene at 70 °C in the 
presence of a catalyst generated in situ from Ni(COD)2 and (R)-BINAP (L8) formed the α-arylated 
product 9a in only 19% yield, while the analogous reaction with 1-chloro-3-methoxybenzene at 
65 °C generated a 5% yield of the coupled product 9b (Scheme 5a). The poor yields observed in 
α-arylations of dihydropyrroloindolone 2a may result from decomposition of the [L8]Ni(Ar)(Cl) 
intermediate formed after oxidative addition becoming competitive with the productive reaction 
pathway at elevated temperatures. To test the plausibility of this hypothesis, we performed the α-
arylation of 2a in the presence of a single-component [L8]Ni(η2 -NC-Ph) precatalyst that is known 
to oxidatively add aryl halides at 25 °C and attenuate decomposition of the oxidative addition 
product [L8]Ni(Ar)(Cl).29, 74-75 The reactions of 2a with chlorobenzene and bromobenzene formed 
9a in 38% and 47% yields, respectively, when the reactions were performed at 25 °C in the 
presence of 10 mol % of [L8]Ni(η2 -NC-Ph) (Scheme 5b). 
α-Arylations of dihydropyrroloindolone 2a occurred in the highest yields when they were 
performed at 25 °C in the presence of 15 mol % of [L8]Ni(η2 -NC-Ph) (Scheme 6). α-Arylations 
of 2a with bromobenzene, 3-methoxybromobenzene, and 4-(trifluoromethyl)bromobenzene 
formed 9a−c in 44−78% yield and 99% ee. 
The identification of a catalyst system enabling the synthesis of dihydropyrroloindolones 
with α-chiral quaternary stereocenters by enantioselective α-arylation led us to investigate the 
analogous α-arylations of 2-methyl-2,3-dihydro-1H-pyrrolizin- 1-one (2m). Aryl bromides with 
electron-deficient groups at the meta and para positions (−F, −CF3) and an electron-donating group 
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(−OMe) at the meta position reacted with 2m in the presence of 10 mol % of [L8]Ni(η2 -NC-Ph) 
to form the α-arylated ketones 9d−h in high yields (80−99%) with excellent enantioselectivities 
(98−99%). The α-arylation of 2m with p-bromoanisole occurred with high enantioselectivity but 
formed product 9i in 52% yield. 2-Bromonaphthalene also reacted with 2m to form 9j in 96% 
yield and 99% ee. 
Scheme 5. Reactivity of Dihydropyrroloindolone 2a with Aryl Halides in Ni-Catalyzed α-
Arylationsa,b 
 
aReaction conditions: 2a (0.200 mmol), 4d,k and 8a (0.400 mmol), NaOtBu (0.400 mmol), 
Ni(COD)2 (0.020 mmol), ligand L8 (0.024 mmol), [L8]Ni(η2-NC-Ph) (0.020 mmol), and toluene 
(1.0 mL). bYields of 9a are isolated yields after column chromatography. 
 
This methodology can also be applied to heterocyclic ketones containing α-substitution 
beyond a methyl group. These reactions form α-arylated products in high yield and high 
enantioselectivity. As shown in Scheme 6, dihydropyrrolizinones 2n−p with substituted and 
unsubstituted benzyl groups at the α-position reacted with bromobenzene in the presence of 10 
mol % of [L8]Ni(η2 -NC-Ph) to form α-arylated ketones 9k−m in 69−91% yield and 99% ee. The 
chemoselectivity of the α-arylation is highlighted by the reaction of dihydropyrrolizinone 2p (R = 
4-ClC6H4CH2). Dihydropyrrolizinone 2p reacted exclusively with bromobenzene to form α-
arylated ketone 9m in high yield and ee. 
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α-Heteroarylation of Nitrogen-Containing Five-Membered Heterocyclic Ketones. 
After successfully demonstrating α-arylations of dihydropyrrolizinones with aryl bromides in the 
presence of the benzonitrile-ligated Ni(0)-L8 complex, we sought to identify the benzonitrile-
ligated Ni(0)-L7 complex to enable the formation of α-heteroarylated derivatives. We conducted 
α-heteroarylations of dihydropyrrolizinone 2m with various heteroaryl bromides in the presence 
of a catalyst generated in situ from 10 mol % of Ni(COD)2, 12 mol % of ligand L7, and 2 equiv of 
benzonitrile (Scheme 7). Dihydropyrrolizinone 2m reacts with 2-bromopyridine to form the α-
heteroarylated product 11a in 99% isolated yield and 97% ee. Reactions of 5- and 6-substituted-
2-bromopyridines with 2m generated α-heteroarylated ketones 11b−d in 48−71% yield with 95% 
ee. However, the α-heteroarylation of 2m with 6-bromonicotinonitrile was unproductive and the 
corresponding ketone 11e was not observed under our reaction conditions. The reaction of 5-
bromo-2-(trifluoromethyl)- pyridine with 2m formed 11f in low yield, but the enantioselectivity 
of the α-heteroarylation remained high (92% ee). 
A One-Pot Sequential Alkene Hydroacylation and α- Arylation Process. One-pot 
multicatalytic transformations are attractive processes for sustainable chemical synthesis because 
these processes improve efficiency and eliminate waste and labor associated with the isolation and 
purification of intermediate products. However, these processes are often challenging to achieve 
due to the incompatibility of catalysts, reagents, and solvents employed in each step.76-77 
 To test the feasibility of Ni(0)/IAd-catalyzed exo-selective intramolecular alkene 
hydroacylation and enantioselective Ni(0)/(R)-BINAP-catalyzed α-arylation reactions in a single 
pot, we conducted a series of sequential reactions involving hydroacylation of N-homoallylindole-
2-carboxaldehyde (1b) and α-arylation of the resulting ketone 2b with 1-chloro-3- 
methoxybenzene (see the Experimental section). In a typical sequence, Ni(COD)2, (R)-BINAP, 
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NaOtBu, 1-chloro-3-methoxybenzene, and toluene were added to the reaction mixture under a 
nitrogen atmosphere upon completion of the hydroacylation reaction. The enantioselectivity of 
these sequential reactions was high (>95% ee), but the yield of α-arylated ketone 5d was low 
(30−40%). However, the yield of the sequential hydroacylation and α-arylation could be improved 
significantly by exposing the reaction mixture to air for 5−10 min before addition of the reagents 
for α-arylation and increasing the catalyst loading to 20 mol %. Under these conditions, the one-
pot, sequential hydroacylation and α-arylation generated ketone 5d in 70% yield and 98% ee 
(Scheme 8). 
Scheme 6. Ni-Catalyzed Enantioselective α-Arylation of Dihydropyrroloindolone and 
Dihydropyrrolizinones with Aryl Bromidesa 
 
aReaction conditions: 2a,m-p (0.200 mmol), 8a-g (0.400 mmol), NaOtBu (0.400 mmol), 
[L8]Ni(η2-NC-Ph) (0.020-0.030 mmol), and toluene (1.0 mL). Yields of 9 are isolated yields after 
column chromatography; enantiomeric excesses of 9 were determined by chiral HPLC analysis. 
bReaction run in the presence of 15 mol% of catalyst. cReaction run at 10 °C. 
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Scheme 7. Ni-Catalyzed Enantioselective α-Heteroarylation of Dihydropyrrolizinone with 
Heteroaryl Bromidesa,b 
 
aReaction conditions: 2m (0.200 mmol), 10a-f (0.400 mmol), NaOtBu (0.400 mmol), Ni(COD)2, 
ligand L7 (0.024 mmol), benzonitrile (0.400 mmol), and toluene (1.0 mL). bYields of 11 are 
isolated yields after column chromatography; enantiomeric excesses of 11 were determined by 
chiral HPLC analysis. 
 
Scheme 8. One-Pot Sequential Hydroacylation and α-Arylation Reactiona,b 
 
aReaction conditions: 1b (0.100 mmol), Ni(COD)2 (0.005 mmol), IAd (0.006 mmol), and 
mesitylene (0.5 mL); 4d (0.200 mmol), NaOtBu (0.200 mmol), Ni(COD)2 (0.020 mmol), ligand 
L8 (0.024 mmol), and toluene (0.5 mL). bThe yield of 5d is the isolated yield after column 
chromatography; the enantiomeric excess of 5d was determined by chiral HPLC analysis. 
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Conclusions 
 In summary, we have developed a convenient catalytic strategy that combines alkene 
hydroacylation and enantioselective α-(hetero)arylation reactions to form a wide variety of five- 
and six-membered nitrogen-containing heterocyclic ketones bearing nonracemic, α-chiral 
quaternary stereocenters. The potential to further functionalize the remaining carbonyl moiety 
makes this sequential reaction an attractive strategy to access a wide range of complex chiral 
heterocycles having benzylic quaternary stereocenters. This sequential alkene hydroacylation/α-
arylation protocol can also be performed in a one-pot procedure with good yield and high 
enantioselectivity. 
 The intramolecular Ni-catalyzed hydroacylations proceed with complete exo selectivity to 
form the six-membered nitrogen-containing heterocyclic ketones in moderate to high yields from 
various indole and pyrrole substrates, while NHC-catalyzed hydroacylations of N-allylindoles and 
N-allylpyrroles occur with exo selectivity to form α-substituted five-membered heterocyclic 
ketones in high yields. The five- and six-membered nitrogen-containing heterocyclic ketones 
formed by hydroacylation reactions are convenient substrates for Ni-catalyzed α-(hetero)arylation 
reactions that occur in moderate to high yields with excellent enantioselectivities. The six-
membered heterocyclic ketones react with (hetero)aryl chlorides in the presence of catalyst 
complex generated in situ from Ni(COD)2 and (R)-BINAP or (R)-DIFLUORPHOS at 65−85 °C, 
while reactions of five-membered heterocyclic ketones demand milder reaction conditions to form 
the desired coupling products with chiral quaternary stereocenters in moderate to high yields. 
Studies to develop additional tandem and sequential processes that combine olefin hydroacylation 
reactions with additional catalytic transformations are ongoing in our laboratory. 
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Experimental  
General synthetic details. All air-sensitive procedures were conducted under inert 
atmosphere in a nitrogen-filled dry box or by standard Schlenk techniques. All reactions were 
performed under an atmosphere of nitrogen unless otherwise stated. All glassware for moisture 
sensitive reactions was dried at 140 °C in an oven. Toluene and N,N-dimethylformamide, 
tetrahydrofuran were degassed by purging with argon for 45 minutes and dried with a solvent 
purification system by passing through a one-meter column of activated alumina. Anhydrous 1,4-
dioxane was purchased from Sigma-Aldrich and used as received. Mesitylene was purchased from 
Sigma-Aldrich and was freshly distilled from sodium benzophenone ketyl under vacuum. Flash 
column chromatography was performed on SiliFlash® P60 silica gel (40-63μm, 60Å) or using a 
Teledyne Isco Combiflash® Rf system with RediSep GoldTM columns using hexanes/ethyl 
acetate, hexanes/diethyl ether, hexanes/dichloromethane mixtures. Reaction products were 
visualized on TLC by UV light or by staining with KMnO4 or 2,4-dinitro-phenylhydrazine. 
Instrumentation. HRMS (ESI) analysis was performed at the Iowa State University Chemical 
Instrumentation Facility on an Agilent 6540 QTOF spectrometer. Optical rotations were measured 
on an Atago AP-300 automatic polarimeter.  HPLC analyses were carried out on a Water Alliance 
HPLC system with an e2695 Separations Module and a 2489 (UV/Vis) dual wavelength detector.  
NMR spectra were acquired on Varian MR-400, Bruker DRX-400 and Bruker Avance III 600 
spectrometers at the Iowa State University Chemical Instrumentation Facility. Chemical shifts are 
reported in ppm relative to a residual solvent peak (CDCl3 = 7.26 ppm for 
1H and 77.36 ppm for 
13C; DMSO-d6 = 2.50 for 
1H and 39.52 for 13C). 19F NMR shifts are reported in ppm relative to 
trifluoroacetic acid as an external standard (F3CCO2H = -76.55 ppm). Coupling constants are 
reported in hertz.  
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Materials. 5-Methylindole-2-carboxaldehyde, 5-methoxyindole-2-carboxaldehyde, and 6-
methoxyindole-2-carboxaldehyde were synthesized according to reported literature procedures.78-
82 4-Methoxyindole-2-carboxaldehyde and 6-trifluoromethylindole-2-carboxaldehyde were 
synthesized according to the known literature procedure.82-84 5-Fluoroindole-2-carboxaldehyde 
was synthesized according to a literature procedure.82, 85 Indole-2-carboxaldehyde was synthesized 
from ethyl indole-2-carboxylate according to a known literature procedure.82 Ethyl indole-2-
carboxylate, 4-bromobut-1-ene S2a and pyrrole-2-carboxaldehyde S1h were purchased from AK 
Scientific and used without further purification. 3-Methylbut-3-en-1-ol, (E)-hex-3-en-1-ol, allyl 
bromide, cinnamyl bromide, activated manganese dioxide, sodium tert-butoxide, lithium 
aluminum hydride, benzonitrile, anhydrous 1,4-dioxane, 1,8-diazabicyclo[5.4.0]undec-7-ene 
(DBU) were purchased from Sigma-Aldrich and used without further purification. 4-bromo-2-
methylbut-1-ene S2b was synthesized from 3-methylbut-3-en-1-ol according to a known literature 
procedure.86 (E)-Hex-3-en-1-yl 4-methylbenzenesulfonate S2c was synthesized from (E)-hex-3-
en-1-ol according to a known literature procedure.87 Substituted cinnamyl bromides S2d and S2e 
were synthesized according to the known literature procedure.78, 88-89 1a, 1m, 1n were synthesized 
according to the known literature procedure.82 Organocatalyst 3 was synthesized according to the 
known literature procedure.90 IAd, ItBu, IMes, IPr were synthesized according to the known 
literature procedure.91-92 Aryl chlorides 4a, 4c, 4e-f, 4j, heteroaryl chlorides 6b, 6e-h were 
purchased from Combi-blocks and used without further purification. Aryl chloride 4g, heteroaryl 
chlorides 6c-d, aryl bromides 8a-f and heteroaryl bromides 10a-f were purchased from AK 
scientific and used without further purification. Aryl chloride 4d, heteroaryl chloride 6i were 
purchased from TCI America and used without further purification. Aryl chloride 4i and aryl 
bromide 8g were purchased from Alfa Aesar and used without further purification. Aryl chloride 
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4h was purchased from Oakwood Chemicals and used without further purification. Aryl chloride 
4k and heteroaryl chloride 6a were purchased from Sigma-Aldrich and used without further 
purification. Aryl chloride 4b was purchased from Acros Organics and used without further 
purification. Ni(COD)2, (R)-BINAP, rac-BINAP, (R)-SEGPHOS, (R)-xylyl-BINAP, (S)-
DIFLUORPHOS, (R)-DIFLUORPHOS, (R)-CTH-P-PHOS were purchased from Strem 
Chemicals and used without further purification. [(R)-BINAP]Ni(ƞ2-NC-Ph) was synthesized 
according to the known literature procedure.93 
General Procedure A: Synthesis of N-Homoallylindole-2-carboxaldehydes (1b-h, 1j-k) and 
N-Homoallylpyrrole-2-carboxaldehydes (1i, 1l)        
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N-Homoallylindole-2-carboxaldehydes (1b-h, 1j-k) and N-homoallylpyrrole-2-
carboxaldehydes (1i, 1l) were prepared from the appropriate homoallyl bromides or tosylates (S2a-
c) and indole- and pyrrole-2-carboxaldehydes (S1a-h). To the appropriate indole-2-
carboxaldehyde (S1a-g) or pyrrole-2-carboxaldehyde S1h (1.0 equiv) and Cs2CO3 (1.2 equiv) was 
added DMF (0.27 M S1). The resulting mixture was stirred at room temperature for 0.5 h. The 
appropriate homoallylic bromide or tosylate S2 (1.2 equiv) was added dropwise. The mixture was 
heated to 90 °C and stirred at the same temperature for 24 h. The reaction mixture was cooled to 
room temperature, quenched with water, and the resulting solution was extracted with EtOAc (3x). 
The combined organic layers were washed with water, washed with brine, dried over Mg2SO4, and 
concentrated under reduced pressure. The crude product was purified by flash column 
chromatography on silica gel (hexane:EtOAc) to give the appropriate N-homoallylindole-2-
carboxaldehyde (1b-h, 1j-k) or N-homoallylpyrrole-2-carboxaldehyde (1i, 1l). 
General Procedure B: Synthesis of 1-Cinnamyl-1H-pyrrole-2-carboxaldehydes (1o-p)       
 
 
 
1-Cinnamyl-1H-pyrrole-2-carboxaldehydes (1o-p) were prepared according to a modified 
literature procedure from the appropriate cinnamyl bromides (S2d-e) and pyrrole-2-
carboxaldehyde (S1h).82  To the pyrrole-2-carboxaldehyde (1.0 equiv) and Cs2CO3 (1.2 equiv) was 
added DMF (0.27 M S1h).  The resulting mixture was stirred at room temperature for 0.5 h.  The 
appropriate cinnamyl bromide (1.2 equiv) was added dropwise.  The mixture was stirred at room 
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temperature until the reaction was judged to be complete by thin-layer chromatography. Water 
was added to the reaction mixture and the resulting solution was extracted with EtOAc (3x). The 
combined organic layers were washed with water, brine, dried over Na2SO4, and concentrated 
under reduced pressure. The crude product was purified by flash column chromatography on silica 
gel (hexane:EtOAc) to give the appropriate 1-cinnamyl-1H-pyrrole-2-carboxaldehydes (1o-p). 
 1-(But-3-en-1-yl)-1H-indole-2-carboxaldehyde (1b): Prepared according to 
the general procedure A from S1b (3.00 g, 20.7 mmol) and S2a (3.35 g, 24.8 
mmol). The mixture was purified by flash column chromatography (95:5 
hexane:EtOAc) to give 1b as a light yellow solid in 62% yield (2.55 g, 12.8 mmol). 1H NMR (400 
MHz, CDCl3) δ 2.36 (dt, J = 7.2, 7.2 Hz, 2H), 4.43  (t, J = 7.2 Hz, 2H), 4.82 – 4.89 (m, 2H), 5.65 
(ddt, J = 17.0, 10.2, 7.2 Hz, 1H), 6.99 – 7.04 (m, 2H), 7.23 – 7.24 (m, 2H), 7.55 (dd, J = 8.1, 0.8 
Hz, 1H), 9.69 (s, 1H). 13C NMR (101 MHz, CDCl3) δ 35.0, 44.2, 110.9, 117.4, 118.1, 121.0, 123.6, 
126.5, 127.0, 134.7, 135.4, 140.3, 182.6. HRMS (ESI): Calcd. for C13H14NO
+ ([M+H]+): 
200.1070, Found: 200.1068. 
 
 1-(But-3-en-1-yl)-4-methoxy-1H-indole-2-carboxaldehyde (1c): Prepared 
according to the general procedure A from S1b (0.258 g, 1.47 mmol) and S2a 
(0.239 g, 1.77 mmol).  The mixture was purified by column chromatography 
(90:10 hexane:EtOAc) to give 1c as yellow oil in 34% yield (0.115 g, 0.502 mmol). 1H NMR (400 
MHz, CDCl3)  2.53 (dt, J = 7.3, 7.3 Hz, 2H), 3.96 (s, 3H), 4.58 (t, J = 7.3 Hz, 2H), 4.97 – 5.05 
(m, 2H), 5.81 (ddt, J = 17.1, 10.2, 7.3 Hz, 1H), 6.50 (d, J = 8.0 Hz, 1H), 6.98 (d, J = 8.0 Hz, 1H), 
7.32 (t, J = 8.0 Hz, 1H), 7.35 (d, J = 0.8 Hz, 1H), 9.80 (s, 1H). 13C NMR (101 MHz, CDCl3)  
35.1, 44.7, 55.6, 99.9, 103.7, 116.1, 117.5, 118.4, 128.4, 134.6, 134.9, 141.9, 155.4, 182.3. HRMS 
(ESI) Calcd. for C14H16NO2
+ ([M+H]+): 230.1176, Found: 230.1179. 
40 
 
 
 1-(But-3-en-1-yl)-5-methyl-1H-indole-2-carboxaldehyde (1d): 
Prepared according to the general procedure A from S1c (0.242 g, 1.52 
mmol) and S2a (0.246 g, 1.82 mmol). The mixture was purified by flash 
column chromatography (95:5 hexane: EtOAc) to give 1d as a light yellow oil in 59% yield (0.191 
g, 0.895 mmol). 1H NMR (400 MHz, CDCl3) δ 2.48 (s, 3H), 2.55 (dt, J = 7.2, 7.2 Hz, 2H), 4.62 
(t, J = 7.2 Hz, 2H), 4.99 – 5.08 (m, 2H), 5.83 (ddt, J = 17.1, 10.2, 7.2 Hz, 1H), 7.19 (d, J = 0.64 
Hz, 1H), 7.26 – 7.28 (m, 1H), 7.34 (d, J = 8.6 Hz, 1H), 7.52 – 7.53 (m, 1H), 9.87 (s, 1H). 13C 
NMR (101 MHz, CDCl3) δ 21.6, 35.2, 44.5, 110.7, 117.5, 117.7, 122.9, 126.9, 129.3, 130.6, 135.0, 
135.6, 139.1, 182.8. HRMS (ESI): Calcd. for C14H16NO
+ ([M+H]+): 214.1226, Found: 214.1225. 
 
 1-(But-3-en-1-yl)-5-methoxy-1H-indole-2-carboxaldehyde (1e): 
Prepared according to the general procedure A from S1d (0.343 g, 1.96 
mmol) and S2a (0.317 g, 2.35 mmol). The mixture was purified by flash 
column chromatography (90:10 hexanes:EtOAc) to give 1e as yellow solid in 60% yield (0.270 g, 
1.18 mmol). 1H NMR (400 MHz, CDCl3) δ 2.49 (dt, J = 7.0, 7.0 Hz, 2H), 3.82 (s, 3H), 4.54 (t, J 
= 7.0 Hz, 2H), 4.95 – 5.01 (m, 2H), 5.71 – 5.82 (m, 1H), 7.05 – 7.11 (m, 3H), 7.27 (d, J = 9.0 Hz, 
1H), 9.80 (s, 1H). 13C NMR (101 MHz, CDCl3) δ 35.1, 44.4, 55.8, 102.8, 111.9, 117.2, 117.5, 
119.2, 126.8, 134.8, 135.6, 136.1, 154.9, 182.5. HRMS (ESI) Calcd. for C14H16NO2+ ([M+H]+): 
230.1176, Found: 230.1176. 
 
 1-(But-3-en-1-yl)-5-fluoro-1H-indole-2-carboxaldehyde (1f): Prepared 
according to the general procedure A from S1e (0.136 g, 0.834 mmol) and 
S2a (0.135 g, 1.00 mmol).  The mixture was purified by column 
chromatography (95:5 hexanes:EtOAc) to give 1f as yellow oil in 55% yield (0.100 g, 0.460 
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mmol). 1H NMR (400 MHz, CDCl3)  2.52 (dt, J = 7.2, 7.2 Hz, 2H), 4.60 (t, J = 7.2 Hz, 2H), 4.97 
- 5.03 (m, 2H), 5.78 (ddt, J = 17.1, 10.2, 7.2 Hz, 1H), 7.17 (ddd, J = 9.1, 9.1, 2.5 Hz, 1H), 7.22 (s, 
1H), 7.34 - 7.37 (m, 2H), 9.87 (s, 1H). 13C NMR (101 MHz, CDCl3)  35.2, 44.7, 107.6 (d, J = 
23.2 Hz, 1C), 112.1 (d, J = 9.1 Hz, 1C), 116.4 (d, J = 27.3 Hz, 1C), 117.5 (d, J = 6.1 Hz, 1C), 
117.8, 126.6 (d, J = 10.3 Hz, 1C), 134.7, 136.6, 137.2, 158.4 (d, J = 239.4 Hz, 1C), 182.9. 19F 
NMR (CDCl3, 376 MHz): δ -122.8 (m, 1F). HRMS (ESI) Calcd. for C13H13FNO+ ([M+H]+):  
218.0976, Found: 218.0970. 
 
 1-(But-3-en-1-yl)-6-methoxy-1H-indole-2-carboxaldehyde (1g): 
Prepared according to the general procedure A from S1f (0.283 g, 1.62 
mmol) and S2a (0.262 g, 1.94 mmol). The mixture was purified by flash 
column chromatography (90:10 hexane:EtOAc) to give 1g as a dark yellow oil in 57% yield (0.211 
g, 0.920 mmol). 1H NMR (400 MHz, CDCl3)  δ 2.53 (dt, J = 7.2, 7.2 Hz, 2H), 3.89 (s, 3H), 4.56 
(t, J = 7.2 Hz,  2H), 4.99 – 5.07 (m, 2H), 5.82 (ddt, J = 17.1, 10.2, 7.2 Hz, 1H), 6.73 (m, 1H), 6.83 
(dd, J = 8.8, 2.2 Hz, 1H), 7.16 (s, 1H), 7.58 (d, J = 8.8 Hz, 1H), 9.73 (s, 1H). 13C NMR (101 MHz, 
CDCl3) δ 34.9, 44.4, 55.8, 92.3, 113.0, 117.5, 119.0, 121.2, 124.6, 135.0, 135.2, 141.9, 160.3, 
181.6. HRMS (ESI) Calcd. for C14H16NO2
+ ([M+H]+): 230.1176, Found: 230.1174. 
 
 1-(But-3-en-1-yl)-6-(trifluoromethyl)-1H-indole-2-carboxaldehyde 
(1h): Prepared according to the general procedure A from S1g (0.512 g, 
2.40 mmol) and S2a (0.389 g, 2.88 mmol).  The mixture was purified by 
column chromatography (90:10 hexanes:EtOAc) to give 1h as yellow oil in 17% yield (0.110 g, 
0.412 mmol). 1H NMR (400 MHz, CDCl3)  2.55 (dt, J = 7.2, 7.2 Hz, 2H), 4.66 (t, J = 7.2 Hz, 
2H), 4.99 - 5.04 (m, 2H), 5.79 (ddt, J = 17.1, 10.2, 7.2 Hz, 1H), 7.31 (m, 1H), 7.39 (dd, J = 8.4, 
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1.0 Hz, 1H), 7.70 (s, 1H), 7.84 (d, J = 8.4 Hz, 1H), 9.94 (s, 1H). 13C NMR (101 MHz, CDCl3)  
35.2, 44.8, 108.8 (q, J = 4.0 Hz, 1C), 117.4, 117.6 (q, J = 3.0 Hz, 1C), 118.1, 124.5, 124.9 (q, J = 
272.7 Hz, 1C), 128.6, 128.9, 134.4, 137.4, 139.2, 183.1. 19F NMR (CDCl3, 376 MHz): δ -61.2. 
HRMS (ESI) Calcd C14H13F3NO
+ ([M+H]+): 268.0944, Found: 268.0948. 
 1-(But-3-en-1-yl)-1H-pyrrole-2-carboxaldehyde (1i): Prepared according to the 
general procedure A from S1h (0.539 g, 5.67 mmol) and S2a (0.918 g, 6.80 mmol). 
The mixture was purified by flash column chromatography (90:10 hexane:EtOAc) 
to give 1k as a green oil in 57% yield (0.480 g, 3.22 mmol). 1H NMR (400 MHz, CDCl3) δ 2.47 
(dt, J = 7.0, 7.0 Hz, 2H), 4.34 (t, J = 7.0 Hz, 2H), 4.97 (s, 1H), 5.00 – 5.02 (m, 1H), 5.71 (ddt, J = 
17.6, 9.6, 7.0 Hz, 1H), 6.17 (dd, J = 3.6, 2.6 Hz, 1H), 6.89 – 6.90 (m, 2H), 9.51 (s, 1H). 13C NMR 
(101 MHz, CDCl3) δ 35.8, 48.8, 109.6, 117.7, 125.1, 131.4, 131.6, 134.4, 179.4. HRMS (ESI) 
Calcd C9H12NO
+ ([M+H]+): 150.0913, Found: 150.0915. 
 
 1-(3-Methylbut-3-en-1-yl)-1H-indole-2-carboxaldehyde (1j): Prepared 
according to the general procedure A from S1a (0.500 g, 3.44 mmol) and 17% 
solution of S2b (3.620 g, 4.13 mmol) in THF. The mixture was purified by flash 
column chromatography (90:10 hexane:EtOAc) to give 1i  as a light yellow solid in 30% yield 
(0.220 g, 1.03 mmol). 1H NMR (400 MHz, CDCl3) δ 1.85 (s, 3H), 2.47 (t, J = 7.8 Hz, 2H), 4.67 
(t, J = 7.8 Hz, 2H), 4.72 (s, 1H), 4.81 (s, 1H), 7.17 – 7.21 (m, 1H), 7.25 (s, 1H), 7.42 (d, J = 4.2 
Hz, 2H), 7.75 (dd, J = 8.2, 0.8 Hz, 1H), 9.89 (s, 1H). 13C NMR (101 MHz, CDCl3) δ 22.9, 38.6, 
43.8, 110.8, 112.6, 118.1, 121.1, 123.7, 126.7, 127.1, 135.5, 140.3, 142.7, 182.7. HRMS (ESI): 
Calcd. for C14H16NO
+ ([M+H]+): 214.1226, Found: 214.1226. 
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 (E)-1-(Hex-3-en-1-yl)-1H-indole-2-carboxaldehyde (1k): Prepared 
according to the general procedure A from S1a (1.000 g, 6.89 mmol) and 
S2c (2.100 g, 8.27 mmol). The mixture was purified by flash column 
chromatography (90:10 hexane:EtOAc) to give 1j as a dark yellow oil in 
91% yield (1.43 g, 6.290 mmol) as a 6:1 mixture of 1j and its isomer. 1H NMR (400 MHz, CDCl3) 
δ 0.88 (t, J = 7.4 Hz, 3H), 1.89 – 1.96 (m, 2H), 2.44 – 2.49 (m, 2H), 4.56 (t, J = 7.2 Hz, 2H), 5.39 
- 5.42 (m, 2H), 7.15 – 7.18 (m, 1H), 7.11  (s, 1H), 7.30 - 7.32 (m, 2H), 7.63 (ddd, J = 8.2, 1.0, 1.0 
Hz, 1H), 9.78 (s, 1H). 13C NMR (101 MHz, CDCl3) δ 13.6, 25.6, 33.8, 44.7, 111.0, 117.9, 120.9, 
123.5, 124.9, 126.5, 126.8, 135.0, 135.4, 140.4, 182.5. HRMS (ESI) Calcd C15H18NO+ ([M+H]+): 
228.1383, Found: 228.1386. 
 
   1-(3-Methylbut-3-en-1-yl)-1H-pyrrole-2-carboxaldehyde (1l): Prepared 
according to the general procedure A from S1h (1.000 g, 10.52 mmol) and 17% 
solution of S2b (11.06 g, 12.62 mmol) in THF. The mixture was purified by flash 
column chromatography (90:10 hexane:EtOAc) to give 1l as a dark yellow oil in 43% yield (0.733 
g, 4.49 mmol). 1H NMR (400 MHz, CDCl3) δ 1.71 (s, 3H), 2.41 (t, J = 7.4 Hz, 2H), 4.38 (t, J = 
7.4 Hz, 2H), 4.61 (m, 1H), 4.73 (m, 1H), 6.16 (dd, J = 4.0, 2.6 Hz, 1H), 6.87 – 6.89 (m, 2H), 9.50 
(d, J = 1.0 Hz, 1H). 13C NMR (101 MHz, CDCl3) δ 22.5, 39.6, 47.9, 109.6, 112.7, 125.0, 131.3, 
131.5, 142.1, 179.3. HRMS (ESI) Calcd C10H14NO
+ ([M+H]+): 164.1070, Found: 164.1074. 
 
 (E)-1-(3-(4-Methoxyphenyl)allyl)-1H-pyrrole-2-carboxaldehyde 
(1o): Prepared according to the general procedure B from S1h (0.156 g, 
1.65 mmol) and S2d (0.451 g, 1.98 mmol).  The mixture was purified by 
flash column chromatography (90:10 hexane:EtOAc gradient) to give the 1o as a white solid in 
39% yield (0.155 g, 0.643 mmol).  1H NMR (400 MHz, CDCl3)  3.80 (s, 3H), 5.10 (dd, J = 6.4, 
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1.0 Hz, 2H), 6.19 (ddd, J = 15.8, 6.4, 6.4 Hz, 1H), 6.26 (dd, J = 4.0, 2.6 Hz, 1H), 6.43 (d, J = 15.8 
Hz, 1H), 6.83 (d, J = 8.8 Hz, 2H), 6.96 (dd, J = 4.0, 1.7 Hz, 1H), 7.03 (m, 1H), 7.28 (d, J = 8.8 Hz, 
2H), 9.57 (s, 1H).  13C NMR (101 MHz CDCl3)  51.0, 55.6, 110.3, 114.3, 123.1, 125.1, 128.1, 
129.3, 131.2, 131.7, 132.8, 158.8, 179.8. HRMS (ESI): Calcd. for C15H16NO2
+ ([M+H]+): 
242.1176, found 242.1179. 
 
 (E)-1-(3-(4-Chlorophenyl)allyl)-1H-pyrrole-2-carboxaldehyde (1p): 
Prepared according to the general procedure B from S1h (0.200 g, 2.10 
mmol) and S2e (0.584 g, 2.52 mmol).  The mixture was purified by flash 
column chromatography (90:10 hexane:EtOAc) to give the 1p as a white solid in 74% yield (0.382 
g, 1.55 mmol). 1H NMR (400 MHz, DMSO-d6)  5.09 (d, J = 5.6 Hz, 2H), 6.29 (dd, J = 3.8, 2.6 
Hz, 1H), 6.34 (d, J = 16.0 Hz, 1H), 6.47 (ddd, J = 16.0, 5.6, 5.6 Hz, 1H), 7.07 (dd, J = 3.8, 1.6 Hz, 
1H), 7.34 - 7.37 (m, 3H), 7.41 (d, J = 8.8 Hz, 1H), 9.54 (s, 1H). 13C NMR (101 MHz, CDCl3)  
50.8, 110.3, 110.4, 125.2, 126.2, 128.1, 129.05, 131.3, 131.7, 133.9, 135.05, 179.8. HRMS (ESI): 
Calcd. For C14H13ClNO
+ ([M+H]+): 246.0681, found 246.0683. 
General Procedure C: Synthesis of 8-Methyl-7,8-dihydropyrido[1,2-a]indol-9(6H)-ones (2b-
h) 
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In a nitrogen-filled glovebox, the appropriate N-homoallylindole-2-carboxaldehyde (1b-h) 
(0.100 mmol, 1.0 equiv) was added to a 1-dram vial containing Ni(COD)2 (1.4 mg, 0.00500 mmol, 
0.050 equiv) and IAd (2.0 mg, 0.00600 mmol, 0.060 equiv) in mesitylene (0.5 mL).  The vial was 
sealed with a PTFE/silicone-lined septum cap and removed from the glovebox.  The reaction 
mixture was stirred at 165 °C in an oil bath for 10 h.  The vial was removed from the oil bath and 
allowed to cool to room temperature.  The reaction mixture was filtered through a short plug of 
silica gel (eluting with 20 ml of 3:2 hexanes:EtOAc).  The crude reaction mixture was concentrated 
under reduced pressure.  The crude reaction mixture was purified by flash column silica gel 
chromatography (hexanes:EtOAc) to give the appropriate 8-methyl-7,8-dihydropyrido[1,2-
a]indol-9(6H)-ones (2b-h). 
General Procedure D: Synthesis of 2-Methyl-2,3-dihydro-1H-pyrrolo[1,2-a]indol-1-one (2a),  
7,8-Dihydropyrido[1,2-a]indol-9(6H)-ones (2j-k) and 7-Methyl-6,7-dihydroindolizin-8(5H)-
ones (2i, 2l) 
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In a nitrogen-filled glovebox, the appropriate N-allylindole-2-carboxaldehyde (1a) or N-
homoallylindole-2-carboxaldehyde (1j-k) or N-homoallylpyrrole-2-carboxaldehyde (1i, 1l) (0.100 
mmol, 1.0 equiv) was added to a 1-dram vial containing Ni(COD)2 (4.1 mg, 0.0151 mmol, 0.150 
equiv) and IAd (6.1 mg, 0.0181 mmol, 0.180 equiv) in mesitylene (0.5 mL).  The vial was sealed 
with a PTFE/silicone-lined septum cap and removed from the glovebox.  The reaction mixture was 
stirred at 165 °C in an oil bath for 10 h.  The vial was removed from the oil bath and allowed to 
cool to room temperature.  The reaction mixture was filtered through a short plug of silica gel 
(eluting with 20 mL of 3:2 hexanes:EtOAc).  The crude reaction mixture was concentrated under 
reduced pressure.  The crude reaction mixture was purified by flash column silica gel 
chromatography (hexanes:EtOAc) to give the appropriate 2-methyl-2,3-dihydro-1H-pyrrolo[1,2-
a]indol-1-one (2a), 7,8-dihydropyrido[1,2-a]indol-9(6H)-ones (2j-k) or 7-methyl-6,7-
dihydroindolizin-8(5H)-ones (2i, 2l). 
General Procedure E: Synthesis of 2-Methyl-2,3,-dihydro-1H-pyrrolizin-1-one (2m) and 2-
Benzyl-2,3-dihydro-1H-pyrrolizin-1-ones (2n-p) 
 
 
 2-methyl-2,3-dihydro-1H-pyrrolizin-1-one (2m) and 2-benzyl-2,3-dihydro-1H-pyrrolizin-
1-one (2n-p) were prepared according to a modified literature procedure from the appropriate 1-
allyl-1H-pyrrole-2-carboxaldehyde (1m-p).90  In a nitrogen-filled glovebox, to a 1-dram vial was 
added NHC 3 (5.7 mg, 0.0200 mmol, 0.1 equiv), the appropriate 1-allyl-1H-pyrrole-2-
carboxaldehyde 1m-p (0.200 mmol, 1.0 equiv), DBU (6.1 mg, 0.0400 mmol, 0.2 equiv), and 1,4-
47 
 
dioxane (1.0 mL, 0.2 M 1).  The vial was sealed with a Teflon-lined septum cap.  The reaction 
vessel was removed from the glovebox, and the reaction mixture was stirred at 60 C for 12 h.  
The reaction was cooled to room temperature, and filtered through a plug of silica gel with EtOAc 
as eluent.  The filtrate was concentrated under reduced pressure.  The crude product was purified 
by flash column silica gel chromatography (hexane:EtOAc) to give the appropriate 2-methyl-2,3-
dihydro-1H-pyrrolizin-1-one (2m) and 2-benzyl-2,3-dihydro-1H-pyrrolizin-1-ones (2n-p). 
2-Methyl-2,3-dihydro-1H-pyrrolo[1,2-a]indol-1-one (2a): Prepared 
according to the general procedure D from 1a (19.0 mg, 0.103 mmol). The 
crude product was purified by silica gel chromatography with a CombiFlash system (4 g column, 
100:0→90:10 hexanes/EtOAc) to give 2a as a white solid in 70% yield (13.3 mg, 0.0718 mmol). 
1H NMR (400 MHz, CDCl3) δ 1.44 (d, J = 7.4 Hz, 3H), 3.21 – 3.30 (m, 1H), 3.93 (dd, J = 10.8, 
4.8 Hz, 1H), 4.62 (dd, J = 10.8, 8.0 Hz, 1H), 7.00 (s, 1H), 7.18 (ddd, J = 8.2, 6.6, 1.2 Hz, 1H), 7.32 
– 7.40 (m, 2H), 7.75 (d, J = 8.2 Hz, 1H). 13C NMR (101 MHz, CDCl3) δ 15.8, 45.7, 48.1, 99.4, 
110.8, 121.7, 124.4, 125.3, 132.3, 135.27, 135.35, 196.3. HRMS (ESI): Calcd. for C12H12NO 
([M+H]+): 186.0919, Found: 186.0918. 
8-Methyl-7,8-dihydropyrido[1,2-a]indol-9(6H)-one (2b): Prepared 
according to the general procedure C from 1b (20.0 mg, 0.100 mmol). The 
mixture was purified by flash column chromatography (90:10 
hexane:EtOAc) to give 2b as a yellowish white solid in 95% yield (19.0 mg, 0.095 mmol). 1H 
NMR (400 MHz, CDCl3) δ 1.34 (d, J = 6.8 Hz, 3H), 2.15 (app qd, J = 11.2, 4.6 Hz, 1H), 2.41 (app 
dq, J = 13.6, 4.6 Hz, 1H), 2.67 – 2.76 (m, 1H), 4.11 (ddd, J = 11.2, 11.2, 3.8 Hz, 1H), 4.38 (ddd, J 
= 12.2, 3.8, 3.8 Hz, 1H), 7.16 (t, J = 7.2 Hz, 1H), 7.29 – 7.38 (m, 3H), 7.72 (d, J = 8.0 Hz, 1H). 
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13C NMR (101 MHz, CDCl3) δ 15.1, 31.2, 41.1, 41.3, 105.8, 110.5, 121.3, 123.6, 125.7, 127.2, 
133.7, 137.4, 193.1. HRMS (ESI): Calcd. for C13H14NO
+ ([M+H]+): 200.1070, Found: 200.1068. 
1-Methoxy-8-methyl-7,8-dihydropyrido[1,2-a]indol-9(6H)-one (2c): 
Prepared according to the general procedure C from 1c (23.0 mg, 0.100 
mmol). The mixture was purified by flash column chromatography (90:10 
hexane:EtOAc) to give 2c as a yellow solid in 92% yield (21.2 mg, 0.092 mmol). 1H NMR (600 
MHz, CDCl3) δ 1.34 (d, J = 6.8 Hz, 3H), 2.14 – 2.22 (m, 1H), 2.42 (app dq, J = 13.6, 4.2 Hz, 1H), 
2.70 – 2.76 (m, 1H), 3.96 (s, 3H), 4.13 (ddd, J = 13.6, 11.0, 4.2 Hz, 1H), 4.37 (ddd, J = 12.0, 4.2, 
4.2 Hz, 1H), 6.50 (d, J = 8.0 Hz, 1H), 6.94 (d, J = 8.0 Hz, 1H), 7.29 (t, J = 8.0 Hz, 1H), 7.42 (s, 
1H). 13C NMR (151 MHz, CDCl3) δ 15.1, 31.4, 41.3, 41.4, 55.8, 100.2, 103.4, 103.9, 119.0, 127.0, 
132.8, 139.0 155.6, 192.8. HRMS (ESI) Calcd. for C14H16NO2
+
 ([M+H]
+): 230.1176, Found: 
230.1177. 
2,8-Dimethyl-7,8-dihydropyrido[1,2-a]indol-9(6H)-one (2d): 
Prepared according to the general procedure C from 1d (22.0 mg, 0.103 
mmol). The mixture was purified by flash column chromatography 
(90:10 hexane:EtOAc) to give 2d as a dark yellow solid in 88% yield (19.4 mg, 0.0910 mmol). 1H 
NMR (400 MHz, CDCl3) δ 1.34 (d, J = 6.9 Hz, 3H), 2.16 (app dtd, J = 13.6, 11.0, 4.8 Hz, 1H), 
2.38 – 2.44 (m, 4H), 2.72  (app tt, J = 11.0, 6.8 Hz, 1H), 4.12 (ddd, J = 14.0, 11.0, 4.0 Hz, 1H), 
4.37 (ddd, J = 12.2, 4.0, 4.0 Hz, 1H), 7.18 – 7.20 (m, 2H), 7.24 (d, J = 8.4 Hz, 1H), 7.48 (s, 1H). 
13C NMR (101 MHz, CDCl3) δ 15.2, 21.8, 31.4, 41.1, 41.3, 105.3, 110.2, 122.8, 127.5, 127.9, 
130.7, 133.8, 136.1, 193.2.  HRMS (ESI): Calcd. for C14H16NO
+ ([M+H]+): 214.1226, Found: 
214.1229. 
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2-Methoxy-8-methyl-7,8-dihydropyrido[1,2-a]indol-9(6H)-one 
(2e): Prepared according to the general procedure C from 1e (23.0 mg, 
0.100 mmol). The mixture was purified by flash column 
chromatography (90:10 hexane:EtOAc) to give 2e as a light yellow solid in 90% yield (20.8 mg, 
0.0907 mmol). 1H NMR (400 MHz, CDCl3) δ 1.34 (d, J = 6.9 Hz, 3H), 2.17 (app dtd, J = 13.8, 
10.8, 4.8 Hz, 1H), 2.43 (app dq, J = 13.8, 4.4 Hz, 1H), 2.68 – 2.78 (m, 1H), 3.85 (s, 3H), 4.13 (ddd, 
J = 13.8, 10.8, 4.4 Hz, 1H), 4.37 (ddd, J = 12.2, 4.4, 4.4 Hz, 1H), 7.05 (dd, J = 9.0, 2.4 Hz, 1H), 
7.08 (d, J = 2.4 Hz, 1H), 7.21 (s, 1H), 7.23 – 7.26 (m, 1H). 13C NMR (101 MHz, CDCl3) δ 15.2, 
31.4, 41.2, 41.2, 56.0, 102.9, 105.2, 111.5, 118.0, 127.5, 133.2, 134.1, 155.3, 192.9. HRMS (ESI) 
Calcd. for C14H16NO2
+ ([M+H]+): 230.1176, Found: 230.1179. 
2-Fluoro-8-methyl-7,8-dihydropyrido[1,2-a]indol-9(6H)-one (2f): 
Prepared according to the general procedure C from 1f (22.0 mg, 0.101 
mmol). The mixture was purified by flash column chromatography 
(90:10 hexane:EtOAc) to give 2g as a yellowish white solid in 96% yield (21.2 mg, 0.097 mmol). 
1H NMR (400 MHz, CDCl3) δ 1.35 (d, J = 6.9 Hz, 3H), 2.19 (app dtd, J = 13.8, 11.0, 4.8 Hz, 1H), 
2.45 (app dq, J = 13.8, 4.0 Hz, 1H), 2.70 – 2.79 (m, 1H), 4.16 (ddd, J = 12.2, 11.0, 4.0 Hz, 1H), 
4.40 (ddd, J = 12.2, 4.4, 4.4 Hz, 1H), 7.15 (app td, J = 9.0, 2.4 Hz, 1H), 7.24 (s, 1H), 7.295 (dd, J 
= 9.0, 4.4 Hz, 1H), 7.35 (dd, J = 9.0, 2.4 Hz, 1H). 13C NMR (101 MHz, CDCl3) δ 15.1, 31.3, 41.2, 
41.4, 106.55 (d, J = 5.0 Hz, 1C), 107.6 (d, J = 23.2 Hz, 1C), 111.5 (d, J = 10.1 Hz, 1C), 115.1 (d, 
J = 27.3 Hz, 1C), 127.25 (d, J = 10.1 Hz, 1C), 134.2, 135.0, 158.6 (d, J = 238.4 Hz, 1C), 193.0. 
19F NMR (CDCl3, 376 MHz): δ -122.5 (m, 1F). HRMS (ESI) Calcd. for C13H13FNO+ ([M+H]+): 
218.0976, Found: 218.0979. 
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3-Methoxy-8-methyl-7,8-dihydropyrido[1,2-a]indol-9(6H)-one 
(2g): Prepared according to the general procedure C from 1g (23.0 
mg, 0.100 mmol). The mixture was purified by flash column 
chromatography (90:10 hexane:EtOAc) to give 2f as a light yellow solid in 91% yield (21.0 mg, 
0.0916 mmol). 1H NMR (400 MHz, CDCl3) δ 1.34 (d, J = 6.8 Hz, 3H), 2.16 (app dtd, J = 13.8, 
10.9, 4.4 Hz, 1H), 2.42 (app dq, J = 13.8, 4.0 Hz, 1H), 2.67 - 2.76 (m, 1H), 3.89 (s, 3H), 4.09 (ddd, 
J = 12.1, 10.9, 4.0 Hz, 1H), 4.33 (ddd, J = 12.1, 4.4, 4.4 Hz, 1H), 6.70 (d, J = 2.2 Hz, 1H), 6.83 
(dd, J = 8.8, 2.2 Hz, 1H), 7.25 (s, 1H), 7.58 (d, J = 8.8 Hz, 1H). 13C NMR (101 MHz, CDCl3) δ 
15.2, 31.3, 41.11, 41.13, 55.9, 92.1, 106.5, 113.2, 121.7, 124.5, 133.3, 138.6, 159.4, 192.5. HRMS 
(ESI) Calcd. for C14H16NO2
+ ([M+H]+): 230.1176, Found: 230.1178. 
8-Methyl-3-(trifluoromethyl)-7,8-dihydropyrido[1,2-a]indol-
9(6H)-one (2h): Prepared according to the general procedure C from 
1h (27.0 mg, 0.101 mmol). The mixture was purified by flash column chromatography (90:10 
hexane:EtOAc) to give 2h as a white solid in 75% yield (20.3 mg, 0.0760 mmol). 1H NMR (400 
MHz, CDCl3) δ 1.37 (d, J = 6.8 Hz, 3H), 2.22 (app dtd, J = 13.8, 11.2, 4.8 Hz, 1H), 2.49 (app dq, 
J = 13.8, 4.0 Hz, 1H), 2.74 – 2.83 (m, 1H), 4.22 (ddd, J = 13.8, 11.2, 4.0 Hz, 1H), 4.485 (ddd, J = 
12.2, 4.0, 4.0 Hz, 1H), 7.31 (s, 1H), 7.38 (dd, J = 8.5, 1.0 Hz, 1H), 7.67 (s, 1H), 7.81 (d, J = 8.5 
Hz, 1H). 13C NMR (101 MHz, CDCl3) δ 15.0, 31.2, 41.49, 41.54, 106.6, 108.4 (q, J = 5.05 Hz, 
1C), 117.7 (q, J = 4.0 Hz, 1C), 124.3, 125.1 (q, J = 273.7 Hz, 1C), 127.4 (q, J = 32.3 Hz, 1C), 
129.2, 135.8, 136.2, 193.0. 19F NMR (CDCl3, 376 MHz): δ -61.5 (s, 3F). HRMS (ESI) Calcd 
C14H13F3NO
+ ([M+H]+): 268.0944, Found: 268.0940. 
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7-Methyl-6,7-dihydroindolizin-8(5H)-one (2i): Prepared according to the 
general procedure D from 1k (15.0 mg, 0.100 mmol). The mixture was purified 
by flash column chromatography (90:10 hexane:EtOAc) to give 2k as a white solid in 80% yield 
(12.0 mg, 0.0800 mmol). 1H NMR (600 MHz, CDCl3) δ 1.29 (d, J = 6.8 Hz, 3H), 2.07 (qd, J = 
10.8, 4.4 Hz, 1H), 2.28 – 2.31 (m, 1H), 2.57 – 2.60 (m, 1H), 4.10 (ddd, J = 12.4, 12.4, 3.4 Hz, 1H), 
4.20 (ddd, J = 12.4, 4.4, 4.4 Hz, 1H), 6.25 (d, J = 1.2 Hz, 1H), 6.82 (m, 1H), 7.00 (d, J = 2.4 Hz, 
1H). 13C NMR (151 MHz, CDCl3) δ 15.4, 31.8, 40.3, 44.6, 110.8, 114.3, 125.7, 130.7, 190.2. 
HRMS (ESI) Calcd C9H12NO
+ ([M+H]+): 150.0913, Found: 150.0917. 
8,8-Dimethyl-7,8-dihydropyrido[1,2-a]indol-9(6H)-one (2j): Prepared 
according to the general procedure D from 1i (22.0 mg, 0.103 mmol). The 
mixture was purified by flash column chromatography (80:20 
hexane:EtOAc) to give 2i as a yellow solid in 75% yield (16.5 mg, 0.077 mmol). 1H NMR (600 
MHz, CDCl3) δ 1.32 (s, 6H), 2.25 (t, J = 6.0 Hz, 2H), 4.28 (t, J = 6.0 Hz, 2H), 7.17 (ddd, J = 8.0, 
5.4, 2.4 Hz, 1H), 7.30 (s, 1H), 7.35 – 7.39 (m, 2H), 7.73 (d, J = 8.0 Hz, 1H). 13C NMR (151 MHz, 
CDCl3) δ 24.3, 36.9, 38.8, 41.6, 106.6, 110.6, 121.4, 123.6, 125.8, 127.5, 132.9, 137.5, 195.6. 
HRMS (ESI): Calcd. for C14H16NO
+ ([M+H]+): 214.1226, Found: 214.1225. 
8-Propyl-7,8-dihydropyrido[1,2-a]indol-9(6H)-one (2k): Prepared 
according to a modified version of general procedure D from 1j (68.0 mg, 
0.299 mmol). The mixture was purified by flash column chromatography 
(80:20 hexane:EtOAc) to give 2j as a yellow solid in 15% yield (10.5 mg, 0.0460 mmol). 1H NMR 
(600 MHz, CDCl3) δ 0.98 (t, J = 7.2 Hz, 3H), 1.41 – 1.58 (m, 3H), 1.98 – 2.04 (m, 1H), 2.19 (app 
dtd, J = 13.8, 9.4, 4.6 Hz, 1H), 2.48 (app dq, J = 13.8, 5.4 Hz, 1H), 2.62 – 2.66 (m, 1H), 4.16 (ddd, 
J = 12.4, 9.4, 4.2 Hz, 1H), 4.39 (ddd, J = 12.4, 5.4, 5.4 Hz, 1H), 7.16 (ddd, J = 8.0, 5.8, 2.0 Hz, 
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1H), 7.30 (s, 1H), 7.35 – 7.39 (m, 2H), 7.72 (d, J = 8.0 Hz, 1H). 13C NMR (151 MHz, CDCl3) δ 
14.4, 20.5, 28.3, 31.3, 40.7, 46.1, 106.0, 110.6, 121.4, 123.7, 125.8, 127.3, 133.9, 137.5, 193.0. 
HRMS (ESI) Calcd C15H18NO
+ ([M+H]+): 228.1383, Found: 228.1385. 
7,7-Dimethyl-6,7-dihydroindolizin-8(5H)-one (2l): Prepared according to a 
modified version of general procedure D from 1l (49.0 mg, 0.300 mmol). The 
mixture was purified by flash column chromatography (90:10 hexane:EtOAc) to give 2l as a white 
solid in 20% yield (10.0 mg, 0.0610 mmol). 1H NMR (400 MHz, CDCl3) δ 1.25 (s, 6H), 2.11 (t, 
J = 9.0 Hz, 2H), 4.14 (t, J = 9.0 Hz, 2H), 6.25 (dd, J = 6.0, 3.6 Hz, 1H), 6.80 – 6.81 (m, 1H), 7.00 
(dd, J = 3.6, 1.6 Hz, 1H). 13C NMR (101 MHz, CDCl3) δ 24.6, 37.4, 40.6, 42.2, 111.0, 114.9, 
125.5, 129.6, 192.6. HRMS (ESI) Calcd C10H14NO
+ ([M+H]+): 164.1070, Found: 164.1068. 
2-Methyl-2,3-dihydro-1H-pyrrolizin-1-one (2m): Prepared according to general 
procedure E from 1m (27.0 mg, 0.200 mmol).  The reaction mixture was stirred at 
60 °C for 24 h.  The mixture was purified by flash column chromatography (90:10 
hexane:EtOAc) to give 2m as a white solid in 80% yield (21.6 mg, 0.160 mmol). 1H NMR (400 
MHz, CDCl3)  1.36 (d, J = 7.4 Hz, 3H), 3.10 - 3.18 (m, 1H), 3.85 (dd, J = 11.6, 4.6 Hz, 1H), 4.50 
(dd, J = 11.6, 8.0 Hz, 1H), 6.50 (dd, J = 4.0, 2.4 Hz, 1H), 6.71 (dd, J = 4.0, 0.8 Hz, 1H), 7.00 (m, 
1H). 13C NMR (101 MHz, CDCl3)  15.9, 45.6, 50.3, 108.1, 117.1, 122.9, 132.2, 192.7. HRMS 
(ESI) Calcd C8H10NO
+ ([M+H]+): 136.0757, found 136.0761. 
2-Benzyl-2,3-dihydro-1H-pyrrolizin-1-one (2n): Prepared according to a general 
modified version of general procedure E from 1n (42.0 mg, 0.199 mmol).  The 
mixture was purified by flash column chromatography (90:10 hexane:EtOAc) to 
give 2n as a yellow oil in 96% yield (40.3 mg, 0.191 mmol). 1H NMR (400 MHz, 
CDCl3)  2.79 (dd, J = 15.0, 12.0 Hz, 1H), 3.40 - 3.47 (m, 2H), 3.98 (dd, J = 12.0, 4.4 Hz, 1H), 
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4.26 (dd, J = 12.0, 7.6 Hz, 1H), 6.51 (dd, J = 4.0, 2.2 Hz, 1H), 6.75 (dd, J = 4.0, 0.6 Hz, 1H), 6.96 
(m, 1H), 7.21 - 7.26 (m, 3H), 7.29 - 7.32 (m, 2H). 13C NMR (101 MHz, CDCl3)  36.8, 47.9, 52.5, 
108.4, 117.3, 123.2, 127.0, 129.08, 129.10, 132.5, 139.1, 191.0. HRMS (ESI): Calcd. for 
C14H14NO
+ ([M+H]+): 212.1070, found 212.1072. 
2-(4-Methoxybenzyl)-2,3-dihydro-1H-pyrrolizin-1-one (2o):  Prepared 
according to a modified version of general procedure E from 1o (48.0 mg, 0.199 
mmol).  The mixture was purified by flash column chromatography (90:10 
hexane:EtOAc) to give 2o as a white solid in 99% yield (47.6 mg, 0.197 mmol). 1H 
NMR (400 MHz, CDCl3)  2.77 (dd, J = 14.0, 10.2 Hz, 1H), 3.32 (dd, J = 14.0, 4.4 Hz, 1H), 3.37 
- 3.43 (m, 1H), 3.78 (s, 3H), 3.97 (dd, J = 11.8, 4.4 Hz, 1H), 4.26 (dd, J = 11.8, 7.8 Hz, 1H), 6.50 
(dd, J = 4.0, 2.2 Hz, 1H), 6.75 (dd, J = 4.0, 0.8 Hz, 1H), 6.83 (d, J = 8.6 Hz, 2H), 6.96 (m, 1H), 
7.13 (d, J = 8.6 Hz, 2H). 13C NMR (101 MHz, CDCl3)  35.9, 47.8, 52.7, 55.6, 108.4, 114.4, 
117.3, 123.2, 130.1, 130.9, 132.6, 158.7, 191.2. HRMS (ESI): Calcd. for C15H16NO2
+ ([M+H]+): 
242.1176, found 242.1178.   
2-(4-Chlorobenzyl)-2,3-dihydro-1H-pyrrolizin-1-one (2p): Prepared according 
to a modified version of general procedure E from 1p (49.0 mg, 0.199 mmol).  The 
mixture was purified by flash column chromatography (90:10 hexane:EtOAc) to 
give 2p as a white solid in 99% yield (48.5 mg, 0.197 mmol). 1H NMR (400 MHz, 
CDCl3)  2.75 (dd, J = 14.0, 9.8 Hz, 1H), 3.27 (dd, J = 14.0, 4.4 Hz, 1H), 3.31 - 3.37 (m, 1H), 3.87 
(dd, J = 11.8, 4.4 Hz, 1H), 4.21 (dd, J = 11.8, 7.8 Hz, 1H), 6.44 (dd, J = 4.0, 2.2 Hz, 1H), 6.68 (dd, 
J = 4.0, 0.6 Hz, 1H), 6.89 (m, 1H), 7.08 (d, J = 8.4 Hz, 2H), 7.19 (d, J = 8.4 Hz, 2H). 13C NMR 
(101 MHz, CDCl3)  36.0, 47.7, 52.2, 108.6, 117.4, 123.4, 129.2, 130.5, 132.4, 132.9, 137.4, 190.6. 
HRMS (ESI): Calcd. for C14H13ClNO
+ ([M+H]+): 246.0680, found 246.0791. 
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Identification of Catalyst for Ni-catalyzed -Arylation of 8-Methyl-7,8-dihydropyrido[1,2-
a]indol-9(6H)-one (2b) 
 
entry ligand temp (°C) time (h) conva (%) yieldb (%) eec (%) 
1 L5 80 48 99 77 95 
2 L6 80 48 99 72 97 
3 L7 80 48 80 45 97 
4 L7 70 48 75 42 99 
5 L7 60 48 75 69 99 
6 L8 80 48 99 60 97 
7 L8 70 48 99 72 98 
8 L8 65 48 99 99 99 
9 L8 65 24 75 60 98 
10 L8 60 48 60 55 98 
11 L8 60 60 85 80 99 
Reaction conditions: 2b (0.200 mmol), 4a (0.400 mmol), NaOtBu (0.400 mmol), Ni(COD)2 (0.020 
mmol), ligand L5-L8 (0.024 mmol), and toluene (1.0 mL). a Conversion of 2b was determined by 
1H NMR spectroscopy. b Isolated yield after column chromatography. c Determined by chiral 
HPLC analysis. 
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Proposed Reaction Mechanism for Ni-catalyzed -Arylation of 8-Methyl-7,8-
dihydropyrido[1,2-a]indol-9(6H)-one (2b) with Aryl Chloride 
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General Procedure F: Synthesis of (R)-8-Aryl-8-methyl-7,8-dihydropyrido[1,2-a]indol-
9(6H)-ones (5a-d) and (R)-7-Aryl-7-methyl-6,7-dihydroindolizin-8(5H)-one (5l) 
 
 
 
In a nitrogen-filled glovebox, 8-methyl-7,8-dihydropyrido[1,2-a]indol-9(6H)-one (2b) 
(0.100 mmol, 1.0 equiv) or 7-methyl-6,7-dihydroindolizin-8(5H)-one (2k) (0.100 mmol, 1.0 
equiv), Ni(COD)2 (2.8 mg, 0.0100 mmol, 0.10 equiv), (R)-BINAP (7.5 mg, 0.0120 mmol, 0.12 
equiv), NaOtBu (19.3 mg, 0.200 mmol, 2.0 equiv), the appropriate aryl chloride (0.200 mmol, 2.0 
equiv), a magnetic stirring bar, and toluene (0.5 mL) were added to a 1-dram vial. The vial was 
sealed with a cap containing a PTFE septum and removed from the glovebox. The reaction mixture 
was stirred at 65 °C in an oil bath for 48 h.  The vial was removed from the oil bath and allowed 
to cool to room temperature.  The reaction mixture was filtered through short plug of silica gel 
(eluting with 20 mL of 3:2 hexanes:EtOAc).  The crude reaction mixture was concentrated under 
reduced pressure. The crude product was purified with a CombiFlash system with 5-20% ethyl 
acetate in hexanes as eluent to give the appropriate (R)-8-aryl-8-methyl-7,8-dihydropyrido[1,2-
a]indol-9(6H)-ones (5a-d) and (R)-7-aryl-7-methyl-6,7-dihydroindolizin-8(5H)-one (5l).  
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General Procedure G: Synthesis of (R)-8-Aryl-8-methyl-7,8-dihydropyrido[1,2-a]indol-
9(6H)-ones (5e-k) 
 
 
In a nitrogen-filled glovebox, 8-methyl-7,8-dihydropyrido[1,2-a]indol-9(6H)-one (2b) 
(0.100 mmol, 1.0 equiv), Ni(COD)2 (2.80 mg, 0.0100 mmol, 0.10 equiv), (R)-BINAP (7.5 mg, 
0.0120 mmol, 0.12 equiv), NaOtBu (19.3 mg, 0.200 mmol, 2.0 equiv), the appropriate aryl chloride 
4e-k (0.200 mmol, 2.0 equiv), a magnetic stirring bar, and toluene (0.5 mL) were added to a 1-
dram vial. The vial was sealed with a cap containing a PTFE septum and removed from the 
glovebox. The reaction mixture was stirred at 70 °C in an oil bath for 48 h.  The vial was removed 
from the oil bath and allowed to cool to room temperature.  The reaction mixture was filtered 
through short plug of silica gel (eluting with 20 mL of 3:2 hexanes:EtOAc).  The crude reaction 
mixture was concentrated under reduced pressure. The crude product was purified with a 
CombiFlash system with 5-20% ethyl acetate in hexanes as eluent to give the appropriate (R)-8-
aryl-8-methyl-7,8-dihydropyrido[1,2-a]indol-9(6H)-ones (5e-k).  
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General Procedure H: Synthesis of (S)-2-Aryl-2-methyl-2,3-dihydro-1H-pyrrolo[1,2-a]indol-
1-one (9a-c)      
 
 
In a nitrogen-filled glovebox, 2-methyl-2,3-dihydro-1H-pyrrolo[1,2-a]indol-1-one (2a) 
(0.200 mmol, 1.0 equiv), [(R)-BINAP]Ni(2-NC-Ph) (26.3 mg, 0.0300 mmol, 0.15 equiv), 
NaOtBu (38.4 mg, 0.400 mmol, 2.0 equiv), the appropriate aryl bromide 8a-c (0.400 mmol, 2.0 
equiv), a magnetic stirring bar, and toluene (1.0 mL) were added to a 1-dram vial. The vial was 
sealed with a cap containing a PTFE septum and removed from the glovebox. The reaction mixture 
was stirred at 25 °C in for 48 h.  The vial was removed from the oil bath and allowed to cool to 
room temperature.  The reaction mixture was filtered through short plug of silica gel (eluting with 
20 ml of 3:2 hexanes:EtOAc).  The crude reaction mixture was concentrated under reduced 
pressure. The crude product was purified with a CombiFlash system with 5-20% ethyl acetate in 
hexanes as eluent to give the appropriate (S)-2-aryl-2-methyl-2,3-dihydro-1H-pyrrolo[1,2-a]indol-
1-one (9a-c).  
 
 
 
 
 
 
N N
O
9a-c2a
9a; Ar = C6H5
9b; Ar = 3-MeO-C6H4
9c; Ar = 4-CF3-C6H4
Ar
Me
+
8a-c
O
Me
Ar Br
8a; Ar = C6H5
8b; Ar = 3-MeO-C6H4
8c; Ar = 4-CF3-C6H4
toluene, 25 °C, 48 h
NaOtBu (2 equiv)
[(R)-BINAP]Ni(h2-NC-Ph)
(15 mol %)
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General Procedure I: Synthesis of (S)-2-Aryl-2-methyl-2,3-dihydro-1H-pyrrolizin-1-ones 
(9d-j) and (S)-2-Phenyl-2-benzyl-2,3-dihydro-1H-pyrrolizin-1-ones (9k-m) 
 
 
 In a nitrogen-filled glovebox, 2-methyl-2,3,-dihydro-1H-pyrrolizin-1-one (2m) (0.200 
mmol, 1.0 equiv) or 2-benzyl-2,3-dihydro-1H-pyrrolizin-1-ones (2n-p) (0.200 mmol, 1.0 equiv), 
[(R)-BINAP]Ni(2-NC-Ph) (17.5 mg, 0.0200 mmol, 0.10 equiv), NaOtBu (38.4 mg, 0.400 mmol, 
2.0 equiv), the appropriate aryl bromide 8a-g (0.400 mmol, 2.0 equiv), a magnetic stirring bar, and 
toluene (1.0 mL) were added to a 1-dram vial. The vial was sealed with a cap containing a PTFE 
septum and removed from the glovebox. The reaction mixture was stirred at 25 °C for 48 h.  The 
vial was removed from the oil bath and allowed to cool to room temperature.  The reaction mixture 
was filtered through short plug of silica gel (eluting with 20 ml of 3:2 hexanes:EtOAc).  The crude 
reaction mixture was concentrated under reduced pressure. The crude product was purified with a 
CombiFlash system with 5-20% ethyl acetate in hexanes as eluent to give the appropriate (S)-2-
aryl-2-methyl-2,3-dihydro-1H-pyrrolizin-1-ones (9d-j) and (S)-2-aryl-2-benzyl-2,3-dihydro-1H-
pyrrolizin-1-ones (9k-m).  
 
N N
O
9d-m2m-p
9d; R  = Me, Ar = C6H5
9e; R  = Me, Ar = 4-CF3-C6H4
9f; R  = Me, Ar = 3-CF3-C6H4
9g; R  = Me, Ar = 3-F-C6H4
9h; R  = Me, Ar = 3-MeO-C6H4
9i; R  = Me, Ar = 4-MeO-C6H4
9j; R  = Me, Ar = napthyl
9k; R  = CH2-C6H4, Ar
 = C6H5
9l; R  = CH2-(4-MeO)-C6H4, Ar
 = C6H5
9m; R  = CH2-(4-Cl)-C6H4, Ar
 = C6H5
Ar
R
+
8a-g
O
R
Ar Br
8a; Ar = C6H5
8b; Ar = 4-CF3-C6H4
8c; Ar = 3-MeO-C6H4
8d; Ar = 3-CF3-C6H4
8e; Ar = 3-F-C6H4
8f; Ar = 4-MeO-C6H4
8g; Ar = napthyl
toluene, 25 °C, 48 h
NaOtBu (2 equiv)
[(R)-BINAP]Ni(h2-NC-Ph)
(10 mol %)
2m; R  = Me
2n; R  = CH2-C6H4
2o; R  = CH2-(4-MeO)-C6H4
2p; R  = CH2-(4-Cl)-C6H4
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 (R)-8-Methyl-8-(4-(trifluoromethyl)phenyl)-7,8-
dihydropyrido[1,2-a]indol-9(6H)-one (5a): Prepared according 
to the general procedure F from 2b (20.0 mg, 0.100 mmol) and 1-
chloro-4-(trifluoromethyl)benzene 4a (36.2 mg, 0.200 mmol). The crude product was purified by 
silica gel chromatography with a CombiFlash system (4 g column, 100:0→80:20 hexanes/EtOAc) 
to give 5a as a light yellow solid in 99% yield (34.3 mg, 0.099 mmol). The enantiomeric excess 
was determined by HPLC analysis (220 nm, 25 °C) tR 20.4 min (major); tR 27.8 min (minor) 
[Chiracel AS-H (0.46 cm x 25 cm) (from Daicel Chemical Ind., Ltd.) hexane/i-PrOH, 99:1, 1.0 
mL/min] to be 99% ee. [α]D24 = +99.2° (c 0.89, CHCl3). 1H NMR (400 MHz, CDCl3) δ 1.66 (s, 
3H), 2.59 (ddd, J = 14.4, 11.2, 4.9 Hz, 1H), 2.83 (ddd, J = 14.4, 3.8, 3.8 Hz, 1H), 3.89 (ddd, J = 
11.2, 11.2, 3.8 Hz, 1H), 4.30 (ddd, J = 11.2, 4.9, 3.8 Hz, 1H), 7.17 (ddd, J = 7.9, 7.0, 0.8 Hz, 1H), 
7.26 – 7.28 (m, 1H), 7.36 (ddd, J = 8.2, 7.0, 0.8 Hz, 1H), 7.41 – 7.44 (m, 3H), 7.55 – 7.57 (m, 2H), 
7.74 (d, J = 8.2 Hz, 1H). 13C NMR (101 MHz, CDCl3) δ 26.0, 36.7, 39.1, 50.3, 107.3, 110.6, 121.6, 
123.8, 124.3 (q, J = 273.7 Hz, 1C), 126.1 (q, J = 4.0 Hz, 1C), 126.2, 127.1, 127.4, 129.7 (q, J = 
33.3 Hz, 1C), 133.6, 137.6, 146.1, 192.8. 19F NMR (CDCl3, 376 MHz): δ -62.9 (s, 3F). HRMS 
(ESI): Calcd. for C20H17F3NO
+ ([M+H]+):  344.1257, Found: 344.1265. 
(R)-8-(4-Fluorophenyl)-8-methyl-7,8-dihydropyrido[1,2-
a]indol-9(6H)-one (5b): Prepared according to the general 
procedure F from 2b (20.0 mg, 0.100 mmol) and 1-chloro-4-
fluorobenzene 4b (26.2 mg, 0.200 mmol). The crude product was purified by silica gel 
chromatography with a CombiFlash system (4 g column, 100:0→80:20 hexanes/EtOAc) to give 
5b as a light yellow solid in 85% yield (25.0 mg, 0.085 mmol). The enantiomeric excess was 
determined by HPLC analysis (254 nm, 25 °C) tR 28.6 min (major); tR 38.2 min (minor) [Chiracel 
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AS-H (0.46 cm x 25 cm) (from Daicel Chemical Ind., Ltd.) hexane/i-PrOH, 99:1, 1.0 mL/min] to 
be 99% ee. [α]D23 = +152.1° (c 0.53, CHCl3). 1H NMR (600 MHz, CDCl3) δ 1.62 (s, 3H), 2.56 
(ddd, J = 14.4, 11.4, 4.8 Hz, 1H), 2.76 (ddd, J = 14.4, 3.6, 3.6 Hz, 1H), 3.88 (ddd, J = 11.4, 11.4, 
3.6 Hz, 1H), 4.27 (ddd, J = 11.4, 4.8, 3.6 Hz, 1H), 6.97 – 7.00 (m, 2H), 7.16 (ddd, J = 7.8, 6.6, 0.5 
Hz, 1H), 7.24 – 7.27 (m, 3H), 7.35 (ddd, J = 8.1, 7.0, 0.8 Hz, 1H), 7.42 (s, 1H), 7.73 (d, J = 8.1 
Hz, 1H). 13C NMR (101 MHz, CDCl3) δ 26.3, 36.9, 39.1, 49.8, 107.0, 110.6, 116.0 (d, J = 21.3 
Hz, 1C), 121.5, 123.7, 126.1, 127.4, 128.3 (d, J = 7.9 Hz, 1C), 133.7, 137.489 (d, J = 3.4 Hz, 1C), 
137.492, 162.0 (d, J = 247.5 Hz, 1C), 193.4. 19F NMR (CDCl3, 565 MHz): δ -116.0 (s, 1F). HRMS 
(ESI): Calcd. for C19H17FNO
+ ([M+H]+): 294.1289, Found: 294.1293. 
 (R)-tert-Butyl 4-(8-methyl-9-oxo-6,7,8,9-
tetrahydropyrido[1,2-a]indol-8-yl)benzoate (5c): Prepared 
according to the general procedure F from 2b (20.0 mg, 0.100 mmol) and methyl 4-chlorobenzoate 
4c (34.2 mg, 0.200 mmol). The crude product was purified by silica gel chromatography with a 
CombiFlash system (4 g column, 100:0→80:20 hexanes/dichloromethane) to give 5c as a light 
yellow solid in 85% yield (32.1 mg, 0.0855 mmol). The enantiomeric excess was determined by 
HPLC analysis (254 nm, 25 °C) tR 15.4 min (major); tR 25.5 min (minor) [Chiracel OJ-H (0.46 cm 
x 25 cm) (from Daicel Chemical Ind., Ltd.) hexane/i-PrOH, 90:10, 1.0 mL/min] to be 99% ee. 
[α]D25 = +63.2° (c 0.66, CHCl3). 1H NMR (400 MHz, CDCl3) δ 1.54 (s, 9H), 1.64 (s, 3H), 2.58 
(ddd, J = 14.4, 11.6, 4.8 Hz, 1H), 2.82 (ddd, J = 14.4, 3.4, 3.4 Hz, 1H), 3.85 (ddd, J = 11.6, 11.6, 
3.4 Hz, 1H), 4.27 (ddd, J = 11.6, 4.8, 3.4 Hz, 1H), 7.15 (ddd, J = 8.0, 6.7, 1.0 Hz, 1H), 7.22 – 7.26 
(m, 1H), 7.31 – 7.35 (m, 3H), 7.42 (s, 1H), 7.72 (dt, J = 8.0, 1.0 Hz, 1H), 7.94 – 7.87 (m, 2H). 13C 
NMR (101 MHz, CDCl3) δ 26.0, 28.5, 36.7, 39.2, 50.5, 81.4, 107.1, 110.6, 121.5, 123.7, 126.1, 
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126.6, 127.4, 130.3, 131.2, 133.7, 137.5, 146.5, 165.6, 193.1. HRMS (ESI): Calcd. for 
C24H26NO3
+ ([M+H]+): 376.1907, Found: 376.1910. 
 (R)-8-(3-Methoxyphenyl)-8-methyl-7,8-dihydropyrido[1,2-
a]indol-9(6H)-one (5d): Prepared according to general procedure F 
from 2b (20.0 mg, 0.100 mmol) and 1-chloro-3-methoxybenzene 4d 
(28.6 mg, 0.200 mmol). The crude product was purified by silica gel chromatography with a 
CombiFlash system (4 g column, 100:0→80:20 hexanes/EtOAc) to give 5d as a light yellow solid 
in 93% yield (28.5 mg, 0.093 mmol). m.p. = 159 - 161 °C. The enantiomeric excess was 
determined by HPLC analysis (254 nm, 25 °C) tR 30.6 min (major); tR 41.2 min (minor) [Chiracel 
AS-H (0.46 cm x 25 cm) (from Daicel Chemical Ind., Ltd.) hexane/i-PrOH, 99:1, 1.0 mL/min] to 
be 99% ee. [α]D24 = +125.6° (c 0.61, CHCl3). 1H NMR (600 MHz, CDCl3) δ 1.64 (s, 3H), 2.56 
(ddd, J = 14.1, 11.6, 4.6 Hz, 1H), 2.81 (ddd, J = 14.1, 3.4, 3.4 Hz, 1H), 3.76 (s, 3H), 3.93 (ddd, J 
= 11.6, 11.6, 3.4 Hz, 1H), 4.26 – 4.28 (m, 1H), 6.77 (d, J = 6.1 Hz, 1H), 6.86 – 6.88 (m, 2H), 7.16 
(t, J = 7.1 Hz, 1H), 7.23 (t, J = 7.9 Hz, 1H),  7.26 – 7.27 (m, 1H), 7.35 (t, J = 7.1 Hz, 1H), 7.43 (s, 
1H), 7.74 (d, J = 7.9 Hz, 1H). 13C NMR (151 MHz, CDCl3) δ 26.3, 36.7, 39.2, 50.3, 55.5, 106.7, 
110.6, 112.1, 113.2, 119.0, 121.4, 123.6, 125.8, 127.4, 130.1, 133.9, 137.5, 143.3, 160.2, 193.5. 
19F NMR (CDCl3, 376 MHz): δ -63.1.  HRMS (ESI): Calcd. for C20H20NO2+ ([M+H]+): 306.1489, 
Found: 306.1491. 
(R)-8-Methyl-8-(p-tolyl)-7,8-dihydropyrido[1,2-a]indol-9(6H)-
one (5e): Prepared according to the general procedure G from 2b 
(20.0 mg, 0.100 mmol) and 1-chloro-4-methylbenzene 4e (25.4 mg, 0.200 mmol). The crude 
product was purified by silica gel chromatography with a CombiFlash system (4 g column, 
100:0→80:20 hexanes/EtOAc) to give 5e as a yellow solid in 83% yield (24.0 mg, 0.0829 mmol). 
63 
 
The enantiomeric excess was determined by HPLC analysis (254 nm, 25 °C) tR 19.2 min (major); 
tR 25.6 min (minor) [Chiracel AS-H (0.46 cm x 25 cm) (from Daicel Chemical Ind., Ltd.) hexane/i-
PrOH, 99:1, 1.0 mL/min] to be 99% ee. [α]D23 = +115.8° (c 0.52, CHCl3). 1H NMR (600 MHz, 
CDCl3) δ 1.72 (s, 3H), 2.39 (s, 3H), 2.65 (ddd, J = 14.3, 11.8, 4.9 Hz, 1H), 2.89 (ddd, J = 14.3, 
3.4, 3.4 Hz, 1H), 4.00 (ddd, J = 11.8, 11.8, 3.4 Hz, 1H), 4.36 (ddd, J = 11.8, 4.9, 3.4 Hz, 1H), 7.26 
– 7.18 (m, 2H), 7.29 – 7.23 (m, 3H), 7.38 – 7.33 (m, 1H), 7.43 (ddd, J = 8.2, 6.9, 1.0 Hz, 1H), 7.51 
(s, 1H), 7.83 (dd, J = 8.2, 1.0 Hz, 1H). 13C NMR (151 MHz, CDCl3) δ 21.2, 26.4, 36.7, 39.2, 50.0, 
106.7, 110.6, 121.3, 123.6, 125.8, 126.5, 127.4, 129.9, 134.0, 137.1, 137.5, 138.6, 193.8. HRMS 
(ESI): Calcd. for C20H20NO
+ ([M+H]+): 290.1539, Found: 290.1545. 
 (R)-8-(4-Methoxyphenyl)-8-methyl-7,8-dihydropyrido[1,2-
a]indol-9(6H)-one (5f): Prepared according to the general 
procedure G from 2b (20.0 mg, 0.100 mmol) and 1-chloro-4-
methoxybenzene 4f (28.6 mg, 0.200 mmol). The crude product was purified by silica gel 
chromatography with a CombiFlash system (4 g column, 100:0→80:20 hexanes/EtOAc) to give 
5f as a white solid in 92% yield (28.3 mg, 0.0927 mmol). The enantiomeric excess was determined 
by HPLC analysis (254 nm, 25 °C) tR 17.5 min (major); tR 23.6 min (minor) [Chiracel AS-H (0.46 
cm x 25 cm) (from Daicel Chemical Ind., Ltd.) hexane/i-PrOH, 95:5, 1.0 mL/min] to be 98% ee. 
[α]D23 = +109.9° (c 0.56, CHCl3). 1H NMR (600 MHz, CDCl3) δ 1.60 (s, 3H), 2.53 (ddd, J = 14.6, 
11.8, 4.8 Hz, 1H), 2.75 (ddd, J = 14.6, 3.6, 3.6 Hz, 1H), 3.74 (s, 3H), 3.89 (ddd, J = 11.8, 11.8, 3.6 
Hz, 1H), 4.26 (ddd, J = 11.8, 4.8, 3.6 Hz, 1H), 6.82 (d, J = 8.8 Hz, 2H), 7.14 (t, J = 7.4 Hz, 1H), 
7.19 (d, J = 8.8 Hz, 2H), 7.25 – 7.26 (m, 1H), 7.33 (t, J = 7.4 Hz, 1H), 7.40 (s, 1H), 7.72 (d, J = 
8.1 Hz, 1H). 13C NMR (151 MHz, CDCl3) δ 26.4, 36.8, 39.2, 49.7, 55.6, 106.7, 110.6, 114.6, 
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121.4, 123.6, 125.8, 127.4, 128.0, 133.6, 134.0, 137.5, 158.8, 193.9. HRMS (ESI): Calcd. for 
C20H20NO2
+ ([M+H]+): 306.1489, Found: 306.1499. 
  (R)-8-Methyl-8-(3-(trifluoromethyl)phenyl)-7,8-
dihydropyrido[1,2-a]indol-9(6H)-one (5g): Prepared according to 
the general procedure G from 2b (20.0 mg, 0.100 mmol) and 1-chloro-3-(trifluoromethyl)benzene 
4g (36.2 mg, 0.200 mmol). The crude product was purified by silica gel chromatography with a 
CombiFlash system (4 g column, 100:0→80:20 hexanes/EtOAc) to give 5g as an orange solid in 
90% yield (31.0 mg, 0.0903 mmol). The enantiomeric excess was determined by HPLC analysis 
(254 nm, 25 °C) tR 13.7 min (major); tR 18.4 min (minor) [Chiracel AS-H (0.46 cm x 25 cm) (from 
Daicel Chemical Ind., Ltd.) hexane/i-PrOH, 98:2, 1.0 mL/min] to be 99% ee. [α]D24 = +119.6° (c 
0.60, CHCl3). 1H NMR (600 MHz, CDCl3) δ 1.66 (s, 3H), 2.59 (ddd, J = 14.6, 11.0, 4.8 Hz, 1H), 
2.85 (ddd, J = 14.6, 3.8, 3.8 Hz, 1H), 3.93 (ddd, J = 12.4, 11.0, 3.8 Hz, 1H), 4.31 (ddd, J = 12.4, 
4.8, 4.8 Hz, 1H), 7.17 (t, J = 7.8 Hz, 1H), 7.28 (d, J = 8.2 Hz, 1H), 7.40 (ddd, J = 7.8, 7.1, 0.7 Hz, 
1H), 7.39 – 7.42 (m, 1H), 7.44 – 7.45 (m, 2H), 7.50 (d, J = 7.5 Hz, 1H), 7.61 (s, 1H), 7.74 (d, J = 
8.2 Hz, 1H). 13C NMR (151 MHz, CDCl3) δ 26.1, 36.6, 39.1, 50.2, 107.5, 110.6, 121.6, 123.2 (q, 
J = 3.0, 1C), 123.8, 124.3 (q, J = 271.8, 1C), 124.4 (q, J = 4.5, 1C), 126.2, 127.4, 129.7, 130.4 (q, 
J = 3.0, 1C), 131.6 (q, J = 31.7, 1C), 133.5, 137.6, 143.1, 192.7. 19F NMR (CDCl3, 565 MHz): δ 
-63.05 (s, 3F). HRMS (ESI): Calcd. for C20H17F3NO
+ ([M+H]+): 344.1257, Found: 344.1264. 
 (R)-8-(3-Fluorophenyl)-8-methyl-7,8-dihydropyrido[1,2-a]indol-
9(6H)-one (5h): Prepared according to the general procedure G from 
2b (20.0 mg, 0.100 mmol) and 1-chloro-3-fluorobenzene 4h (26.2 mg, 0.200 mmol). The crude 
product was purified by silica gel chromatography with a CombiFlash system (4 g column, 
100:0→80:20 hexanes/EtOAc) to give 5h as a yellow oil in 75% yield (22.0 mg, 0.0750 mmol). 
65 
 
The enantiomeric excess was determined by HPLC analysis (254 nm, 25 °C) tR 18.7 min (major); 
tR 24.0 min (minor) [Chiracel AS-H (0.46 cm x 25 cm) (from Daicel Chemical Ind., Ltd.) hexane/i-
PrOH, 98:2, 1.0 mL/min] to be 99% ee. [α]D23 = +148.6° (c 0.70, CHCl3). 1H NMR (600 MHz, 
CDCl3) δ 1.63 (s, 3H), 2.57 (ddd, J = 14.4, 11.6, 4.8 Hz, 1H), 2.77 (ddd, J = 14.4, 3.6, 3.6 Hz, 1H), 
3.91 (ddd, J = 11.6, 11.6, 3.6 Hz, 1H), 4.28 (ddd, J = 11.6, 4.8, 3.6 Hz, 1H), 6.90 – 6.93 (m, 1H), 
7.00 – 7.04 (m, 2H), 7.16 (ddd, J = 8.2, 7.0, 1.0 Hz, 1H), 7.23 – 7.28 (m, 2H), 7.35 (ddd, J = 8.2, 
1.0, 1.0 Hz, 1H), 7.43 (s, 1H), 7.73 (d, J = 8.2 Hz, 1H). 13C NMR (151 MHz, CDCl3) δ 26.2, 36.8, 
39.1, 50.2, 107.2, 110.6, 113.9 (d, J = 22.6, 1C), 114.5 (d, J = 19.6, 1C), 121.5, 122.4 (d, J = 3.0, 
1C), 123.8, 126.1, 127.4, 130.7 (d, J = 7.5, 1C), 133.7, 137.6, 144.5 (d, J = 6.0, 1C), 163.4 (d, J = 
247.6, 1C), 192.9. 19F NMR (CDCl3, 565 MHz): δ -112.3 (s, 1F). HRMS (ESI): Calcd. for 
C19H17FNO
+ ([M+H]+): 294.1289, Found: 294.1293. 
 (R)-8-(Benzo[d][1,3]dioxol-5-yl)-8-methyl-7,8-
dihydropyrido[1,2-a]indol-9(6H)-one (5i): Prepared according to 
the general procedure G from 2b (20.0 mg, 0.100 mmol) and 5-
chlorobenzo[d][1,3]dioxole 4i (31.4 mg, 0.200 mmol). The crude product was purified by silica 
gel chromatography with a CombiFlash system (4 g column, 100:0→80:20 hexanes/EtOAc) to 
give 5i as a yellow solid in 82% yield (26.3 mg, 0.0823 mmol). The enantiomeric excess was 
determined by HPLC analysis (254 nm, 25 °C) tR 26.0 min (major); tR 36.1 min (minor) [Chiracel 
AS-H (0.46 cm x 25 cm) (from Daicel Chemical Ind., Ltd.) hexane/i-PrOH, 95:5, 1.0 mL/min] to 
be 99% ee. [α]D23 = +132.2° (c 0.48, CHCl3). 1H NMR (600 MHz, CDCl3) δ 1.59 (s, 3H), 2.53 
(ddd, J = 14.2, 11.8, 4.8 Hz, 1H), 2.72 (ddd, J = 14.2, 3.2, 3.2 Hz, 1H), 3.94 (ddd, J = 11.8, 11.8, 
3.2 Hz, 1H), 4.26 (ddd, J = 11.8, 4.8, 3.2 Hz, 1H), 5.90 (d, J = 9.7 Hz, 2H), 6.69 (s, 2H), 6.80 (s, 
1H), 7.15 (t, J = 8.0 Hz, 1H), 7.26 – 7.27 (m, 1H), 7.34 (t, J = 7.4 Hz, 1H), 7.40 (s, 1H), 7.72 (d, J 
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= 8.0 Hz, 1H). 13C NMR (151 MHz, CDCl3) δ 26.5, 36.9, 39.2, 50.1, 101.5, 106.9, 107.2, 108.7, 
110.6, 120.0, 121.4, 123.7, 125.9, 127.4, 133.9, 135.5, 137.5, 146.9, 148.5, 193.5. HRMS (ESI): 
Calcd. for C20H18NO3
+ ([M+H]+): 320.1281, Found: 320.1287. 
 (R)-8-Methyl-8-(naphthalen-2-yl)-7,8-dihydropyrido[1,2-
a]indol-9(6H)-one (5j): Prepared according to the general 
procedure G from 2b (20.0 mg, 0.100 mmol) and 2-chloronaphthalene 4j (32.6 mg, 0.200 mmol). 
The crude product was purified by silica gel chromatography with a CombiFlash system (4 g 
column, 100:0→80:20 hexanes/EtOAc) to give 5j as a yellow solid in 95% yield (31.1 mg, 0.0956 
mmol). The enantiomeric excess was determined by HPLC analysis (254 nm, 25 °C) tR 23.2 min 
(major); tR 37.0 min (minor) [Chiracel AS-H (0.46 cm x 25 cm) (from Daicel Chemical Ind., Ltd.) 
hexane/i-PrOH, 98:2, 1.0 mL/min] to be 99% ee. [α]D24 = +24.4° (c 0.57, CHCl3). 1H NMR (600 
MHz, CDCl3) δ 1.72 (s, 3H), 2.62 (ddd, J = 14.6, 12.8, 4.5 Hz, 1H), 2.94 (ddd, J = 14.6, 3.6, 3.6 
m, 1H), 3.90 (ddd, J = 12.2, 12.2, 3.6 Hz, 1H), 4.28 (ddd, J = 12.2, 4.5, 3.6 Hz, 1H), 7.14 (t, J = 
7.4 Hz, 1H), 7.21 – 7.23 (m, 1H), 7.32 (t, J = 7.4 Hz, 1H), 7.42 – 7.49 (m, 4H), 7.65 (s, 1H), 7.71 
– 7.78 (m, 3H), 7.83 (d, J = 8.6 Hz, 1H). 13C NMR (151 MHz, CDCl3) δ 26.2, 36.8, 39.3, 50.6, 
106.9, 110.6, 121.4, 123.7, 124.3, 125.9, 125.9, 126.4, 126.6, 127.4, 127.7, 128.4, 129.1, 132.6, 
133.6, 134.0, 137.5, 139.1, 193.7. HRMS (ESI): Calcd. for C23H20NO
+ ([M+H]+): 326.1539, 
Found: 326.1543. 
 (R)-8-Methyl-8-phenyl-7,8-dihydropyrido[1,2-a]indol-9(6H)-one 
(5k): Prepared according to the general procedure G from 2b (20.0 mg, 
0.100 mmol) and chlorobenzene 4k (22.6 mg, 0.200 mmol). The crude product was purified by 
silica gel chromatography with a CombiFlash system (4 g column, 100:0→80:20 hexanes/EtOAc) 
to give 5k as a yellow solid in 99% yield (27.4 mg, 0.0995 mmol). The enantiomeric excess was 
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determined by HPLC analysis (254 nm, 25 °C) tR 16.7 min (major); tR 21.7 min (minor) [Chiracel 
AS-H (0.46 cm x 25 cm) (from Daicel Chemical Ind., Ltd.) hexane/i-PrOH, 98:2, 1.0 mL/min] to 
be 98% ee. [α]D23 = +148.7° (c 0.54, CHCl3). 1H NMR (400 MHz, CDCl3) δ 1.62 (s, 3H), 2.54 
(ddd, J = 14.2, 12.0, 4.8 Hz, 1H), 2.79 (ddd, J = 14.2, 3.4, 3.4 Hz, 1H), 3.86 (ddd, J = 12.0, 12.0, 
3.4 Hz, 1H), 4.24 (ddd, J = 12.0, 4.8, 3.4 Hz, 1H), 7.13 (t, J = 7.6 Hz, 1H), 7.18 – 7.34 (m, 7H), 
7.41 (s, 1H), 7.72 (d, J = 8.1 Hz, 1H). 13C NMR (101 MHz, CDCl3) δ 26.3, 36.7, 39.2, 50.3, 106.7, 
110.6, 121.4, 123.6, 125.9, 126.6, 127.3, 127.4, 129.2, 134.0, 137.4, 141.7, 193.7. HRMS (ESI): 
Calcd. for C19H18NO
+ ([M+H]+): 276.1383, Found: 276.1388. 
 (R)-7-(3-Methoxyphenyl)-7-methyl-6,7-dihydroindolizin-8(5H)-one 
(5l): Prepared according to the general procedure F from 2k (20.0 mg, 
0.134 mmol) and 1-chloro-3-methoxybenzene 4d (38.2 mg, 0.268 mmol). The crude product was 
purified by silica gel chromatography with a CombiFlash system (4 g column, 100:0→80:20 
hexanes/EtOAc) to give 5l as a colorless oil in 70% yield (28.7 mg, 0.0939 mmol). The 
enantiomeric excess was determined by HPLC analysis (254 nm, 25 °C) tR 27.2 min (major); tR 
31.7 min (minor) [Chiracel AS-H (0.46 cm x 25 cm) (from Daicel Chemical Ind., Ltd.) hexane/i-
PrOH, 98:2, 1.0 mL/min] to be 91% ee. [α]D25 = +123.4° (c 0.87, CHCl3). 1H NMR (400 MHz, 
CDCl3) δ 1.56 (s, 3H), 2.44 (ddd, J = 14.2, 12.0, 4.6 Hz, 1H), 2.60 (ddd, J = 14.2, 3.4, 3.4 Hz, 1H), 
3.76 (s, 3H), 3.86 (ddd, J = 12.0, 12.0, 3.4 Hz, 1H), 4.03 (ddd, J = 12.0, 4.6, 3.4 Hz, 1H), 6.25 (dd, 
J = 4.0, 2.4 Hz, 1H), 6.74 – 6.86 (m, 4H), 7.11 (dd, J = 4.0, 1.4 Hz, 1H), 7.22 (t, J = 8.0 Hz, 1H). 
13C NMR (101 MHz, CDCl3) δ 26.3, 37.6, 42.6, 49.3, 55.5, 111.1, 112.0, 113.3, 115.2, 119.1, 
125.8, 130.0, 130.8, 144.1, 160.1, 190.4. HRMS (ESI): Calcd. for C16H18NO2
+ ([M+H]+): 
256.1332, Found: 256.1335. 
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 (S)-2-Methyl-2-phenyl-2,3-dihydro-1H-pyrrolo[1,2-a]indol-1-one (9a): 
Prepared according to the general procedure H from 2a (37.0 mg, 0.200 
mmol) and 1-chloro-3-methoxybenzene 8a (63.0 mg, 0.399 mmol). The 
mixture was purified by flash column chromatography (98:2 hexane:EtOAc) to give 9a as a white 
solid in 78% yield (40.7 mg, 0.156 mmol).  The enantiomeric excess was determined by HPLC 
analysis (254 nm, 25 C) tR 12.82 min (major); tR 18.51 min (minor) [Chiracel (AS-H) (from Diacel 
Chemical Ind., Ltd.) hexane/i-PrOH 95:5, 1.0 ml/min] to be 99% ee. []D24 = -228.9  (c 0.59, 
CHCl3). The NMR data is consistent with the data available in literature.
94 1H NMR (400 MHz, 
CDCl3)  1.84 (s, 3H), 4.48 (d, J = 11.0 Hz, 1H), 4.76 (d, J = 11.0 Hz, 1H), 7.14 (s, 1H), 7.21 - 
7.30 (m, 2H), 7.31 - 7.35 (m, 4H), 7.38 - 7.46 (m, 2H), 7.81 (ddd, J = 8.4, 1.2, 1.2 Hz, 1H). 13C 
NMR (101 MHz, CDCl3)  22.6, 56.9, 57.5, 101.0, 111.0, 121.9, 124.6, 125.7, 126.2, 127.7, 129.2, 
132.7, 132.8, 135.6, 142.5, 196.3. 
(S)-2-(3-Methoxyphenyl)-2-methyl-2,3-dihydro-1H-pyrrolo[1,2-
a]indol-1-one (9b): Prepared according to the general procedure H 
from 2a (37.0 mg, 0.199 mmol) and 1-bromo-3-methoxybenzene 8b 
(74.7 mg, 0.399 mmol). The crude product was purified by silica gel chromatography with a 
CombiFlash system (4 g column, 100:0→80:20 hexanes/EtOAc) to give a mixture of 9b and 
possibly, its rotameric isomer in 85:15 ratio, as a yellow solid in 44% combined yield (25.7 mg, 
0.0882 mmol). The enantiomeric excess was determined by HPLC analysis (220 nm, 25 °C) tR 
32.7 min (major); tR 50.0 min (minor) [Chiracel AS-H (0.46 cm x 25 cm) (from Daicel Chemical 
Ind., Ltd.) hexane/i-PrOH, 98:2, 1.0 mL/min] to be 99% ee. [α]D24 = -193.5° (c 0.15, CHCl3). 1H 
NMR (400 MHz, CDCl3) δ 1.81 (s, 3H), 3.77 (s, 3H), 4.47 (d, J = 11.0 Hz, 1H), 4.75 (d, J = 11.0 
Hz, 1H), 6.79 – 6.81 (s, 1H), 6.88 – 6.90 (m, 2H), 7.12 (s, 1H), 7.20 – 7.26 (m, 2H), 7.37 – 7.45 
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(m, 2H), 7.80 (d, J = 8.4 Hz, 1H). 13C NMR (101 MHz, CDCl3) δ 23.6, 55.6, 56.9, 57.4, 101.1, 
111.0, 112.5, 112.9, 118.6, 121.9, 124.6, 125.7, 130.2, 132.7, 134.8, 135.7, 144.1, 160.2, 196.2. 
HRMS (ESI): Calcd. for C19H18NO2
+ ([M+H]+): 292.1332, Found: 292.1334. The extra peaks in 
1H and 13C NMR might have resulted due to the presence of rotameric isomer of 9b. 
 (S)-2-Methyl-2-(4-(trifluoromethyl)phenyl)-2,3-dihydro-1H-
pyrrolo[1,2-a]indol-1-one (9c): Prepared according to the general 
procedure H from 2a (37.0 mg, 0.199 mmol) and 1-bromo-4-
(trifluoromethyl)benzene 8c (89.9 mg, 0.399 mmol). The crude product 
was purified by silica gel chromatography with a CombiFlash system (4 g column, 100:0→80:20 
hexanes/EtOAc) to give a mixture of 9c and possibly its rotameric isomer in 86:14 ratio, as a light 
yellow solid in 68% combined yield (44.6 mg, 0.135 mmol). The enantiomeric excess was 
determined by HPLC analysis (220 nm, 25 °C) tR 13.0 min (major); tR 15.8 min (minor) [Chiracel 
AS-H (0.46 cm x 25 cm) (from Daicel Chemical Ind., Ltd.) hexane/i-PrOH, 95:5, 1.0 mL/min] to 
be 99% ee. [α]D25 = -133.3° (c 0.85, CHCl3). 1H NMR (600 MHz, CDCl3) δ 1.86 (s, 3H), 4.52 (d, 
J = 11.0 Hz, 1H), 4.75 (d, J = 11.0 Hz, 1H), 7.15 (s, 1H), 7.24 (ddd, J = 8.2, 6.7, 1.1 Hz, 1H), 7.40 
– 7.48 (m, 4H), 7.59 (d, J = 8.2 Hz, 2H), 7.82 (d, J = 8.2 Hz, 1H). 13C NMR (151 MHz, CDCl3) δ 
23.8, 56.5, 57.5, 101.6, 111.0, 122.2, 124.3 (q, J = 271.8 Hz, 1C), 124.8, 126.1, 126.2 (q, J = 4.5 
Hz, 1C), 126.8, 130.0 (q, J = 33.2 Hz, 1C), 132.8, 134.4, 135.8, 146.4 (q, J = 1.5 Hz, 1C), 195.3. 
19F NMR (CDCl3, 376 MHz): δ -62.9 (s, 3F). HRMS (ESI): Calcd. for C19H15F3NO+ ([M+H]+): 
330.1100, Found: 330.1107.  
The extra peaks in 1H and 13C NMR might have resulted due to the presence of rotameric isomer 
of 9c. Variable-temperature NMR measurements (Bruker 400 MHz) on a sample of 9c in DMSO-
d6 at temperatures ranging from 20 °C to 135 °C, upper limit of the instrument, did not show 
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coalescence of peaks. Additional NMR studies (1-D selective chemical-exchange NMR) were 
carried out to confirm the presence of rotameric isomer.95 However, the results were inconclusive. 
(S)-2-Methyl-2-phenyl-2,3-dihydro-1H-pyrrolizin-1-one (9d): Prepared 
according to the general procedure I from 2m (27.0 mg, 0.200 mmol) and 1-
bromobenzene 8a (63.0 mg, 0.399 mmol). The crude product was purified by flash 
column chromatography (98:2 hexane:EtOAc) to give 9d as a white solid in 80% yield (33.8 mg, 
0.160 mmol). The enantiomeric excess was determined by HPLC analysis (254 nm, 25 C) tR 28.04 
min (major); tR 46.36 min (minor) [Chiracel OJ-H (0.46 cm x 25 cm) (from Diacel Chemical Ind., 
Ltd.) hexane/i-PrOH 80:20, 1.0 ml/min] to be 99% ee. []D24 = -262.4 (c 0.78, CHCl3). The NMR 
data is consistent with the data available in literature.94 1H NMR (400 MHz, CDCl3)  1.74 (s, 
3H), 4.33 (d, J = 11.8 Hz, 1H), 4.56 (d, J = 11.8 Hz, 1H), 6.58 (dd, J = 4.0, 2.4 Hz, 1H), 6.82 (dd, 
J = 4.0, 0.6 Hz, 1H), 7.05 – 7.06 (m, 1H), 7.21 - 7.25 (m, 1H), 7.27 – 7.33 (m, 4H). 13C NMR (101 
MHz, CDCl3)  23.2, 57.1, 58.7, 109.2, 117.3, 123.0, 125.9, 127.2, 128.8, 131.3, 142.6, 192.6. 
 (S)-2-Methyl-2-(4-(trifluoromethyl)phenyl)-2,3-dihydro-1H-pyrrolizin-1-
one (9e): Prepared according to the general procedure I from 2m (27.0 mg, 0.199 
mmol) and 1-bromo-4-(trifluoromethyl)benzene 8b (89.9 mg, 0.399 mmol). The 
crude product was purified by silica gel chromatography with a CombiFlash 
system (4 g column, 100:0→80:20 hexanes/EtOAc) to give 9e as a light yellow solid in 90% yield 
(50.0 mg, 0.179 mmol). The enantiomeric excess was determined by HPLC analysis (220 nm, 25 
°C) tR 21.0 min (major); tR 29.1 min (minor) [Chiracel AS-H (0.46 cm x 25 cm) (from Daicel 
Chemical Ind., Ltd.) hexane/i-PrOH, 98:2, 1.0 mL/min] to be 99% ee. [α]D23 = -68.0° (c 0.62, 
CHCl3). 1H NMR (600 MHz, CDCl3) δ 1.78 (s, 3H), 4.38 (d, J = 11.8 Hz, 1H), 4.57 (d, J = 11.8 
Hz, 1H), 6.62 (dd, J = 4.0, 2.2 Hz, 1H), 6.86 (dd, J = 4.0, 1.0 Hz, 1H), 7.10 (d, J = 2.2 Hz, 1H), 
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7.43 (d, J = 8.4 Hz, 2H), 7.58 (d, J = 8.4 Hz, 2H). 13C NMR (151 MHz, CDCl3) δ 23.6, 57.4, 58.6, 
110.0, 118.1, 123.6, 124.3 (q, J = 271.8 Hz, 1C), 126.1 (q, J = 4.5 Hz, 1C), 126.8, 129.8 (q, J = 
33.2 Hz, 1C), 131.3, 146.8, 191.5. 19F NMR (CDCl3, 376 MHz): δ -62.9 (s, 3F). HRMS (ESI): 
Calcd. for C15H13F3NO
+ ([M+H]+): 280.0944, Found: 280.0949. 
(S)-2-Methyl-2-(3-(trifluoromethyl)phenyl)-2,3-dihydro-1H-pyrrolizin-
1-one (9f): Prepared according to the general procedure I from 2m (27.0 mg, 
0.199 mmol) and 1-bromo-3-(trifluoromethyl)benzene 8d (89.9 mg, 0.399 
mmol). The crude product was purified by silica gel chromatography with a CombiFlash system 
(4 g column, 100:0→80:20 hexanes/EtOAc) to give 9f as a yellow oil in 88% yield (49.0 mg, 0.175 
mmol). The enantiomeric excess was determined by HPLC analysis (254 nm, 25 °C) tR 17.5 min 
(major); tR 25.0 min (minor) [Chiracel AS-H (0.46 cm x 25 cm) (from Daicel Chemical Ind., Ltd.) 
hexane/i-PrOH, 98:2, 1.0 mL/min] to be 99% ee. [α]D23 = -67.3° (c 0.74, CHCl3). 1H NMR (400 
MHz, CDCl3) δ 1.78 (s, 3H), 4.39 (d, J = 11.8 Hz, 1H), 4.56 (d, J = 11.8 Hz, 1H), 6.62 (dd, J = 
4.0, 2.0 Hz, 1H), 6.86 (dd, J = 4.0, 1.0 Hz, 1H), 7.10 (dd, J = 2.0, 1.0 Hz, 1H), 7.42 – 7.53 (m, 
3H), 7.58 (s, 1H). 13C NMR (101 MHz, CDCl3) δ 23.8, 57.3, 58.6, 110.0, 118.1, 123.1 (q, J = 4.0 
Hz, 1C), 123.7, 124.3 (q, J = 273.7 Hz, 1C), 124.5 (q, J = 4.0 Hz, 1C), 129.7, 129.9 (q, J = 2.0 Hz, 
1C), 131.3, 131.4 (q, J = 32.3 Hz, 1C), 143.8, 191.6. 19F NMR (CDCl3, 376 MHz): δ -62.8 (s, 3F). 
HRMS (ESI): Calcd. for C15H13F3NO
+ ([M+H]+): 280.0944, Found: 280.0947. 
(S)-2-(3-Fluorophenyl)-2-methyl-2,3-dihydro-1H-pyrrolizin-1-one (9g): 
Prepared according to the general procedure I from 2m (27.0 mg, 0.199 mmol) 
and 1-bromo-3-fluorobenzene 8e (69.9 mg, 0.399 mmol). The crude product 
was purified by silica gel chromatography with a CombiFlash system (4 g column, 100:0→80:20 
hexanes/EtOAc) to give 9g as a light yellow oil in 92% yield (42.3 mg, 0.184 mmol). The 
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enantiomeric excess was determined by HPLC analysis (254 nm, 25 °C) tR 25.2 min (major); tR 
35.5 min (minor) [Chiracel AS-H (0.46 cm x 25 cm) (from Daicel Chemical Ind., Ltd.) hexane/i-
PrOH, 98:2, 1.0 mL/min] to be 99% ee. [α]D24 = -80.6° (c 0.84, CHCl3). 1H NMR (400 MHz, 
CDCl3) δ 1.74 (s, 3H), 4.35 (d, J = 11.8 Hz, 1H), 4.55 (d, J = 11.8 Hz, 1H), 6.60 (dd, J = 4.0, 2.4 
Hz, 1H), 6.85 (dd, J = 4.0, 0.8 Hz, 1H), 6.92 – 6.97 (m, 1H), 7.01 – 7.09 (m, 3H), 7.27 – 7.31 (m, 
1H). 13C NMR (101 MHz, CDCl3) δ 23.5, 57.2, 58.8, 109.9, 113.6 (d, J = 23.2 Hz, 1C), 114.5 (d, 
J = 21.2 Hz, 1C), 117.9, 121.9 (d, J = 3.0 Hz, 1C), 123.5, 130.6 (d, J = 9.1 Hz, 1C), 131.4, 145.4 
(d, J = 7.1 Hz, 1C), 163.3 (d, J = 247.4 Hz, 1C), 191.8. 19F NMR (CDCl3, 376 MHz): δ -112.3 (m, 
1F). HRMS (EI): Calcd. for C14H13FNO
+ ([M+H]+): 230.0976, Found: 230.0979. 
 (S)-2-(3-Methoxyphenyl)-2-methyl-2,3-dihydro-1H-pyrrolizin-1-one 
(9h): Prepared according to the general procedure I from 2m (27.0 mg, 0.199 
mmol) and 1-bromo-3-methoxybenzene 8c (74.7 mg, 0.399 mmol). The 
crude product was purified by silica gel chromatography with a CombiFlash system (4 g column, 
100:0→80:20 hexanes/EtOAc) to give 9h as a light yellow oil in 99% yield (48.0 mg, 0.199 mmol). 
The enantiomeric excess was determined by HPLC analysis (254 nm, 25 °C) tR 25.6 min (major); 
tR 28.6 min (minor) [Chiracel AS-H (0.46 cm x 25 cm) (from Daicel Chemical Ind., Ltd.) hexane/i-
PrOH, 95:5, 1.0 mL/min] to be 98% ee. [α]D24 = -95.1° (c 0.95, CHCl3). 1H NMR (600 MHz, 
CDCl3) δ 1.74 (s, 3H), 3.77 (s, 3H), 4.33 (d, J = 11.6 Hz, 1H), 4.56 (d, J = 11.6 Hz, 1H), 6.59 (dd, 
J = 4.0, 2.2 Hz, 1H), 6.79 (ddd, J = 8.2, 2.2, 0.8 Hz, 1H), 6.83 (dd, J = 4.0, 0.8 Hz, 1H), 6.88 – 
6.85 (m, 2H), 7.06 – 7.07 (m, 1H), 7.24 (t, J = 8.2 Hz, 1H). 13C NMR (151 MHz, CDCl3) δ 23.5, 
55.6, 57.4, 59.0, 109.6, 112.3, 112.8, 117.7, 118.6, 123.3, 130.1, 131.7, 144.5, 160.2, 192.5. 
HRMS (ESI): Calcd. for C15H16NO2
+ ([M+H]+): 242.1176, Found: 242.1180. 
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 (S)-2-(4-Methoxyphenyl)-2-methyl-2,3-dihydro-1H-pyrrolizin-1-one (9i): 
Prepared according to the general procedure I from 2m (27.0 mg, 0.199 mmol) 
and 1-bromo-4-methoxybenzene 8f (74.2 mg, 0.399 mmol). The crude product 
was purified by silica gel chromatography with a CombiFlash system (4 g 
column, 100:0→80:20 hexanes/EtOAc) to give 9i as a yellow oil in 52% yield (25.0 mg, 0.104 
mmol). The enantiomeric excess was determined by HPLC analysis (220 nm, 25 °C) tR 18.0 min 
(major); tR 25.0 min (minor) [Chiracel AS-H (0.46 cm x 25 cm) (from Daicel Chemical Ind., Ltd.) 
hexane/i-PrOH, 90:10, 1.0 mL/min] to be 99% ee. [α]D25 = -87.7° (c 0.36, CHCl3). 1H NMR (400 
MHz, CDCl3) δ 1.73 (s, 3H), 3.78 (s, 3H), 4.33 (d, J = 11.6 Hz, 1H), 4.54 (d, J = 11.6 Hz, 1H), 
6.59 (dd, J = 4.0, 2.2 Hz, 1H), 6.82 – 6.86 (m, 3H), 7.06 (m, 1H), 7.20 – 7.22 (m, 2H). 13C NMR 
(101 MHz, CDCl3) δ 23.6, 55.6, 56.8, 59.1, 109.5, 114.5, 117.6, 123.2, 127.4, 131.7, 134.9, 158.9, 
193.0. HRMS (ESI): Calcd. for C15H16NO2
+ ([M+H]+): 242.1176, Found: 242.1180. 
 (S)-2-Methyl-2-(naphthalen-2-yl)-2,3-dihydro-1H-pyrrolizin-1-one (9j): 
Prepared according to the general procedure I from 2m (27.0 mg, 0.199 mmol) 
and 2-bromonaphthalene 8g (82.7 mg, 0.399 mmol). The crude product was 
purified by silica gel chromatography with a CombiFlash system (4 g column, 
100:0→80:20 hexanes/EtOAc) to give 9j as a light yellow solid in 96% yield (50.3 mg, 0.192 
mmol). The enantiomeric excess was determined by HPLC analysis (220 nm, 25 °C) tR 24.1 min 
(major); tR 36.0 min (minor) [Chiracel AS-H (0.46 cm x 25 cm) (from Daicel Chemical Ind., Ltd.) 
hexane/i-PrOH, 95:5, 1.0 mL/min] to be 99% ee. [α]D23 = -287.1° (c 0.81, CHCl3). 1H NMR (400 
MHz, CDCl3) δ 1.87 (s, 3H), 4.42 (d, J = 11.8 Hz, 1H), 4.66 (d, J = 11.8 Hz, 1H), 6.62 (dd, J = 
4.0, 2.2 Hz, 1H), 6.88 (dd, J = 4.0, 1.0 Hz, 1H), 7.10 (dd, J = 2.2, 1.0 Hz, 1H), 7.31 (dd, J = 8.6, 
2.0 Hz, 1H), 7.43 – 7.50 (m, 2H), 7.77 – 7.82 (m, 4H). 13C NMR (101 MHz, CDCl3) δ 23.6, 57.6, 
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58.9, 109.6, 117.8, 123.4, 124.4, 125.1, 126.4, 126.7, 127.8, 128.5, 129.1, 131.8, 132.7, 133.5, 
140.1, 192.7. HRMS (ESI): Calcd. for C18H16NO
+ ([M+H]+): 262.1226, Found: 262.1231. 
 (S)-2-Benzyl-2-phenyl-2,3-dihydro-1H-pyrrolizin-1-one (9k): Prepared 
according to the modified version of  the general procedure I from 2n (42.0 mg, 
0.199 mmol) and bromobenzene 8a (63.0 mg, 0.398 mmol) at 10 °C.  The mixture 
was purified by flash column chromatography (98:2 hexane:EtOAc) to give 9k as a white solid in 
69% yield (39.6 mg, 0.138 mmol). The enantiomeric excess was determined by HPLC analysis 
(254 nm, 25 C) tR 35.24 min (major); tR 48.92 min (minor) [Chiracel OJ-H (0.46 cm x 25 cm) 
(from Diacel Chemical Ind., Ltd.) hexane/i-PrOH 80:20, 1.0 ml/min] to be 99% ee. []D24 = -
219.1 (c 0.78, CHCl3). 1H NMR (600 MHz, CDCl3)  3.33 (d, J = 13.8 Hz, 1H), 3.63 (d, J = 13.8 
Hz, 1H), 4.53 (d, J =12.0 Hz, 1H), 4.57 (d, J = 12.0 Hz, 1H), 6.45 (dd, J = 4.2, 2.4 Hz, 1H), 6.73 
(dd, J = 4.2, 1.2 Hz, 1H), 6.90 (m, 1H), 7.05 – 7.08 (m, 2H), 7.14 – 7.20 (m, 3H), 7.25 – 7.29 (m, 
1H), 7.34 (t, J = 8.0 Hz, 2H), 7.43 (d, J = 8.0 Hz, 2H). 13C NMR (101 MHz, CDCl3)  43.2, 53.5, 
62.0, 109.3, 117.4, 123.3, 126.7, 127.2, 127.3, 128.3, 129.1, 130.5, 132.2, 136.7, 141.9, 191.3. 
HRMS (ESI): Calcd. for C20H18NO
+ ([M+H]+): 288.1383, found 288.1390. 
 (S)-2-(4-Methoxybenzyl)-2-phenyl-2,3-dihydro-1H-pyrrolizin-1-one 
(9l): Prepared according to the general procedure I from 2o (48.0 mg, 0.199 
mmol) and bromobenzene 8a (63.0 mg, 0.398 mmol).  The mixture was 
purified by flash column chromatography (98:2 hexane:EtOAc) to give 9l as 
a white solid in 91% yield (57.6 mg, 0.181 mmol). []D24 = -81.2 (c 1.22, CHCl3)  The 
enantiomeric excess was determined by HPLC analysis (254 nm, 25 C) tR 29.37 min (major); tR 
42.10 min (minor) [Chiracel AD-H (0.46 cm x 25 cm) (from Daicel Chemical Ind., Ltd.) hexane/i-
PrOH, 95:5, 1.0 ml/min] to be 99%.   1H NMR (400 MHz, CDCl3)  3.15 (d, J = 14.0 Hz, 1H), 
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3.51 (d, J = 14.0 Hz, 1H), 3.65 (s, 3H), 4.43 (d, J = 11.8 Hz, 1H), 4.48 (d, J = 11.8 Hz, 1H) 6.37 
(dd, J = 4.0, 2.2 Hz, 1H), 6.61 - 6.65 (m, 3H), 6.82 – 6.83 (m, 1H), 6.89 (d, J = 8.6 Hz, 2H), 7.16 
– 7.20 (m, 1H), 7.25 (t, J = 7.2 Hz, 2H), 7.34 (d, J = 8.6 Hz, 2H).  13C NMR (101 MHz, CDCl3)  
42.4, 53.5, 55.5, 62.2, 109.2, 114.0, 117.4, 123.3, 126.7, 127.5, 128.6, 129.0, 131.5, 132.3, 142.1, 
158.7, 191.5. HRMS (ESI) Calcd. for C21H20NO2
+ ([M+H]+):  318.1489, found 318.1494. 
 (S)-2-(4-Chlorobenzyl)-2-phenyl-2,3-dihydro-1H-pyrrolizin-1-one (9m): 
Prepared according to the general procedure I from 2p (49.0 mg, 0.199 mmol) 
and bromobenzene 8a (63.0 mg, 0.399 mmol).  The mixture was purified by 
flash column chromatography (98:2 hexane:EtOAc) to give 9m as a white solid 
in 84% yield (54.0 mg, 0.168 mmol).  The enantiomeric excess was determined by HPLC analysis 
(254 nm, 25 C) tR 21.01 min (major); tR 24.97 min (minor) [Chiracel AS-H (0.46 cm x 25 cm) 
(from Diacel Chemical Ind., Ltd.) hexane/i-PrOH 95:5, 1.0 ml/min] to be 99%. []D24 = -70.1 (c 
0.68, CHCl3).  1H NMR (600 MHz, CDCl3)  3.28 (d, J = 13.8 Hz, 1H), 3.58 (d, J = 13.8 Hz, 1H), 
4.47 (d, J = 12.0 Hz, 1H), 4.57 (d, J = 12.0 Hz, 1H), 6.47 (dd, J = 3.6, 1.8 Hz, 1H), 6.73 (d, J = 
3.6 Hz, 1H), 6.92 (m, 1H), 6.99 (d, J = 8.0 Hz, 2H), 7.13 (d, J = 8.0 Hz, 2H), 7.24 - 7.29 (m, 1H), 
7.34 (t, J = 7.8 Hz, 2H), 7.40 (d, J = 7.8 Hz, 2H). 13C NMR (101 MHz, CDCl3)  42.6, 53.4, 61.9, 
109.5, 117.6, 123.4, 126.7, 127.7, 128.7, 129.2, 131.8, 132.1, 133.1, 135.1, 141.6, 191.0. HRMS 
(ESI) Calcd. for C20H17ClNO
+ ([M+H]+): 322.0993, found 322.0998. 
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General Procedure J: Synthesis of (R)-8-Methyl-8-(pyridin-2-yl)-7,8-dihydropyrido[1,2-
a]indol-9(6H)-one (7a) 
 
 
In a nitrogen-filled glovebox, 8-methyl-7,8-dihydropyrido[1,2-a]indol-9(6H)-one (2b) 
(0.100 mmol, 1.0 equiv), Ni(COD)2 (2.8 mg, 0.0100 mmol, 0.10 equiv), (R)-DIFLUORPHOS (9.2 
mg, 0.0120 mmol, 0.12 equiv), NaOtBu (19.3 mg, 0.200 mmol, 2.0 equiv), 2-chloropyridine 6a 
(0.200 mmol, 2.0 equiv), a magnetic stirring bar, and toluene (0.5 mL) were added to a 1-dram 
vial. The vial was sealed with a cap containing a PTFE septum and removed from the glovebox. 
The reaction mixture was stirred at 80 °C in an oil bath for 48 h.  The vial was removed from the 
oil bath and allowed to cool to room temperature.  The reaction mixture was filtered through short 
plug of silica gel (eluting with 20 mL of 3:2 hexanes:EtOAc). The crude reaction mixture was 
concentrated under reduced pressure. The crude product was purified with a CombiFlash system 
with 5-20% ethyl acetate in hexanes as eluent to give (R)-8-methyl-8-(pyridin-2-yl)-7,8-
dihydropyrido[1,2-a]indol-9(6H)-one (7a).  
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General Procedure K: Synthesis of (R)-8-Heteroaryl-8-methyl-7,8-dihydropyrido[1,2-
a]indol-9(6H)-ones (7b-i) 
 
 
 
In a nitrogen-filled glovebox, 8-methyl-7,8-dihydropyrido[1,2-a]indol-9(6H)-one (2b) 
(0.100 mmol, 1.0 equiv), Ni(COD)2 (2.8 mg, 0.0100 mmol, 0.10 equiv), (R)-DIFLUORPHOS (9.2 
mg, 0.0120 mmol, 0.12 equiv), NaOtBu (19.3 mg, 0.200 mmol, 2.0 equiv), the appropriate 
heteroaryl chloride 6b-i (0.200 mmol, 2.0 equiv), a magnetic stirring bar, and toluene (0.5 mL) 
were added to a 1-dram vial. The vial was sealed with a cap containing a PTFE septum and 
removed from the glovebox. The reaction mixture was stirred at 85 °C in an oil bath for 48 h.  The 
vial was removed from the oil bath and allowed to cool to room temperature.  The reaction mixture 
was filtered through short plug of silica gel (eluting with 20 mL of 3:2 hexanes:EtOAc).  The crude 
reaction mixture was concentrated under reduced pressure. The crude product was purified with a 
CombiFlash system with 5-10% ethyl acetate in hexanes as eluent to give the appropriate (R)-8-
heteroaryl-8-methyl-7,8-dihydropyrido[1,2-a]indol-9(6H)-ones (7b-i).  
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General Procedure L: Synthesis of (R)-2-Heteroaryl-2-methyl-2,3-dihydro-1H-pyrrolizin-1-
one (11a-d) and (S)-2-Methyl-2-(6-(trifluoromethyl)pyridin-3-yl)-2,3-dihydro-1H-
pyrrolizin-1-one (11f) 
 
 
In a nitrogen-filled glovebox, 2-methyl-2,3-dihydro-1H-pyrrolizin-1-one (2m) (0.200 
mmol, 1.0 equiv), Ni(COD)2 (5.5 mg, 0.0200 mmol, 0.10 equiv), (R)-DIFLUORPHOS (18.4 mg, 
0.0240 mmol, 0.12 equiv),  NaOtBu (38.4 mg, 0.400 mmol, 2.0 equiv), benzonitrile (41.2 mg, 
0.400 mmol, 2.0 equiv), the appropriate heteroaryl bromide 10a-f (0.400 mmol, 2.0 equiv), a 
magnetic stirring bar, and toluene (1.0 mL) were added to a 1-dram vial. The vial was sealed with 
a cap containing a PTFE septum and removed from the glovebox. The reaction mixture was stirred 
at 25 °C for 48 h.  The vial was removed from the oil bath and allowed to cool to room temperature.  
The reaction mixture was filtered through short plug of silica gel (eluting with 20 mL of 3:2 
hexanes:EtOAc).  The crude reaction mixture was concentrated under reduced pressure. The crude 
product was purified with a CombiFlash system with 5-20% ethyl acetate in hexanes as eluent to 
give the appropriate (R)-2-heteroaryl-2-methyl-2,3-dihydro-1H-pyrrolizin-1-one (11a-d) and (S)-
2-methyl-2-(6-(trifluoromethyl)pyridin-3-yl)-2,3-dihydro-1H-pyrrolizin-1-one (11f).  
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 (R)-8-Methyl-8-(pyridin-2-yl)-7,8-dihydropyrido[1,2-a]indol-
9(6H)-one (7a): Prepared according to the general procedure J from 2b 
(20.0 mg, 0.100 mmol) and 2-chloropyridine 6a (22.8 mg, 0.200 mmol). 
The crude product was purified by silica gel chromatography with a CombiFlash system (4 g 
column, 100:0→80:20 hexanes/EtOAc) to give 7a as a light yellow solid in 72% yield (20.0 mg, 
0.0724 mmol). The enantiomeric excess was determined by HPLC analysis (254 nm, 25 °C) tR 
21.2 min (major); tR 28.5 min (minor) [Chiracel AS-H (0.46 cm x 25 cm) (from Daicel Chemical 
Ind., Ltd.) hexane/i-PrOH, 99:1, 1.0 mL/min] to be 99% ee. [α]D23 = -79.2° (c 0.78, CHCl3). 1H 
NMR (600 MHz, CDCl3) δ 1.66 (s, 3H), 2.49 (ddd, J = 13.8, 11.6, 5.0 Hz, 1H), 3.24 (ddd, J = 
13.8, 3.2, 3.2 Hz, 1H), 4.01 (ddd, J = 11.6, 11.6, 3.2 Hz, 1H), 4.29 (ddd, J = 11.6, 5.0, 3.2 Hz, 1H), 
7.12 – 7.15 (m, 2H), 7.25 – 7.28 (m, 2H), 7.33 (ddd, J = 8.4, 6.8, 1.2 Hz, 1H), 7.40 (s,  1H), 7.57 
(ddd, J = 8.4, 8.4, 1.2 Hz, 1H), 7.71 (dt, J = 8.2, 0.8 Hz, 1H), 8.57 (m, 1H). 13C NMR (151 MHz, 
CDCl3) δ 25.4, 35.5, 39.5, 52.7, 106.8, 110.7, 121.4, 122.2, 122.5, 123.7, 125.9, 127.4, 133.8, 
137.3, 137.6, 149.6, 160.7, 193.2. HRMS (ESI): Calcd. for C18H17N2O
+ ([M+H]+): 277.1335, 
Found: 277.1339. 
 (R)-8-(5-Fluoropyridin-2-yl)-8-methyl-7,8-dihydropyrido[1,2-
a]indol-9(6H)-one (7b): Prepared according to the general 
procedure K from 2b (20.0 mg, 0.100 mmol) and 2-chloro-5-fluoropyridine (6b) (26.4 mg, 0.200 
mmol). The crude product was purified by silica gel chromatography with a CombiFlash system 
(4 g column, 100:0→80:20 hexanes/EtOAc) to give 7b as a yellow oil in 82% yield (24.2 mg, 
0.0822 mmol). The enantiomeric excess was determined by HPLC analysis (254 nm, 25 °C) tR 
20.0 min (major); tR 26.1 min (minor) [Chiracel AS-H (0.46 cm x 25 cm) (from Daicel Chemical 
Ind., Ltd.) hexane/i-PrOH, 99:1, 1.0 mL/min] to be 98% ee. [α]D23 = +112.0° (c 0.52, CHCl3). 1H 
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NMR (400 MHz, CDCl3) δ 1.64 (s, 3H), 2.48 (ddd, J = 13.9, 11.6, 5.0 Hz, 1H), 3.20 (ddd, J = 
13.9, 3.6, 3.6 Hz, 1H), 4.03 (ddd, J = 11.6, 11.6, 3.6 Hz, 1H), 4.30 (ddd, J = 11.6, 5.0, 3.6 Hz, 1H), 
7.14 (ddd, J = 8.0, 6.8, 1.0 Hz, 1H), 7.28 – 7.30 (m, 3H), 7.34 (ddd, J = 8.4, 6.8, 1.0 Hz, 1H), 7.40 
(s, 1H), 7.72 (d, J = 8.0 Hz, 1H), 8.41 (t, J = 1.6 Hz, 1H). 13C NMR (101 MHz, CDCl3) δ 25.5, 
35.4, 39.4, 52.2, 107.1, 110.7, 121.5, 123.1 (d, J = 4.2 Hz, 1C), 123.7, 124.0 (d, J = 18.3 Hz, 1C), 
126.1, 127.4, 133.5, 137.6, 137.8, 156.7 (d, J = 3.7 Hz, 1C), 158.8 (d, J = 257.2 Hz, 1C), 193.0. 
19F NMR (CDCl3, 376 MHz): δ -129.4 (m, 1F). HRMS (ESI): Calcd. for C18H16FN2O+ ([M+H]+): 
295.1241, Found: 295.1243. 
 (R)-6-(8-Methyl-9-oxo-6,7,8,9-tetrahydropyrido[1,2-a]indol-8-
yl)nicotinonitrile (7c): Prepared according to the general 
procedure K from 2b (20.0 mg, 0.100 mmol) and 6-chloronicotinonitrile 6c (27.8 mg, 0.200 
mmol). The crude product was purified by silica gel chromatography with a CombiFlash system 
(4 g column, 100:0→80:20 hexanes/EtOAc) to give 7c as a light yellow solid in 93% yield (28.1 
mg, 0.0932 mmol). The enantiomeric excess was determined by HPLC analysis (254 nm, 25 °C) 
tR 22.5 min (major); tR 38.9 min (minor) [Chiracel AS-H (0.46 cm x 25 cm) (from Daicel Chemical 
Ind., Ltd.) hexane/i-PrOH, 90:10, 1.0 mL/min] to be 33% ee. [α]D25 = +4.2° (c 0.95, CHCl3). 1H 
NMR (400 MHz, CDCl3) δ 1.67 (s, 3H), 2.51 (ddd, J = 14.0, 11.0, 5.0 Hz, 1H), 3.24 (ddd, J = 
14.0, 3.9, 3.9 Hz, 1H), 4.05 (ddd, J = 12.6, 11.0, 3.9 Hz, 1H), 4.32 (ddd, J = 12.6, 5.0, 3.9 Hz, 1H), 
7.16 (ddd, J = 8.2, 6.9, 0.8 Hz, 1H), 7.29 (dd, J = 8.4, 0.8 Hz, 1H), 7.37 (ddd, J = 8.4, 6.9, 1.0 Hz, 
1H), 7.41 (s, 1H), 7.46 (dd, J = 8.4, 0.8 Hz, 1H), 7.72 (ddd, J = 8.2, 0.8, 0.8 Hz, 1H), 7.86 (dd, J 
= 8.4, 2.2 Hz, 1H), 8.83 (dd, J = 2.2, 0.8 Hz, 1H). 13C NMR (151 MHz, CDCl3) δ 25.3, 35.0, 39.3, 
53.0, 107.7, 108.8, 110.7, 116.8, 121.7, 122.4, 123.8, 126.4, 127.4, 133.2, 137.8, 140.2, 152.3, 
165.5, 191.8. HRMS (ESI): Calcd. for C19H16N3O
+ ([M+H]+): 302.1288, Found: 302.1296. 
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 (R)-8-Methyl-8-(5-(trifluoromethyl)pyridin-2-yl)-7,8-
dihydropyrido[1,2-a]indol-9(6H)-one (7d): Prepared according 
to the general procedure K from 2b (20.0 mg, 0.100 mmol) and 2-
chloro-5-(trifluoromethyl)pyridine 6d (36.4 mg, 0.200 mmol). The crude product was purified by 
silica gel chromatography with a CombiFlash system (4 g column, 100:0→80:20 hexanes/EtOAc) 
to give 7d as a yellow oil in 55% yield (19.0 mg, 0.0552 mmol). The enantiomeric excess was 
determined by HPLC analysis (254 nm, 25 °C) tR 17.5 min (major); tR 19.9 min (minor) [Chiracel 
AS-H (0.46 cm x 25 cm) (from Daicel Chemical Ind., Ltd.) hexane/i-PrOH, 98:2, 0.5 mL/min] to 
be 65% ee. [α]D23 = +34.0° (c 0.76, CHCl3). 1H NMR (400 MHz, CDCl3) δ 1.68 (s, 3H), 2.51 (ddd, 
J = 13.9, 11.6, 5.0 Hz, 1H), 3.26 (ddd, J = 13.9, 3.8, 3.8 Hz, 1H), 4.05 (ddd, J = 12.2, 11.6, 3.8 Hz, 
1H), 4.32 (ddd, J = 12.2, 5.0, 3.8 Hz, 1H),  7.15 (ddd, J = 8.0, 6.8, 0.8 Hz, 1H), 7.28 – 7.30 (m, 
1H), 7.36 (ddd, J = 8.0, 6.8, 0.6 Hz, 1H), 7.41 (s, 1H), 7.43 – 745 (m, 1H), 7.72 (d, J = 8.4 Hz, 
1H), 7.81 (dd, J = 8.4, 2.0 Hz, 1H), 8.83 (d, J = 2.0 Hz, 1H). 13C NMR (101 MHz, CDCl3) δ 25.4, 
35.2, 39.4, 52.8, 107.4, 110.7, 121.6, 122.0, 123.7, 123.8 (q, J = 273.6 Hz, 1C), 125.5 (q, J = 33.3 
Hz, 1C), 126.2, 127.4, 133.4, 134.3 (q, J = 4.0 Hz, 1C), 137.7, 146.5 (q, J = 4.0 Hz, 1C), 164.9 (q, 
J = 2.0 Hz, 1C), 192.3. 19F NMR (CDCl3, 376 MHz): δ -62.7 (s, 3F). HRMS (ESI): Calcd. for 
C19H16F3N2O
+ ([M+H]+): 345.1209, Found: 345.1218. 
  (R)-8-Methyl-8-(6-methylpyridin-2-yl)-7,8-dihydropyrido[1,2-
a]indol-9(6H)-one (7e): Prepared according to the general procedure 
K from 2b (20.0 mg, 0.100 mmol) and 2-chloro-6-methylpyridine 6e 
(25.6 mg, 0.200 mmol). The crude product was purified by silica gel chromatography with a 
CombiFlash system (4 g column, 100:0→80:20 hexanes/EtOAc) to give 7e as a yellow solid in 
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72% yield (21.0 mg, 0.0723 mmol). The enantiomeric excess was determined by HPLC analysis 
(254 nm, 25 °C) tR 12.2 min (major); tR 17.6 min (minor) [Chiracel AS-H (0.46 cm x 25 cm) (from 
Daicel Chemical Ind., Ltd.) hexane/i-PrOH, 99:1, 1.0 mL/min] to be 75% ee. [α]D25 = +171.8° (c 
0.74, CHCl3). 1H NMR (400 MHz, CDCl3) δ 1.63 (s, 3H), 2.43 (ddd, J = 13.8, 11.8, 5.2 Hz, 1H), 
2.51 (s, 3H), 3.29 (ddd, J = 13.8, 3.8, 3.8 Hz, 1H), 4.04 (ddd, J = 11.8, 11.8, 3.8 Hz, 1H), 4.27 
(ddd, J = 11.8, 5.2, 3.8 Hz, 1H), 6.96 – 7.03 (m, 2H), 7.13 (ddd, J = 7.8, 6.7, 1.2 Hz, 1H), 7.26 – 
7.35 (m, 2H), 7.37 (s, 1H), 7.41 (t, J = 7.8 Hz, 1H), 7.71 (d, J = 8.0, 1H). 13C NMR (101 MHz, 
CDCl3) δ 25.0, 25.5, 35.2, 39.6, 52.6, 106.6, 110.6, 118.9, 121.3, 121.9, 123.6, 125.7, 127.3, 133.9, 
137.2, 137.5, 158.4, 159.7, 193.6. HRMS (ESI): Calcd. for C19H19N2O
+ ([M+H]+): 291.1492, 
Found: 291.1495. 
 (R)-8-(6-Methoxypyridin-2-yl)-8-methyl-7,8-dihydropyrido[1,2-
a]indol-9(6H)-one (7f): Prepared according to the general procedure 
K from 2b (20.0 mg, 0.100 mmol) and 2-chloro-6-methoxypyridine 
6f (28.8 mg, 0.200 mmol). The crude product was purified by silica gel chromatography with a 
CombiFlash system (4 g column, 100:0→80:20 hexanes/EtOAc) to give 7f as a light yellow solid 
in 75% yield (23.1 mg, 0.0754 mmol). The enantiomeric excess was determined by HPLC analysis 
(254 nm, 25 °C) tR 12.0 min (major); tR 15.6 min (minor) [Chiracel AS-H (0.46 cm x 25 cm) (from 
Daicel Chemical Ind., Ltd.) hexane/i-PrOH, 98:2, 1.0 mL/min] to be 95% ee. [α]D23 = +183.8° (c 
0.54, CHCl3). 1H NMR (400 MHz, CDCl3) δ 1.65 (s, 3H), 2.46 (ddd, J = 13.8, 12.0, 5.0 Hz, 1H), 
3.14 (ddd, J = 13.8, 3.8, 3.0 Hz, 1H), 3.81 (s, 3H), 3.98 (ddd, J = 12.0, 12.0, 3.8 Hz, 1H), 4.29 
(ddd, J = 12.0, 5.0, 3.0 Hz, 1H), 6.57 (dd, J = 8.2, 0.6 Hz, 1H), 6.78 (dd, J = 7.4, 0.6 Hz, 1H), 7.14 
(ddd, J = 8.2, 6.8, 1.2 Hz, 1H), 7.26 – 7.36 (m, 2H), 7.38 (s, 1H), 7.43 (dd, J = 8.2, 7.4 Hz, 1H), 
7.72 (ddd, J = 8.2, 1.2, 1.2 Hz, 1H). 13C NMR (101 MHz, CDCl3) δ 24.8, 35.8, 39.5, 52.4, 53.5, 
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106.4, 109.4, 110.6, 114.5, 121.3, 123.6, 125.8, 127.4, 134.1, 137.5, 139.6, 158.6, 163.8, 193.2. 
HRMS (ESI): Calcd. for C19H19N2O2
+ ([M+H]+): 307.1441, Found: 307.1445. 
 (R)-8-(4-Methoxypyridin-2-yl)-8-methyl-7,8-
dihydropyrido[1,2-a]indol-9(6H)-one (7g): Prepared according to 
the general procedure K from 2b (20.0 mg, 0.100 mmol) and 2-
chloro-4-methoxypyridine 6g (28.8 mg, 0.200 mmol). The crude product was purified by silica gel 
chromatography with a CombiFlash system (4 g column, 100:0→80:20 hexanes/EtOAc) to give 
7g as a white solid in 50% yield (15.3 mg, 0.0499 mmol). The enantiomeric excess was determined 
by HPLC analysis (220 nm, 25 °C) tR 11.9 min (major); tR 14.4 min (minor) [Chiracel AS-H (0.46 
cm x 25 cm) (from Daicel Chemical Ind., Ltd.) hexane/i-PrOH, 95:5, 1.0 mL/min] to be 86% ee. 
[α]D25 = +17.2° (c 0.46, CHCl3). 1H NMR (400 MHz, CDCl3) δ 1.63 (s, 3H), 2.45 (ddd, J = 13.8, 
11.8, 5.1 Hz, 1H), 3.23 (ddd, J = 13.8, 3.2, 3.2 Hz, 1H), 3.74 (s, 3H), 4.03 (ddd, J = 11.8, 11.8, 3.2 
Hz, 1H), 4.28 (ddd, J = 11.8, 5.1, 3.2 Hz, 1H), 6.65 (dd, J = 5.8, 2.4 Hz, 1H), 6.76 (d, J = 2.4 Hz, 
1H), 7.13 (ddd, J = 8.0, 7.0, 0.6 Hz, 1H), 7.28 – 7.35 (m, 2H), 7.39 (s, 1H), 7.71 (d, J = 8.0 Hz, 
1H), 8.38 (d, J = 5.8 Hz, 1H). 13C NMR (101 MHz, CDCl3) δ 25.4, 35.4, 39.6, 52.7, 55.4, 106.8, 
108.3, 108.6, 110.7, 121.3, 123.6, 125.9, 127.4, 133.8, 137.6, 150.8, 162.4, 166.6, 193.3. HRMS 
(ESI): Calcd. for C19H19N2O2
+ ([M+H]+): 307.1441, Found: 307.1443. 
 (R)-8-Methyl-8-(6-(trifluoromethyl)pyridin-3-yl)-7,8-
dihydropyrido[1,2-a]indol-9(6H)-one (7h): Prepared according 
to the general procedure K from 2b (20.0 mg, 0.100 mmol) and 5-chloro-2-
(trifluoromethyl)pyridine 6h (36.4 mg, 0.200 mmol). The crude product was purified by silica gel 
chromatography with a CombiFlash system (4 g column, 100:0→80:20 hexanes/EtOAc) to give 
7h as a yellow solid in 80% yield (27.7 mg, 0.0804 mmol). The enantiomeric excess was 
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determined by HPLC analysis (254 nm, 25 °C) tR 16.1 min (major); tR 33.5 min (minor) [Chiracel 
AS-H (0.46 cm x 25 cm) (from Daicel Chemical Ind., Ltd.) hexane/i-PrOH, 90:10, 1.0 mL/min] 
to be 99% ee. [α]D23 = +65.7° (c 1.03, CHCl3). 1H NMR (600 MHz, CDCl3) δ 1.72 (s, 3H), 2.63 
(ddd, J = 14.6, 10.1, 4.8 Hz, 1H), 2.89 (ddd, J = 14.6, 4.8, 4.8 Hz, 1H), 3.99 (ddd, J = 12.5, 10.1, 
4.8 Hz, 1H), 4.35 (ddd, J = 12.5, 4.8, 4.8 Hz, 1H), 7.18 (ddd, J = 8.4, 6.6, 0.6 Hz, 1H), 7.29 – 7.30 
(m, 1H), 7.39 (ddd, J = 8.4, 6.6, 0.8 Hz, 1H), 7.46 (s, 1H), 7.61 (d, J = 8.4 Hz, 1H), 7.74 (d, J = 
8.4 Hz, 1H), 7.78 (dd, J = 8.4, 2.0 Hz, 1H), 8.76 (d, J = 2.0 Hz, 1H). 13C NMR (151 MHz, CDCl3) 
δ 25.3, 36.4, 38.9, 48.9, 108.1, 110.6, 120.7 (q, J = 2.7 Hz, 1C), 121.7 (q, J = 274.0 Hz, 1C), 121.9, 
123.9, 126.7, 127.4, 133.0, 136.4, 137.8, 141.2, 147.3 (q, J = 35.0 Hz, 1C), 148.6, 191.4. 19F NMR 
(CDCl3, 565 MHz): δ -68.5 (s, 3F). HRMS (ESI): Calcd. for C19H16F3N2O+ ([M+H]+): 345.1209, 
Found: 345.1213. 
 (R)-8-Methyl-8-(thiophen-3-yl)-7,8-dihydropyrido[1,2-a]indol-
9(6H)-one (7i): Prepared according to the general procedure K from 2b 
(20.0 mg, 0.100 mmol) and 3-chlorothiophene 6i (23.8 mg, 0.200 mmol). The crude product was 
purified by silica gel chromatography with a CombiFlash system (4 g column, 100:0→80:20 
hexanes/EtOAc) to give 7i as a light yellow solid in 92% yield (27.2 mg, 0.0924 mmol). The 
enantiomeric excess was determined by HPLC analysis (254 nm, 25 °C) tR 23.0 min (major); tR 
27.9 min (minor) [Chiracel AS-H (0.46 cm x 25 cm) (from Daicel Chemical Ind., Ltd.) hexane/i-
PrOH, 98:2, 1.0 mL/min] to be 94% ee. [α]D23 = +84.2° (c 0.55, CHCl3). 1H NMR (400 MHz, 
CDCl3) δ 1.63 (s, 3H), 2.55 (ddd, J = 14.0, 11.8, 4.6 Hz, 1H), 2.70 (ddd, J = 14.0, 3.6, 3.6 Hz, 1H), 
3.94 (ddd, J = 11.8, 11.8, 3.6 Hz, 1H), 4.29 (ddd, J = 11.8, 4.6, 3.6 Hz, 1H), 6.96 (d, J = 1.4 Hz, 
1H), 7.04 (dd, J = 5.0, 1.4 Hz, 1H), 7.15 (t, J = 7.4 Hz, 1H), 7.25 – 7.36 (m, 3H), 7.41 (s, 1H), 7.73 
(d, J = 8.1 Hz, 1H). 13C NMR (101 MHz, CDCl3) δ 25.8, 37.1, 39.2, 48.1, 107.1, 110.6, 121.4, 
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121.6, 123.7, 126.0, 126.1, 126.7, 127.4, 133.5, 137.5, 142.6, 192.6. HRMS (ESI): Calcd. for 
C17H16NOS
+ ([M+H]+): 282.0947, Found: 282.0951. 
 (R)-2-Methyl-2-(pyridin-2-yl)-2,3-dihydro-1H-pyrrolizin-1-one (11a): 
Prepared according to the general procedure L from 2m (27.0 mg, 0.199 mmol) 
and 2-bromopyridine 10a (63.1 mg, 0.399 mmol). The crude product was purified 
by silica gel chromatography with a CombiFlash system (4 g column, 100:0→80:20 
hexanes/EtOAc) to give 11a as a light yellow oil in 99% yield (42.0 mg, 0.198 mmol). The 
enantiomeric excess was determined by HPLC analysis (254 nm, 25 °C) tR 10.6 min (major); tR 
13.7 min (minor) [Chiracel AS-H (0.46 cm x 25 cm) (from Daicel Chemical Ind., Ltd.) hexane/i-
PrOH, 90:10, 1.0 mL/min] to be 97% ee. [α]D25 = -136.8° (c 0.89, CHCl3). 1H NMR (400 MHz, 
CDCl3) δ 1.77 (s, 3H), 4.24 (d, J = 11.4 Hz, 1H), 5.31 (d, J = 11.4 Hz, 1H), 6.55 (dd, J = 4.0, 2.2 
Hz, 1H), 6.78 (dd, J = 4.0, 1.0 Hz, 1H), 7.09 (m, 1H), 7.16 (ddd, J = 7.2, 4.8, 1.2 Hz, 1H), 7.61 – 
7.69 (m, 2H), 8.51 (ddd, J = 4.8, 1.7, 1.2 Hz, 1H). 13C NMR (101 MHz, CDCl3) δ 24.6, 55.8, 60.0, 
109.3, 117.5, 121.5, 122.5, 123.6, 131.4, 137.1, 149.3, 160.7, 191.9. HRMS (ESI): Calcd. for 
C13H13N2O
+ ([M+H]+): 213.1022, Found: 213.1024. 
 (R)-2-Methyl-2-(6-methylpyridin-2-yl)-2,3-dihydro-1H-pyrrolizin-1-one 
(11b): Prepared according to the general procedure L from 2m (27.0 mg, 0.199 
mmol) and 2-bromo-6-methylpyridine 10b (68.7 mg, 0.399 mmol). The crude 
product was purified by silica gel chromatography with a CombiFlash system (4 g 
column, 100:0→80:20 hexanes/EtOAc) to give 11b as a light yellow oil in 71% yield (32.0 mg, 
0.141 mmol). The enantiomeric excess was determined by HPLC analysis (254 nm, 25 °C) tR 8.00 
min (major); tR 10.2 min (minor) [Chiracel AS-H (0.46 cm x 25 cm) (from Daicel Chemical Ind., 
Ltd.) hexane/i-PrOH, 90:10, 1.0 mL/min] to be 95% ee. [α]D23 = -53.2° (c 0.53, CHCl3). 1H NMR 
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(400 MHz, CDCl3) δ 1.74 (s, 3H), 2.47 (s, 3H), 4.20 (d, J = 11.4 Hz, 1H), 5.41 (d, J = 11.4 Hz, 
1H), 6.54 (dd, J = 4.0, 2.2 Hz, 1H), 6.77 (dd, J = 4.0, 1.0 Hz, 1H), 7.00 – 7.01 (m, 1H), 7.08 (m, 
1H), 7.41 – 7.43 (m, 1H), 7.53 (t, J = 7.6 Hz, 1H). 13C NMR (101 MHz, CDCl3) δ 24.89, 24.92, 
55.6, 59.9, 109.0, 117.2, 118.3, 121.9, 123.4, 131.5, 137.2, 158.0, 159.8, 192.3. HRMS (ESI): 
Calcd. for C14H15N2O
+ ([M+H]+): 227.1179, Found: 227.1179. 
 (R)-2-(6-Methoxypyridin-2-yl)-2-methyl-2,3-dihydro-1H-pyrrolizin-1-one 
(11c): Prepared according to the general procedure L from 2m (27.0 mg, 0.199 
mmol) and 2-bromo-6-methoxypyridine 10c (75.1 mg, 0.399 mmol). The crude 
product was purified by silica gel chromatography with a CombiFlash system (4 g 
column, 100:0→80:20 hexanes/EtOAc) to give 11c as a light yellow oil in 51% yield (24.8 mg, 
0.102 mmol). The enantiomeric excess was determined by HPLC analysis (254 nm, 25 °C) tR 8.92 
min (major); tR 11.5 min (minor) [Chiracel AS-H (0.46 cm x 25 cm) (from Daicel Chemical Ind., 
Ltd.) hexane/i-PrOH, 90:10, 1.0 mL/min] to be 95% ee. [α]D23 = -60.2° (c 0.80, CHCl3). 1H NMR 
(400 MHz, CDCl3) δ 1.74 (s, 3H), 3.77 (s, 3H), 4.21 (d, J = 11.2 Hz, 1H), 5.16 (d, J = 11.2 Hz, 
1H), 6.55 (dd, J = 4.0, 2.2 Hz, 1H), 6.60 (dd, J = 8.2, 0.6 Hz, 1H), 6.78 (dd, J = 4.0, 1.0 Hz, 1H), 
7.07 – 7.08 (m, 1H), 7.10 (dd, J = 7.4, 0.6 Hz, 1H), 7.54 (dd, J = 8.2, 7.4 Hz, 1H). 13C NMR (101 
MHz, CDCl3) δ 23.4, 53.4, 56.1, 59.9, 109.1, 109.5, 113.7, 117.3, 123.2, 131.7, 139.6, 158.4, 
163.5, 191.9. HRMS (ESI): Calcd. for C14H15N2O2
+ ([M+H]+): 243.1128, Found: 243.1131. 
 (R)-2-(5-Fluoropyridin-2-yl)-2-methyl-2,3-dihydro-1H-pyrrolizin-1-one 
(11d): Prepared according to the general procedure L from 2m (27.0 mg, 0.199 
mmol) and 2-bromo-5-fluoropyridine 10d (70.3 mg, 0.399 mmol). The crude 
product was purified by silica gel chromatography with a CombiFlash system (4 g 
column, 100:0→80:20 hexanes/EtOAc) to give 11d as a colorless oil in 48% yield (22.0 mg, 
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0.0955 mmol). The enantiomeric excess was determined by HPLC analysis (254 nm, 25 °C) tR 
10.1 min (major); tR 12.9 min (minor) [Chiracel AS-H (0.46 cm x 25 cm) (from Daicel Chemical 
Ind., Ltd.) hexane/i-PrOH, 90:10, 1.0 mL/min] to be 95% ee. [α]D25 = -113.6° (c 0.81, CHCl3). 1H 
NMR (400 MHz, CDCl3) δ 1.75 (s, 3H), 4.24 (d, J = 11.6 Hz, 1H), 5.29 (d, J = 11.6 Hz, 1H), 6.56 
(dd, J = 4.0, 2.2 Hz, 1H), 6.79 (dd, J = 4.0, 1.0 Hz, 1H), 7.09 – 7.10 (m, 1H), 7.38 (ddd, J = 8.8, 
8.2, 3.0 Hz, 1H), 7.66 (ddd, J = 8.8, 4.0, 0.4 Hz, 1H), 8.34 (d, J = 3.0 Hz, 1H). 13C NMR (101 
MHz, CDCl3) δ 24.9, 55.7, 59.5 (d, J = 1.0 Hz, 1C), 109.5, 117.6, 122.5 (d, J = 5.0 Hz, 1C), 123.7 
(d, J = 2.0 Hz, 1C), 123.9, 131.1, 137.3 (d, J = 24.2 Hz, 1C), 156.5 (d, J = 4.0 Hz, 1C), 158.9 (d, 
J = 257.5 Hz, 1C), 191.5. 19F NMR (CDCl3, 376 MHz): δ -129.7 (s, 1F). HRMS (ESI): Calcd. for 
C13H12FN2O
+ ([M+H]+): 231.0928, Found: 231.0931.  
 (S)-2-Methyl-2-(6-(trifluoromethyl)pyridin-3-yl)-2,3-dihydro-1H-
pyrrolizin-1-one (11f): Prepared according to the general procedure L from 2m 
(27.0 mg, 0.199 mmol) and 5-bromo-2-(trifluoromethyl)pyridine 10f (90.3 mg, 
0.399 mmol). The crude product was purified by silica gel chromatography with 
a CombiFlash system (4 g column, 100:0→80:20 hexanes/EtOAc) to give 11f as a colorless oil in 
23% yield (13.0 mg, 0.046 mmol). The enantiomeric excess was determined by HPLC analysis 
(254 nm, 25 °C) tR 21.7 min (major); tR 26.2 min (minor) [Chiracel AS-H (0.46 cm x 25 cm) (from 
Daicel Chemical Ind., Ltd.) hexane/i-PrOH, 90:10, 1.0 mL/min] to be 92% ee. [α]D25 = -51.9° (c 
0.38, CHCl3). 1H NMR (400 MHz, CDCl3) δ 1.82 (s, 3H), 4.45 (d, J = 11.8 Hz, 1H), 4.62 (d, J = 
11.8 Hz, 1H), 6.63 (dd, J = 4.0, 2.2 Hz, 1H), 6.88 (dd, J = 4.0, 0.6 Hz, 1H), 7.12 (m, 1H), 7.65 (d, 
J = 8.2 Hz, 1H), 7.89 (dd, J = 8.2, 2.0 Hz, 1H), 8.68 (d, J = 2.0 Hz, 1H). 13C NMR (101 MHz, 
CDCl3) δ 24.0, 55.9, 57.7, 110.6, 118.5, 120.7 (q, J = 2.7 Hz, 1C), 121.7 (q, J = 275.0 Hz, 1C), 
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124.0, 130.8, 135.5, 141.7, 147.4 (q, J = 35.1 Hz, 1C), 148.3, 190.2. 19F NMR (CDCl3, 376 MHz): 
δ -68.2 (s, 3F). HRMS (ESI): Calcd. for C14H12F3N2O+ ([M+H]+): 281.0896, Found: 281.0896. 
Identification of Reaction Conditions for One-pot Synthesis of (R)-8-(3-Methoxyphenyl)-8-
methyl-7,8-dihydropyrido[1,2-a]indol-9(6H)-one (5d) via Sequential Hydroacylation/-
Arylation 
 
 Hydroacylationd -Arylation 
Entr
y 
Mesitylen
e 
(mL) 
Conva 
of 1b 
(%) 
Catalyst 
loading 
(x mol %) 
Toluen
e (mL) 
Final 
conc  
(M) 
Conva 
of 2b 
(%) 
Yieldb 
5d 
(%) 
eec 
(%) 
1e 0.50 99 10 0.50 0.10 20 15 n.d 
2f 0.50 99 10 0.50 0.10 22 19 n.d 
3 0.50 99 10 0.50 0.10 43 40 
(40) 
98 
4 0.50 99 10 0 0.20 0 0 -- 
5 0.25 99 10 0.50 0.13 45 40 n.d 
6 0.13 99 10 0.50 0.16 50 40 n.d 
7 0.25 99 10 0.25 0.20 30 10 n.d 
8 0.13 99 10 0.37 0.20 50 30 n.d 
9 0.50 99 15 0.50 0.10 70 54 
(51) 
99 
10 0.50 99 20 0.50 0.10 99 75 
(70) 
98 
Reaction conditions: 1b (0.100 mmol), 4d (0.200 mmol), NaOtBu (0.200 mmol) a Conversion of 
1b and 2b were determined by 1H NMR spectroscopy. b NMR yield using dibromomethane as 
internal standard, isolated yield of 5d is shown in parentheses. c Determined by chiral HPLC 
analysis. d The crude reaction mixture was exposed to air for 5-10 mins before addition of reagents 
for –arylation under inert atmosphere. e The crude reaction mixture was not exposed to air before 
addition of reagents for –arylation. f  Bubbled N2 for 15 mins before addition of reagents for –
arylation under inert atmosphere. n.d = Not determined 
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Procedure for One-pot Synthesis of (R)-8-(3-Methoxyphenyl)-8-methyl-7,8-
dihydropyrido[1,2-a]indol-9(6H)-one (5d) 
 
In a nitrogen-filled glovebox, 1-(but-3-en-1-yl)-1H-indole-2-carboxaldehyde (1b) (20.0 
mg, 0.100 mmol, 1.0 equiv) was added to a 1-dram vial containing solution of Ni(COD)2 (1.4 mg, 
0.00500 mmol, 0.050 equiv) and IAd (2.0 mg, 0.00600 mmol, 0.060 equiv) in mesitylene (0.5 
mL).  The vial was sealed with a PTFE/silicone-lined septum cap and removed from the glovebox. 
The reaction mixture was stirred at 165 °C in an oil bath for 10 h. The vial was removed from the 
oil bath and allowed to cool to room temperature. The reaction mixture was allowed to stir in air 
at room temperature for 5-10 min. The vial was taken inside the glove box and Ni(COD)2 (5.6 mg, 
0.0200 mmol, 0.20 equiv), (R)-BINAP (15.0 mg, 0.0240 mmol, 0.24 equiv), NaOtBu (19.3 mg, 
0.200 mmol, 2.0 equiv), 1-chloro-3-methoxybenzene (4d) (28.6 mg, 0.200 mmol, 2.0 equiv), and 
toluene (0.5 mL) were added. The vial was sealed and removed from the glovebox. The reaction 
mixture was stirred at 65 °C in an oil bath for 48 h.  The vial was removed from the oil bath and 
allowed to cool to room temperature.  The reaction mixture was filtered through a short plug of 
silica gel (eluting with 20 mL of 3:2 hexanes:EtOAc). The crude reaction mixture was concentrated 
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under reduced pressure. The crude product was purified with a CombiFlash system with 10% ethyl 
acetate in hexanes as eluent to give (R)-8-(3-methoxyphenyl)-8-methyl-7,8-dihydropyrido[1,2-
a]indol-9(6H)-one (5d) as a light yellow solid in 70% yield (21.5 mg, 0.0704 mmol). The 
enantiomeric excess was determined by HPLC analysis (254 nm, 25 °C) tR 30.6 min (major); tR 
41.2 min (minor) [Chiracel AS-H (0.46 cm x 25 cm) (from Daicel Chemical Ind., Ltd.) hexane/i-
PrOH, 99:1, 1.0 mL/min] to be 98% ee. [α]D24 = +125.4° (c 0.92, CHCl3).  
Absolute Stereochemistry and Structure of 5d 
Single crystal X-ray structure determination of 5d was performed using Cu radiation to 
determine the absolute configuration of the molecule. The systematic absences in the diffraction 
data were consistent for the stated space group. The position of almost all non-hydrogen atoms 
were found by direct methods. The remaining atoms were located in an alternating series of least-
squares cycles on difference Fourier maps. All non-hydrogen atoms were refined in full-matrix 
anisotropic approximation. All hydrogen atoms were placed in the structure factor calculation at 
idealized positions and were allowed to ride on the neighboring atoms with relative isotropic 
displacement coefficients. CCDC 1447403 contains the supplementary crystallographic data for 
this paper. These data can be obtained free of charge from the Cambridge Crystallographic Data 
Centre via http://www.ccdc.cam.ac.uk/data_request/cif. 
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CHAPTER III 
  N-HETEROCYCLIC CARBENE-CATALYSED INTRAMOLECULAR 
HYDROACYLATION TO FORM BASIC NITROGEN-CONTAINING 
HETEROCYCLES 
Modified from Organic & Biomolecular Chemistry 2016, 14, 9981-9984. Copyright ©2016 The 
Royal Society of Chemistry 
James A. Walker Jr. and Levi Stanley 
Abstract 
 We report catalytic, intramolecular hydroacylations of N-allylimidazole-2-
carboxaldehydes and N-allylbenzimidazole-2-carboxaldehydes. These exo-selective 
hydroacylations occur in the presence of a N-heterocyclic carbene catalyst to generate 5,6-dihydro- 
7H-pyrrolo[1,2-α]imidazol-7-ones and 1,2-dihydro-3H-benzo[d]pyrrolo[1,2-α]imidazol-2-ones in 
high yields (66–99%). In addition, hydroacylations of N-allylimidazole-2-carboxaldehydes in the 
presence of a chiral, non-racemic NHC catalyst occur, forming 5,6-dihydro-7H-pyrrolo[1,2-
α]imidazol-7-ones in moderate-to-high yields (39–98%) with modest enantioselectivities (56–79% 
ee) 
Introduction 
 Intramolecular hydroacylations of alkenes in the presence of transition-metal catalysts are 
well-known processes to generate a variety of valuable cyclic ketones.1-6 Transition metal-
catalysed alkene hydroacylations to form and functionalize nitrogen-containing heterocycles, in 
many cases with high yields and enantioselectivities, have been the focus of recent studies to 
improve the synthetic utility of these important C–C bond forming processes.7-11 However, alkene 
hydroacylations to form nitrogen heterocycles containing a basic nitrogen atom often do not occur 
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in the presence of rhodium, cobalt, and nickel complexes that are excellent catalysts of alkene 
hydroacylation due to inhibition of the catalyst in the presence of basic nitrogen atoms.7 
 N-Heterocyclic carbenes (NHCs)12-16 are a widely utilized class of organocatalysts and 
offer a promising alternative to transition-metal catalysts for alkene hydroacylation reactions.17-20 
Key to our studies, NHCs have been shown to tolerate additives containing basic nitrogen atoms.21 
 
Scheme 1. (a) NHC-catalyzed enantioselective intramolecular hydroacylations of unactivated 
alkenes and (b) NHC-catlyzed, exo-selective hyddroacylation of N-allylimidazole and N-
allylbenzimidazole-2-carboxaldehydes. 
 
The potential to further develop alkene hydroacylation reactions as a platform to generate 
polycyclic nitrogen heterocycles led us to investigate NHC-catalysed intramolecular 
hydroacylations of N-allylimidazole-2-carboxaldehydes and N-allylbenzimidazole-2-
carboxaldehydes. The development of such reactions offers the potential to rapidly generate 
dihydropyrroloimidazolone22-23 and dihydrobenzopyrroloimidazolone24-25 derivatives through 
exo-selective hydroacylations. Building on reports from Glorius and co-workers (Scheme 1a)21, 26-
28 and a recent study from our laboratory29 on NHC-catalysed intramolecular hydroacylations of 
unactivated alkenes, we now report NHC-catalysed, exo-selective hydroacylations of N-
allylimidazole- and N-allylbenzimidazole-2-carboxaldehydes to a form a variety of 
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dihydropyrroloimidazolones and dihydrobenzopyrroloimidazolones in moderate to high yields 
(Scheme 1b). 
Table 1. Identification of reaction conditions for NHC-catalysed hydroacylation of N-
allylimidazole-2-carboxaldehyde 1aa 
 
entry base temp. (°C) conv.b (%) yield 3ac (%) 
1 DBU 25 100 14 
2 DBU 60 100 96 
3 DBU 80 100 95 
4 DBU 100 100 45 
5 DBU 120 100 0 
6d DBU 60 100 21 
7e DBU 60 82 81 
8d,e DBU 60 70 33 
9 Et3N 60 100 0 
10 NaOAc 60 100 7 
11 KOAc 60 100 18 
12 K3PO4 60 100 99 
aReaction conditions: 1a (0.20 mmol), 2 (0.02 mmol), base (0.04 mmol), 1,4-dioxane (0.4 mL), 12 
h. bDetermined by 1H NMR spectroscopy of the crude reaction mixture using dibromomethane as 
an internal standard. cIsolated yield of 3a. dReaction run in the presence of 10 mol % DBU. 
eReaction run in the presence of 5 mol % 2. 
 
Results & Discussion 
To identify general reaction conditions for the NHC-catalysed hydroacylation of N-
allylimidazole- and N-allylbenzimidazole-2-carboxaldehydes, we evaluated the model reaction of 
N-allylimidazole-2-carboxaldehyde 1a in the presence of triazolium chloride 230 and a variety of 
organic and inorganic bases (Table 1). An initial survey of reaction conditions showed that reaction 
temperature dramatically impacts the yield of dihydropyrroloimidazolone 3a (entries 1–5). 
Reactions of 1a run at 60 or 80 °C formed 3a in 96% and 95% yield when 20 mol% DBU was 
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employed as the base (entries 2 and 3). In contrast, reactions of 1a carried out at room temperature 
and at or above 100 °C led to the formation of 3a in low-to-moderate yield (entries 1, 4 and 5). 
The low yields of ketone 3a in reactions conducted at room temperature and at or above 
100 °C result from a benzoin condensation that is the primary reaction pathway at room 
temperature and deactivation of the NHC catalyst at or above 100 °C.27 The reaction of 1a 
conducted at room temperature leads to the nearly quantitative formation of benzoin condensation 
product 4a within minutes (Scheme 2). Heating the reaction mixture containing benzoin 
condensation product 4a to 60 °C in the presence of the NHC catalyst generated from triazolium 
chloride 2 leads to high yield of ketone 3a (see Fig. S2 in the Experimental section) In contrast, 
heating the reaction mixture containing 4a at 100 or 120 °C in the presence of the NHC catalyst 
generated from triazolium chloride 2 did not lead to high yields of 3a, likely because the NHC 
catalyst decomposes at these temperatures. The balance of the mass in these reactions is composed 
of the benzoin condensation product which is readily oxidized to the corresponding diketone upon 
exposure of the reaction mixture to air (see synthesis of S1 in the Experimental section).31 
 
Scheme 2. Rapid NHC-catalysed benzoin condensation of 1a at room temperature 
 
The loading of catalyst and base and the identity of the base are also important reaction 
variables that must be controlled to generate 3a in high yield (Table 1, entries 6–12). Lowering the 
loading of DBU to 10 mol% (entry 6), triazolium chloride 2 to 5 mol% (entry 7) or both (entry 8) 
was detrimental to the yield of 3a. The model reaction formed 3a in low yield when we replaced 
DBU with a relatively weak organic or inorganic base, such as triethylamine, sodium acetate, or 
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potassium acetate (entries 9–11). However, the identity of the base is not limited to DBU. The 
model reaction generates the hydroacylation product 3a in nearly quantitative yield when tribasic 
potassium phosphate is used as the base (entry 12). 
Table 2. NHC-catalyzed hydroacylation of N-allylimidazole-2-carboxaldehydes 1a-ja 
 
entry 1 R1 R2 yield 3b (%) 
1 1a H H 96(99)c 
2 1b C6H5 H 96 
3 1c 4-MeO-C6H4 H 85 
4 1d 4-Cl-C6H4 H 99 
5 1e H C6H5 99 
6 1f H 4-MeO-C6H4 99(88)
c 
7 1g H 4-Cl-C6H4 95(81)
c 
8 1h H 4-F-C6H4 99 
9 1i H 3-F-C6H4 99 
10 1j H 2-F-C6H4 99 
aReaction conditions: 1a-j (0.20 mmol), triazolium 2 (0.02 mmol), DBU (0.04 mmol) and 1,4-
dioxane (0.4 mL). bIsolated yield of 3 after column chromatography. cReaction run in the presence 
of 10 mol % 2 and 20 mol % K3PO4. 
 
A summary of NHC-catalysed intramolecular hydroacylations of N-allylimidazole-2-
carboxaldehydes containing a range of substituted allyl units is shown in Table 2. The 
hydroacylation of N-allylimidazole-2-carboxaldehyde forms 3a in high yield when either DBU or 
K3PO4 is used as the base (Table 2, entry 1). Reactions of N-allylimidazole-2-carboxaldehydes 
containing electron-neutral, electron-rich, or electron-deficient aryl groups at the terminal position 
of the allyl unit formed heterocyclic ketones 3b–3d in good to excellent yields (85–99%, entries 
2–4). Aryl substitution at the internal position of the allyl unit is also well tolerated. 
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Hydroacylations of N-allylimidazole-2-carboxaldehydes containing aryl groups with a variety of 
electronic properties and substitution patterns at the internal position of the allyl unit occur to form 
heterocyclic ketones 3e–3j containing a quaternary carbon center in high yields (95–99%, entries 
5–10). 
 
Scheme 3. NHC-catalysed hyddroacylation of N-allylbenzimidazole-2-carboxaldehydes. Reaction 
conditions: 5a-g (0.20 mmol), triazolium 2 (0.02 mmol), DBU (0.04 mmol) and 1,4-dioxane (0.4 
mL). Yields of 3 are isolated after column chromatography. Yields in parentheses correspond to 
reactions run in the presence of 10 mol % 2 and 20 mol % K3PO4. 
 
The NHC-catalysed hydroacylations of N-allylbenzimidazole- 2-carboxaldehydes 5a–f 
also occur to form heterocyclic ketone products 6a–f in moderate-to-high yields (59–97%, Scheme 
3). N-Allylbenzimidazole-2-carboxaldehydes containing unsubstituted allyl units, allyl units with 
terminal or internal aryl substitution, and 5,6-dimethylbenzimidazole units are all suitable 
substrates for the NHC-catalysed hydroacylation reaction. The NHC-catalysed hydroacylation of 
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N-allylbenzimidazole-2-carboxaldehyde 5a formed the corresponding ketone 6a in 97% yield. 
Hydroacylations of 5b–c, substrates containing aryl substitution at the terminal position of the allyl 
unit, generated ketones 6b–c in 83–87% yield. Intramolecular hydroacylations of N-
allylbenzimidazole-2-carboxaldehydes 5d–f containing substitution at the internal position of the 
allyl unit and on the benzimidazole backbone formed ketones 6d–f in 66–93% yield. 
 
Table 3. Enantioselective NHC-catalysed hydroacylation of N-allylimidazole-2-carboxaldehydes 
1e-ja 
 
entry 1 R yield 3b (%) eec (%) 
1 1e C6H5 90 71 
2 1f 4-MeO-C6H4 98 79 
3 1g 4-Cl-C6H4 96 67 
4 1h 4-F-C6H4 81 75 
5 1i 3-F-C6H4 93 67 
6 1j 2-F-C6H4 39 56 
aReaction conditions: 1e-j (0.10 mmol), triazolium 7 (0.01 mmol), DBU (0.02 mmol) and 1,4-
dioxane (0.2 mL). bIsolated yield of 3 after column chromatography. cDetermined by chiral HPLC 
analysis. 
 
In addition to hydroacylations of N-allylimidazole-2-carboxaldehydes and N-
allylbenzimidazole-2-carboxaldehydes conducted in the presence of an achiral NHC catalyst, we 
investigated enantioselective hydroacylations of N-allylimidazole-2-carboxaldehydes 1e–j 
catalyzed by the chiral, non-racemic NHC derived from triazolium tetrafluoroborate 7 (Table 3). 
The hydroacylations of N-allylimidazole-2-carboxaldehydes 1e–i occur to form heterocyclic 
ketone products 3e–i in high yields (81–98%, entries 1–5) with modest enantioselectivities (67–
79% ee). However, the hydroacylation of N-allylimidazole-2-carboxaldehyde 1j (R = 2-F-C6H4) 
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generated heterocyclic ketone 3j in 39% yield with 56% ee (entry 6). The absolute configuration 
of chiral, non-racemic heterocyclic ketones 3e–j was assigned as (S) based on analogy with a 
previous report by Glorius and coworkers.21 
Conclusions 
In conclusion, we have established exo-selective NHC-catalyzed intramolecular 
hydroacylation of N-allylimidazoleand N-allylbenzimidazole-2-carboxaldehydes as a practical 
approach to generate 5,6-dihydro-7H-pyrrolo[1,2-α]imidazol-7- ones and 1,2-dihydro-3H-
benzo[d]pyrrolo[1,2-α]imidazol-2- ones in high yields. This synthetic methodology represents a 
new example of NHC-catalysed hydroacylation of unactivated alkenes that enables efficient 
hydroacylations of nitrogen heterocycles containing basic nitrogen atoms. 
Experimental  
 General Experimental. All air-sensitive procedures were conducted under inert 
atmosphere in a nitrogen-filled dry box or by standard Schlenk techniques.  All reactions were 
performed under an atmosphere of nitrogen unless otherwise stated.  All glassware for moisture 
sensitive reactions was dried at 140 °C in an oven.  Tetrahydrofuran, methylene chloride and N,N-
dimethylformamide were degassed by purging with argon for 45 minutes and dried with a solvent 
purification system by passing through a one-meter column of activated alumina.  Anhydrous 1,4-
dioxane was purchased from Aldrich. Flash column chromatography was performed on SiliFlash® 
P60 silica gel (40-63 m, 60Å) or using a Teledyne Isco Combiflash® Rf system with RediSep 
GoldTM columns using hexanes/ethyl acetate or dichloromethane/methanol mixtures as 
eluents.  Reactions products were visualized on TLC by UV light or by staining with KMnO4. 
 Instrumentation. HRMS (ESI) analysis was performed at the Iowa State University 
Chemical Instrumentation Facility on an Agilent 6540 QTOF spectrometer.  NMR spectra were 
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acquired on Varian MR-400 and Bruker Avance III 600 spectrometers at the Iowa State University 
Chemical Instrumentation Facility. Chemical shifts are reported in ppm relative to a residual 
solvent peak (CDCl3 = 7.26 ppm for 
1H and 77.16 ppm for 13C, DMSO-d6 = 2.50 for 
1H and 39.52 
for 13C).  19F NMR shifts are reported in ppm relative to trifluoroacetic acid as an external standard 
(F3CCO2H = -76.55 ppm).  Coupling constants are reporting in hertz 
Materials. (E)-1-(3-Bromoprop-1-en-1yl)-4-methoxybenzene (S1c), (E)-1-(3-
Bromoprop-1-en-2-yl)-4-chlorobenzene (S1d) were synthesized according to reported literature 
procedures.32 1-(3-Bromoprop-1-en-2-yl)-4-fluorobenzene (S1h), 1-(3-bromoprop-1-en-2yl)-4-
chlorobenzene (S1g), 1-(3-bromoprop-1-en-2-yl)-4-methoxybenzene (S1f), 1-(3-bromoprop-1-
en-2-yl)-3-fluorobenzene (S1i), 1(3-bromoprop-1-en-2-yl)-2-fluorobenzene (S1j), and (3-
bromoprop-1-en-2-yl)benzene (S1e) were synthesized according to a literature procedure.33 (1H-
Benzo[d]imidazol-2-yl)methanol and (5,6-dimethyl-1H-benzo[d]imidazol-2-yl)methanol were 
synthesized according to a literature procedure.34 Cinnamyl bromide (S1b), allyl bromide (S1a), 
activated manganese dioxide, anhydrous 1,4-dioxane, 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU) 
were purchased from Aldrich and used without further purification.  Imidazole-2-carboxaldehyde 
was purchased from AK Scientific and used without further purification. Triazolium chloride 2 
was synthesized according to a literature procedure.26 Triazolium tetrafluoroborate 7 was 
synthesized according to a literature procedure.35 
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General Procedure A: Synthesis of N-allylimdazole-2-carboxaldehydes (1a-j): 
 
     N-Allylimidazole-2-carboxaldehydes (1a-j) were prepared according to a modified literature 
procedure from the appropriate allyl bromides (S1a-j) and imidazole-2-carboxaldehyde.36 To the 
appropriate N-allylimidazole-carboxaldehyde (1.0 equiv) and Cs2CO3 or K2CO3 (1.2 equiv) was 
added DMF (0.27 M).  The resulting mixture was stirred at room temperature for 0.5 h.  The 
appropriate allyl bromide (1.2 equiv) was added dropwise.  The mixture was stirred at room 
temperature until the reaction was judged to be complete by thin-layer chromatography.  Water 
was added to the reaction mixture and the resulting solution was extracted with EtOAc (3x).  The 
combined organic layers were washed with water and brine, dried over Na2SO4, and concentrated 
under reduced pressure.  The crude product was purified by flash column chromatography on silica 
gel (hexane:EtOAc) to give the appropriate N-allylimidazole-2-carboxaldehyde (1a-j). 
1-allyl-1H-imidazole-2-carboxaldehyde (1a):  Prepared according to general 
procedure A from imidazole-2-carboxaldehyde (0.500 g, 5.20 mmol) and allyl 
bromide S1a (0.674 mL, 7.80 mmol).  The crude reaction mixture was purified by 
flash column chromatography (90:10 hexane:EtOAc) to give 1a as a brown oil in 49% yield (350 
mg, 2.54 mmol) 1H NMR (400 MHz, CDCl3)  4.96 (d, J = 6.0 Hz, 2H), 5.02 (dd, J = 16.0, 0.8 
Hz, 1H), 5.17 (dd, J = 10.4, 0.8 Hz, 1H), 5.89 (ddt, J = 16.0, 10.4, 6.0 Hz, 1H), 7.11 (app s, 1H), 
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7.21 (app s, 1H), 9.72 (s, 1H).  13C NMR (101 MHz, CDCl3)  49.7, 118.5, 126.0, 131.6, 132.4, 
143.1, 181.9. HRMS (ESI): Calcd. for C7H9N2O
+ ([M+H]+): 137.0709, Found: 137.0718. 
1-cinnamyl-1H-imidazole-2-carboxaldehyde (1b): Prepared according to 
general procedure A from imidazole-2-carboxaldehyde (1.44 g, 15.0 mmol) and 
cinnamyl bromide S1b (3.31 mL, 22.5 mmol).  The crude reaction mixture was 
purified by flash column chromatography (70:30 hexanes:EtOAc) to give 1b as a 
light yellow solid in 51% yield (1.63 g, 7.68 mmol). 1H NMR (400 MHz, CDCl3)  5.12 (dd, J = 
6.4, 1.2 Hz, 2H), 6.22 (dt, J = 15.6, 6.4 Hz, 1H), 6.47 (d, J = 15.6 Hz, 1H), 7.16 (app s, 1H), 7.18-
7.30 (m, 6H), 9.77 (s, 1H). 13C NMR (101 MHz, CDCl3)  49.5, 123.3, 126.0, 126.7, 128.4, 128.8, 
131.9, 134.4, 135.8, 143.3, 182.3. HRMS (ESI): Calcd. for C13H13N2O
+ ([M+H]+): 213.1022, 
Found: 213.1026.  
(E)-1-(3-(4-methoxyphenyl)allyl)-1H-imidazole-2-carboxaldehyde (1c): 
Prepared according to general procedure A from imidazole-2-carbaldehyde 
(62.0 mg, 0.640 mmol), and trans-p-methoxycinnamyl bromide S1c (0.219 g, 
0.970 mmol). The crude reaction mixture was purified by flash column 
chromatography (100:0 hexanes:EtOAc to 90:10 hexanes:EtOAc) to give 1c as a brown oil in 39% 
yield (0.060 g, 0.25 mmol).  1H NMR (400 MHz, CDCl3)  3.73 (s, 3H), 5.09 (d, J = 6.0 Hz, 2H), 
6.09 (dt, J = 15.6, 6.0 Hz, 1H), 6.44 (d, J = 15.6 Hz, 1H), 6.78 (d, J = 8.0 Hz, 2H), 7.14-7.30 (m, 
4H), 9.77 (s, 1H).  13C NMR (101 MHz, CDCl3)  49.7, 55.4, 114.2, 120.9, 125.9, 128.0, 128.5, 
131.9, 134.0, 143.3, 159.9, 182.3. HRMS (ESI): Calcd. for C14H15N2O2
+ ([M+H]+): 243.1128, 
Found: 243.1135.  
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(E)-1-(3-(4-chlorophenyl)allyl)-1H-imidazole-2-carboxaldehyde (1d): 
Prepared according to general procedure A from imidazole-2-carboxaldehyde 
(0.140 g, 1.44 mmol) and trans-p-chlorocinnamyl bromide S1d (0.500 g, 2.16 
mmol). The crude reaction mixture was purified by flash column 
chromatography (100:0 hexanes:EtOAc to 90:10 hexanes:EtOAc) to give 1d as an off-white solid 
in 23% yield (0.082 g, 0.33 mmol). 1H NMR (400 MHz, CDCl3)  5.11 (d, J = 8.0 Hz, 2H), 6.18 
(dt, J = 16.0, 8.0 Hz, 1H), 6.38 (d, J = 16.0 Hz, 1H), 7.15 (app s, 1H), 7.17-7.22 (m, 4H), 7.25 (app 
s, 1H), 9.77 (s, 1H). 13C NMR (101 MHz, CDCl3)  49.4, 124.1, 126.0, 127.9, 129.0, 132.0, 132.9, 
134.1, 134.3, 143.3, 182.3. HRMS (ESI): Calcd. for C13H12ClN2O
+ ([M+H]+): 247.0633, Found: 
247.0642. 
1-(2-phenylallyl)-1H-imidazole-2-carboxaldehyde (1e): Prepared according to 
general procedure A from imidazole-2-carboxaldehyde (0.200 g, 2.08 mmol) and 2-
phenylallyl bromide S1e (0.615 g, 3.12 mmol). The crude reaction mixture was 
purified by flash column chromatography (100:0 hexanes:EtOAc to 90:10 
hexanes:EtOAc) to give 1e as a brown oil in 65% yield (0.286 g, 1.35 mmol).  1H NMR (400 
MHz, CDCl3)  4.81 (s, 1H), 5.38 (app s, 3H), 7.05 (app s, 1H), 7.16 (app s, 1H), 7.18-7.28 (m, 
1H), 7.23 (d, J = 8.0 Hz, 2H), 7.31 (dd, J = 8.0, 1.2 Hz, 2H), 9.74 (s, 1H). 13C NMR (101 MHz, 
CDCl3)  50.8, 115.2, 126.2, 126.3, 128.5, 128.7, 131.8, 137.8, 143.3, 143.6, 182.2. HRMS (ESI): 
Calcd. for C13H13N2O
+ ([M+H]+): 213.1022, Found: 213.1020 
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1-(2-(4-methoxyphenyl)allyl)-1H-imidazole-2-carboxaldehyde (1f): Prepared 
according to general procedure A from imidazole-2-carbaldehyde (0.455 g, 4.74 
mmol) and 1-(3-bromoprop-1-en-2-yl)-4-methoxybenzene S1f (1.29g, 5.68 mmol). 
The crude reaction mixture was purified by flash column chromatography (100:0 
hexanes:EtOAc to 90:10 hexanes:EtOAc) to give 1f as a light-brown solid in 12% yield (0.138 g, 
0.570 mmol). 1H NMR (400 MHz, CDCl3)  3.79 (s, 3H), 4.85 (s, 1H), 5.41 (s, 1H), 5.44 (s, 2H), 
6.84 (d, J = 8.4 Hz, 2H), 7.13 (app s, 1H), 7.24 (app s, 1H), 7.33 (d, J = 8.4 Hz, 2H), 9.83 (s, 1H). 
13C NMR (101 MHz, CDCl3)  51.0, 55.4, 114.0, 114.1, 126.3, 127.4, 130.2, 131.8, 142.9, 143.4, 
159.9, 182.3. HRMS (ESI): Calcd. for C14H15N2O2
+ ([M+H]+): 243.1128, Found:243.1127 
1-(2-(4-chlorophenyl)allyl)-1H-imidazole-2-carboxaldehyde (1g): Prepared 
according to general procedure A from imidazole-2-carboxaldehyde (0.390 g, 4.11 
mmol) and 1-(3-bromoprop-1-en-2-yl)-4-chlorobenzene S1g (1.14 g, 4.93 mmol). The 
crude reaction mixture was purified by flash column chromatography  (100:0 
hexanes:EtOAc to 90:10 hexanes:EtOAc) to give 1g as a off-white solid in 30% yield (0.300 g, 
1.23 mmol).  1H NMR (400 MHz, CDCl3)  4.94 (s, 1H), 5.45 (s, 2H), 5.47 (s, 1H), 7.14 (app s, 
1H), 7.27 (d, J = 8.4 Hz, 2H), 7.27 (app s, 1H), 7.46 (d, J = 8.4 Hz, 2H), 9.82 (s, 1H). 13C NMR 
(101 MHz, CDCl3)  50.7, 115.9, 122.7, 126.3, 127.9, 131.9, 132.0, 136.8, 142.8, 143.3, 182.3. 
HRMS (ESI): Calcd. for C13H12ClN2O
+ ([M+H]+): 247.0633, Found: 247.0624 
1-(2-(4-fluorophenyl)allyl)-1H-imidazole-2-carboxaldehyde (1h): Prepared 
according to general procedure A from imidazole-2-carboxaldehyde (0.306 g, 3.19 
mmol) and 1-(3-bromoprop-1-en-2-yl)-4-fluorobenzene S1h (0.823 g, 3.83 mmol). 
The crude reaction mixture was purified by flash column chromatography  (100:0 
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hexanes:EtOAc to 90:10 hexanes:EtOAc) to give 1h as a brown amorphous solid in 23% yield 
(0.168 g, 0.730 mmol).  1H NMR (400 MHz, CDCl3)  4.88 (s, 1H), 5.40 (s, 1H), 5.43 (s, 2H), 
7.00 (dd, J = 8.8, 8.8 Hz, 2H), 7.13 (app s, 1H), 7.25 (d, J = 0.8 Hz, 1H), 7.35 (dd, J = 8.8, 5.2 Hz, 
2H), 9.81 (d, J = 1.2 Hz, 1H). 13C NMR (101 MHz, CDCl3)  50.9, 115.3 (d, J = 1.2 Hz, 2C), 
115.7 (d, J = 21.8 Hz, 2C), 126.3, 128.0 (d, J = 8 Hz, 1C), 131.9, 133.9 (d, J = 3.4 Hz, 1C), 142.8, 
143.3, 162.9 (d, J = 249.5 Hz, 1C), 182.3. 19F NMR (CDCl3, 376 MHz):  -113.48 (m, 1F). HRMS 
(ESI): Calcd. for C13H12FN2O
+ ([M+H]+): 231.0928, Found: 231.0922 
1-(2-(3-fluorophenyl)allyl)-1H-imidazole-2-carboxaldehyde (1i): Prepared 
according to general procedure A from imidazole-2-carboxaldehyde (0.291 g, 3.03 
mmol) and 1-(3-bromoprop-1-en-2-yl)-3-flurobenzene S1i ( 0.784 g, 3.64 mmol). 
The crude reaction mixture was purified by flash column chromatography (100:0 
hexanes:EtOAc to 90:10 hexanes:EtOAc) to give 1i as a brown oil in 28% yield (0.195 g, 0.846 
mmol). 1H NMR (400 MHz, CDCl3)  4.94 (s, 1H), 5.46 (s, 2H), 5.50 (s, 1H), 7.00 (m, 1H), 7.10 
(app dt, J = 15.6, 2.4 Hz, 1H), 7.15 (app s, 1H), 7.18(ddd, J = 7.6, 1.6, 0.8 Hz, 1H), 7.28 (d, J = 
0.8 Hz, 1H), 7.28-7.34 (m, 1H), 9.83 (d, J = 0.8 Hz, 1H). 13C NMR (101 MHz, CDCl3)  50.6, 
113.4 (d, J = 22.2 Hz, 1C), 115.4 (d, J = 21.2 Hz, 1C), 116.1, 121.9 (d, J = 3.0 Hz, 1C), 126.3, 
130.3 (d, J = 8.4 Hz, 1C), 131.9, 140.1 (d, J = 7.6 Hz, 1C), 142.7 (d, J = 2.2 Hz, 1C), 143.3, 162.9 
(d, J = 247.6 Hz, 1C), 182.2. 19F NMR (CDCl3 376 MHz):  -112.71 (m, 1F). HRMS (ESI): Calcd. 
for C13H12FN2O
+ ([M+H]+): 231.0928, Found: 231.0922 
1(2-(2-fluorophenyl)allyl)-1H-imidazole-2-carbaldehyde (1j): Prepared according 
to general procedure A from imidazole-2-carbaldehyde (0.570 g, 5.88 mmol) and 1-
(3-bromoprop-1-en-2-yl)-2-fluorobenzene S1j (1.52 g, 7.01 mmol). The crude 
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reaction mixture was purified by flash column chromatography (100:0 hexanes:EtOAc to 90:10 
hexanes:EtOAc) to give 1j as a brown oil in 15% yield (0.200 g, 0.866 mmol). 1H NMR (400 
MHz, CDCl3)  5.12 (s, 1H), 5.38 (s, 1H), 5.42 (s, 2H), 7.02-7.12 (m, 2H), 7.14 (s, 1H), 7.20-7.32 
(m, 3H), 9.80 (d, J = 0.8 Hz, 1H). 13C NMR (101 MHz, CDCl3)  51.4, 115.9 (d, J = 22.4 Hz, 1C), 
118.6 (d, J = 2.2 Hz, 1C), 124.5 (d, J = 3.4 Hz, 1C), 126.2 (d, J = 14.4 Hz, 1C), 126.6, 130.1 (d, J 
= 8.4 Hz, 1C), 130.2 (d, J = 3.8 Hz, 1C), 131.7, 140.0, 143.4, 159.9 (d, J = 248.6 Hz, 1C), 181.9. 
19F NMR (CDCl3, 376 MHz):  -115.31 (m, 1F). HRMS (ESI): Calcd. for C13H12FN2O+ 
([M+H]+): 231.0928, Found: 231.0926. 
General Procedure B: Synthesis of N-allylbenzimidazole-2-carboxaldehyde (5a-f) 
 
   N-allylbenzimidazole-2-carboxaldehydes (5a-f) were prepared according to a modified 
literature procedure from (1H-benzo[d]imidazol-2-yl)methanol or (5,6-dimethyl-1H-
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benzo[d]imidazol-2-yl)methanol.37 To a solution of (1H-benzo[d]imidazol-2-yl)methanol or (5,6-
dimethyl-1H-benzo[d]imidazol-2-yl)methanol in THF (0.3M) was added Et3N (5 equiv). The 
solution was refluxed for 1 h.  The appropriate allyl bromide  (1.2-5.0 equiv)(S1a-d) was added, 
and the mixture refluxed overnight.  Water was added to the cooled reaction mixture. The resulting 
mixture was extracted with Et2O (3x).  The organic layer was dried (Na2SO4) and concentrated 
under reduced pressure to afford the appropriate crude N-allylbenzimidazol-2-methanol (S2a-f). 
To a solution of the crude N-allylbenzimidazol-2-methanol (1.00 equiv) in DCM (4 mM) was 
added activated MnO2 (30.0 equiv).  The resulting mixture was refluxed overnight.  The cooled 
reaction mixture was filtered through a plug of celite.  The combined organic layers were 
concentrated under reduced pressure.  The crude product was purified by flash column 
chromatography on silica gel (DCM:EtOAc or hexanes:EtOAc) to give the appropriate N-
allylbenzimidazole-2-carboxaldehyde (5a-f). 
1-allyl-1H-benzo[d]imidazole-2-carboxaldehyde (5a): Prepared according 
to general procedure B from (1H-benzo[d]imidazol-2-yl)methanol (0.500 g, 
3.37 mmol) and allyl bromide S1a (291 L, 3.37 mmol) to give the crude 
product S2a (0.201 g, 1.06 mmol). Oxidation with MnO2 (0.929 mg, 10.69 mmol) generated crude 
5a.  The crude reaction mixture was purified by flash column chromatography (100:0 
hexanes:EtOAc to 90:10 hexanes EtOAc) to give 5a as an orange solid in 20% yield over two-
steps (0.128 g, 0.687 mmol).  1H NMR (600 MHz, CDCl3)  5.03 (dd, J = 16.8, 0.6 Hz, 1H), 5.19 
(dd, J = 10.2, 0.6 Hz, 1H), 5.25 (app dt, J = 5.4, 1.2 Hz, 2H), 5.98 (ddt, J = 16.8, 10.2, 5.4 Hz, 1H), 
7.37-7.40 (m, 1H), 7.45-7.46 (m, 2H), 7.93 (d, J = 8.4 Hz, 1H), 10.10 (s, 1H).  13C NMR (151 
MHz, CDCl3)  46.9, 111.2, 117.8, 122.5, 124.3, 127.0, 132.1, 136.4, 143.0, 145.8, 184.9 HRMS 
(ESI): Calcd. for C11H11N2O
+ ([M+H]+): 187.0866, Found: 187.0872 
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1-cinnamyl-1H-benzo[d]imidazole-2-carboxaldehyde (5b): Prepared 
according to general procedure B from (1H-benzo[d]imidazol-2-yl)methanol 
(0.801 g, 5.41 mmol) and S1b (4.00 mL, 27.0 mmol) to give the crude product 
S2b (0.258 g, 0.980 mmol).  Oxidation with MnO2 (2.55 g, 29.3 mmol) generated crude 5b.  The 
crude reaction mixture was purified by flash column chromatography (100:0 DCM:EtOAc to 95:5 
DCM:EtOAc) to give 5b as a light-orange solid in 9% yield over two-steps (0.132 g, 0.500 mmol).  
1H NMR (600 MHz, CDCl3)  5.43 (dd, J = 6.0, 1.2, Hz, 2H), 6.34 (dt, J = 16.2, 6.0 Hz, 1H), 6.56 
(d, J = 16.2 Hz, 1H), 7.25 (t, J = 7.2 Hz, 1H), 7.30 (t, J = 7.2 Hz, 2H), 7.33 (d, J = 7.2 Hz, 2H), 
7.44 (ddd, J = 15.6, 8.4, 1.2 Hz, 1H), 7.50 (ddd, J = 15.6, 8.4, 1.2 Hz, 1H), 7.56 (d, J = 8.4 Hz, 
1H), 7.99 (d, J = 8.4 Hz, 1H), 10.17 (s, 1H). 13C NMR (151 MHz, CDCl3)  46.7, 111.2, 122.5, 
123.2, 124.3, 126.6, 127.1, 128.2, 128.6, 133.4, 135.8, 136.3, 143.0, 145.8, 184.9. HRMS (ESI): 
Calcd. for C17H15N2O
+ ([M+H]+): 263.1179, Found: 263.1181. 
(E)-1-(3-(4-chlorophenyl)allyl)-1H-benzo[d]imidazole-2-
carboxaldehyde (5c): Prepared according to general procedure B from 
(1H-benzo[d]imidazol-2-yl)methanol (0.452 g, 3.05 mmol) and S1c (3.53 
g, 15.2 mmol) to give the crude product S2c (0.227 g, 0.765 mmol). Oxidation with MnO2 (1.98 
g, 22.8 mmol) generated crude 5c. The crude reaction mixture was purified by flash column 
chromatography (100:0 hexanes:EtOAc to 85:15 hexanes:EtOAc) to give 5c as a white solid in 
7% yield over two-steps (0.059 g, 0.20 mmol). 1H NMR (600 MHz, CDCl3)  5.40 (dd, J = 6.0, 
1.2 Hz, 2H), 6.29 (dt, J = 15.6, 6.0 Hz, 1H), 6.46 (d, J = 15.6 Hz, 1H), 7.20-7.24 (m, 4H), 7.41 
(ddd, J = 15.0, 8.4, 1.2 Hz, 1H), 7.48, (ddd, J = 15.0, 8.4, 1.2 Hz, 1H), 7.52 (d, J = 8.4 Hz, 1H), 
7.96 (d, J = 8.4 Hz, 1H), 10.13 (s, 1H). 13C NMR (151 MHz, CDCl3)  46.5, 111.1, 122.7, 123.9, 
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124.4, 127.2, 127.9, 128.9, 132.1, 133.9, 134.4, 136.4, 143.0, 145.8, 185.1. HRMS (ESI): Calcd. 
for C17H14ClN2O
+ ([M+H]+): 297.0789, Found: 297.0789. 
1-(2-phenylallyl)-1H-benzo[d]imidazole-2-carboxaldehyde (5d): Prepared 
according to general procedure B from (1H-benzo[d]imidazol-2-yl)methanol 
(0.725 g, 4.89 mmol) and S1d (4.82 g, 24.5 mmol) to give the crude product S2d 
(0.437 g, 1.65 mmol), Oxidation with MnO2 (4.31 g, 49.6 mmol) generate crude 
5d. The crude reaction mixture was purified by flash column chromatography (100:0 
hexanes:EtOAc to 90:10 hexanes:EtOAc) to give 5d as an orange solid in 16% yield over two-
steps (0.210 g, 0.801 mmol).  1H NMR (600 MHz, CDCl3)  4.51 (s, 1H), 5.33 (s, 1H), 5.67 (s, 
2H), 7.30-7.38 (m, 3H), 7.38-7.42 (m, 1H), 7.43-7.48 (m, 4H), 7.94 (d, J = 8.4 Hz, 1H), 10.11 (s, 
1H).  13C NMR (151 MHz, CDCl3)  48.2, 111.6, 113.1, 122.5, 124.4, 126.4, 127.2, 128.5, 128.7, 
136.7, 138.5, 142.9, 143.3, 146.0, 184.9. HRMS (ESI): Calcd. for C17H15N2O
+ ([M+H]+): 
263.1179, Found: 263.1184. 
1-allyl-5,6-dimethyl-1H-benzo[d]imidazole-2-carboxaldehyde (5e): 
Prepared according to general procedure B from (5,6-dimethyl-1H-
benzo[d]imidazol-2-yl)methanol (1.00 g, 5.67 mmol) and S1a (0.589 ml, 6.81 
mmol) to give the crude product S2e (0.289 g, 1.35 mmol). Oxidation with MnO2 (3.55 g, 41.9 
mmol) generated crude 5e. The crude reaction mixture was purified by flash column 
chromatography (100:0 DCM:EtOAc to 90:10 DCM:EtOAc) to give 5e as a white solid in 4% 
yield over two-steps (0.047 g, 0.22 mmol).  1H NMR (400 MHz, CDCl3)  2.39 (s, 3H), 2.42 (s, 
3H), 5.00 (dd, J = 17.2, 0.8 Hz, 1H), 5.18 (dd, J = 10.4, 0.8 Hz, 1H), 5.21 (m, 2H), 5.93-6.02 (m, 
1H), 7.20 (s, 1H), 7.66 (s, 1H), 10.05 (s, 1H). 13C NMR (101 MHz, CDCl3)  20.6, 21.2, 46.9, 
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110.9, 117.5, 121.9, 132.3, 134.0, 135.2, 137.5, 141.9, 145.4, 184.7.  HRMS (ESI): Calcd. for 
C13H15N2O
+ ([M+H]+): 215.1179, Found: 215.1184. 
(E)-1-(3-(4-chlorophenyl)allyl)-5,6-dimethyl-1H-
benzo[d]imidazole-2-carboxaldehyde (5f): Prepared according to 
general procedure B from (5,6-dimethyl-1H-benzo[d]imidazol-2-
yl)methanol (1.00 g, 5.74 mmol) and S1c (1.58 g, 6.81 mmol) to give the crude product S2f (0.330 
g, 1.01 mmol). Oxidation with MnO2 (2.65 g, 30.5 mmol) generated crude 5f. The crude reaction 
mixture was purified by flash column chromatography (100:0 DCM:EtOAc to 90:10 
DCM:EtOAc) to give 5f as a yellow oil in 3% yield over two-steps (0.050 g, 0.15 mmol). 1H NMR 
(400 MHz, CDCl3)  2.40 (s, 3H), 2.42 (s, 3H), 5.34 (d, J = 5.6 Hz, 2H), 6.28 (dt, J = 16.0, 5.6 Hz, 
1H), 6.41 (d, J = 16 Hz, 1H), 7.18-7.23 (m, 4H), 7.25 (s, 1H), 7.68 (s, 1H), 10.07 (s, 1H).  13C 
NMR (101 MHz, CDCl3)  20.6, 21.3, 46.3, 110.7, 122.0, 124.2, 127.8, 128.8, 131.7, 133.8, 134.1, 
134.5, 135.1, 137.6, 141.9, 145.3, 184.7. HRMS (ESI): Calcd. for C19H18ClN2O
+ ([M+H]+): 
325.1102, Found: 325.1093 
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General Procedure C: Synthesis of dihydropyrroloimidazolones (3a-j), 
dihydrobenzopyrroloimidazolones (6a-f) 
 
Dihydropyrroloimidazolones (3a-j) and dihydrobenzopyrroloimidazolones (6a-f) were 
prepared according to a modified literature procedure from the appropriate carboxaldehyde (1a-j) 
or (5a-f).26 In a nitrogen-filled glovebox, to a 1-dram vial was added triazolium 2 (0.020 mmol, 
0.10 equiv), the appropriate carboxaldehyde 1a-j or 5a-f (0.20 mmol, 1.0 equiv), DBU (6 L, 0.04 
mmol, 0.2 equiv), and 1,4-dioxane (0.4 mL, 0.5 M).  The vial was sealed with a teflon-lined septum 
cap.  The reaction vessel was removed from the glovebox and the reaction mixture was stirred at 
60 °C for 12 h.  The reaction was cooled to room temperature and filtered through a plug of silica 
gel with EtOAc as eluent.  The filtrate was concentrated under reduced pressure.  The crude 
product was purified by flash column silica gel chromatography (hexane:EtOAc) to give the 
appropriate dihydropyrroloimidazolones (3a-j) and dihydrobenzopyrroloimidazolones (6a-f). 
 6-methyl-5,6-dihydro-7H-pyrrolo[1,2-a]imidazole-7-one (3a): Prepared according 
to general procedure C from 1-allyl-1H-imidazole-2-carbaldehyde 1a (0.041 g, 0.30 
mmol), DBU (9 L, 0.06 mmol) and triazolium 2 (9.0 mg, 0.030 mmol).  The crude reaction 
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mixture was purified by column chromatography (100:0 hexane:EtOAc to 90:10 hexane:EtOAc) 
to afford 3a in 96% yield (0.039 g, 0.29 mmol) as a yellow oil.  1H NMR (600 MHz, CDCl3)  
1.40 (d, J = 7.8 Hz, 3H), 3.19-3.24 (m, 1H), 3.92 (dd, J = 12.0, 3.6 Hz, 1H), 4.58 (dd, J = 12.0, 7.8 
Hz, 1H), 7.23 (app s, 1H), 7.57 (app s, 1H). 13C NMR (151 MHz, CDCl3)  15.4, 44.9, 48.7, 120.0, 
139.4, 146.5, 190.3. HRMS (ESI): Calcd. for C7H9N2O
+ ([M+H]+): 137.0709, Found 137.0716. 
 6-benzyl-5,6-dihydro-7H-pyrrolo[1,2-a]imidazole-7-one (3b): Prepared 
according to general procedure C from 1-cinnamyl-1H-imidazole-2-carbaldehyde 
1b (0.064 g, 0.30 mmol), DBU (8.97 L, 0.0600 mmol) and triazolium 2 (9.0 mg, 
0.030 mmol).  The crude reaction mixture was purified by flash column chromatography (90:10 
hexanes:EtOAc) to afford 3b in 96% yield (0.061 mg, 0.29 mmol) as an off-white solid.  1H NMR 
(400 MHz, CDCl3)  2.82 (dd, J = 14.0, 10.4 Hz, 1H), 3.35 (dd, J = 14.0, 4.4 Hz, 1H), 3.45 (dddd, 
J = 10.4, 7.6, 4.4, 4.0 Hz, 1H), 3.98 (dd, J = 12.0, 4.0 Hz, 1H), 4.28 (dd, J = 12.0, 7.6 Hz, 1H), 
7.11 (app s, 1H), 7.12-7.27 (m, 5H), 7.52 (app s, 1H).  13C NMR (101 MHz, CDCl3)  36.1, 46.1, 
51.5, 120.2, 127.1, 128.9, 129.0, 137.7, 139.5, 146.7, 188.8. HRMS (ESI): Calcd. for C13H13N2O
+ 
([M+H]+): 213.1022, Found: 213.1019. 
 6-(4-methoxybenzyl)-5,6-dihydro-7H-pyrrolo[1,2-a]imidazole-7-one (3c): 
Prepared according to general procedure C from (E)-1-(3-(4-methoxyphenyl)allyl)-
1H-imidazole-2-carbaldehyde 1c (0.048 g, 0.20 mmol), DBU (6 L, 0.04 mmol) 
and triazolium 2 (6 mg, 0.02 mmol).  The crude reaction mixture was purified by 
column chromatography (90:10 hexanes:EtOAc) to afford 3c in 85% yield (0.041 g, 0.17 mmol) 
as an off-white solid. 1H NMR (600 MHz, CDCl3)  2.87 (dd, J = 14.4, 9.6 Hz, 1H), 3.32 (dd, J = 
14.4, 4.8 Hz, 1H), 3.43-3.49 (m, 1H), 3.77 (s, 3H), 4.03 (dd, J = 12.0, 3.6 Hz, 1H), 4.33 (dd, J = 
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12.0, 7.8 Hz, 1H), 6.82 (d, J = 7.8 Hz, 2H), 7.11 (d, J = 7.8 Hz, 2H), 7.16 (app s, 1H), 7.57 (app s, 
1H). 13C NMR (151 MHz, CDCl3)  35.2, 46.0, 51.7, 55.4, 114.4, 120.1, 129.5, 129.9, 139.5, 
146.8, 158.7, 188.9. HRMS (ESI): Calcd. for C14H15N2O2
+ ([M+H]+): 243.1128, Found 243.1121. 
6-(4-chlorobenzyl)-5,6-dihydro-7H-pyrrolo[1,2-a]imidazole-7-one (3d): 
Prepared according to general procedure C from (E)-1-(3-(4-chlorophenyl)allyl)-
1H-imidazole-2-carbaldehyde 1d (0.049 g, 0.20 mmol), triazolium 2 (6 mg, 0.02 
mmol) and DBU (6 L, 0.04 mmol).  The crude reaction mixture was purified by 
flash column chromatography with (100:0 hexanes:EtOAc to 90:10 hexanes:EtOAc) to afford 3d 
in 99% yield (0.049 g, 0.20 mmol) as an off-white solid.  1H NMR (600 MHz, CDCl3)  2.88 (dd, 
J = 14.4, 10.2 Hz, 1H), 3.32 (dd, J = 14.4, 4.2 Hz, 1H), 3.43-3.49 (m, 1H), 4.00 (dd, J = 12.0, 4.2 
Hz, 1H), 4.36 (dd, J = 12.0, 7.8 Hz, 1H), 7.13 (d, J = 7.8 Hz, 2H), 7.17 (app s, 1H), 7.24 (d, J = 
7.8 Hz, 2H), 7.54 (app s, 1H).  13C NMR (151 MHz, CDCl3)  35.3, 46.0, 51.2, 120.3, 129.1, 
130.2, 132.9, 136.1, 139.5, 146.5, 188.4. HRMS (ESI): Calcd. for C13H12ClN2O
+ ([M+H]+): 
247.0633, Found 247.0632. 
6-methyl-6-phenyl-5,6-dihydro-7H-pyrrolo[1,2-a]imidazole-7-one (3e): 
Prepared according to general procedure C from 1-(2-phenylallyl)-1H-imidazole-
2-carbaldehyde 1e (0.042 g, 0.20 mmol), triazolium 2 (6 mg, 0.02 mmol) and DBU 
(6 L, 0.04 mmol).  The crude reaction mixture was purified by flash column chromatography 
with (90:10 hexanes:EtOAc) to afford 3e in 99% yield (0.042 g, 0.20 mmol) as an off white solid. 
1H NMR (600 MHz, CDCl3)  1.78 (s, 3H), 4.42 (d, J = 12.0 Hz, 1H), 4.66 (d, J = 12.0 Hz, 1H), 
7.25-7.37 (m, 6H), 7.69 (app s, 1H).  13C NMR (151 MHz, CDCl3)  23.7, 56.7, 57.2, 120.2, 125.9, 
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127.7, 129.1, 139.9, 141.3, 145.9, 190.3. HRMS (ESI): Calcd. for C13H13N2O
+ ([M+H]+): 
213.1022, Found: 213.1029. 
6-(4-methoxyphenyl)-6-methyl-5,6-dihydro-7H-pyrrolo[1,2-a]imidazole-7-
one (3f): Prepared according to general procedure C from 1-(2-(4-
methoxyphenyl)allyl)-1H-imidazole-2-carbaldehyde 1f (0.048 g, 0.20 mmol), 
triazolium 2 (6 mg, 0.02 mmol), and DBU (6 L, 0.04 mmol).  The crude reaction mixture was 
purified by flash column chromatography with (90:10 hexanes:EtOAc) to afford 3f in 99% yield 
(0.048 g, 0.20 mmol) as an off white solid. 1H NMR (600 MHz, CDCl3)  1.73 (s, 3H), 3.76 (s, 
3H), 4.37 (d, J = 12.0 Hz, 1H), 4.61 (d, J = 12.0 Hz, 1H), 6.84 (d, J = 9.0 Hz, 2H), 7.19 (d, J = 9.0 
Hz, 2H), 7.27 (d, J = 0.6 Hz,, 1H), 7.65 (d, J = 0.6 Hz, 1H).  13C NMR (151 MHz, CDCl3)  23.8, 
55.4, 56.1, 57.2, 114.5, 120.1, 127.1, 133.3, 139.8, 146.0, 159.1, 190.6. HRMS (ESI): Calcd. for 
C14H15N2O2
+ ([M+H]+): 243.1128, Found: 243.1123. 
6-(4-chlorophenyl)-6-methyl-5,6-dihydro-7H-pyrrolo[1,2-a]imidazole-7-one 
(3g): Prepared according to general procedure C from 1-(2-(4-chlorophenyl)allyl)-
1H-imidazole-2-carbaldehyde 1g (0.049 g, 0.20 mmol), triazolium 2 ( 6 mg, 0.02 
mmol) and DBU (6 L, 0.04 mmol).  The crude reaction mixture was purified by flash column 
chromatography with (90:10 hexanes:EtOAc) to afford 3g 95% yield (0.047 g, 0.19 mmol) as an 
off white solid. 1H NMR (600 MHz, CDCl3)  1.73 (s, 3H), 4.41 (d, J = 12.0 Hz, 1H), 4.60 (d, J 
= 12.0 Hz, 1H), 7.16 (d, J = 8.4 Hz, 2H), 7.30 (app s, 1H), 7.44 (d, J = 8.4 Hz, 2H), 7.67 (app s, 
1H).  13C NMR (151 MHz, CDCl3) 23.8, 56.3, 56.8, 120.4, 121.8, 127.8, 132.2, 140.2, 140.3, 
145.6, 189.7. HRMS (ESI): Calcd. for C13H12ClN2O
+ ([M+H]+): 247.0633, Found: 247.0638. 
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6-(4-fluorophenyl)-6-methyl-5,6-dihydro-7H-pyrrolo[1,2-a]imidazole-7-one 
(3h): Prepared according to general procedure C from 1-(2-(4-fluorophenyl)allyl)-
1H-imidazole-2-carbaldehyde 1h (0.046 g, 0.20 mmol), triazolium 2 (6 mg, 0.02 
mmol) and DBU (6 L, 0.04 mmol).  The crude reaction mixture was purified by 
flash column chromatography with (90:10 hexanes:EtOAc) to afford 3h in 99% yield (0.046 g, 
0.20 mmol) as an orange oil. 1H NMR (600 MHz, CDCl3)  1.77 (s, 3H), 4.45 (d, J = 12.0 Hz, 
1H), 4.64 (d, J = 12.0 Hz, 1H), 7.03 (dd, J = 9.0, 9.0 Hz, 2H), 7.28 (dd, J = 9.0, 5.4 Hz, 2H), 7.33 
(app s, 1H), 7.69 (app s, 1H). 13C NMR (151 MHz, CDCl3)  23.7, 56.1, 57.1, 115.9 (d, J = 21.4 
Hz, 2C), 120.3, 127.7 (d, J = 8.2 Hz, 2C), 137.0 (d, J = 3.2 Hz, 1C), 140.1, 145.7, 162.1 (d, J = 
247.2 Hz, 1C), 190.1. 19F NMR (CDCl3, 565 MHz):  -115.08 (s, 1F) HRMS (ESI): Calcd. for 
C13H12FN2O
+ ([M+H]+): 231.0928, Found: 231.0923. 
6-(3-fluorophenyl)-6-methyl-5,6-dihydro-7H-pyrrolo[1,2-a]imidazole-7-
one (3i): Prepared according to general procedure C from 1-(2-(3-
fluorophenyl)allyl)-1H-imidazole-2-carbaldehyde 1i (0.046 g, 0.20 mmol), 
triazolium 2 (6 mg, 0.02 mmol) and DBU (6 L, 0.04 mmol).  The crude reaction mixture was 
purified by flash column chromatography with (90:10 hexanes:EtOAc) to afford 3i in 99% yield 
(0.046 g, 0.20 mmol) as an orange oil.  1H NMR (600 MHz, CDCl3)  1.78 (s, 3H), 4.45 (d, J = 
12.0 Hz, 1H), 4.66 (d, J = 12.0 Hz, 1H), 6.95-7.01 (m, 1H), 7.03-7.07 (m, 2H), 7.32 (ddd, 12, 10.2, 
3.6 Hz, 1H), 7.35 (app s, 1H), 7.71 (app s, 1H).  13C NMR (151 MHz,CDCl3)  23.7, 56.4 (d, J = 
1.66 Hz, 1C), 56.9, 113.4 (d, J = 22.6 Hz, 1C), 114.7 (d, J = 19.6 Hz, 1C), 120.4, 121.6 (d, J = 3.0 
Hz, 1C), 130.7 (d, J = 8.2 Hz, 1C), 140.2, 143.7 (d, J = 6.0 Hz, 1C), 145.7, 163.1 (d, J = 247.0 Hz, 
1C), 189.6. 19F NMR (CDCl3, 565 MHz):  -111.98 (s, 1F). HRMS (ESI): Calcd. for C13H12FN2O+ 
([M+H]+): 231.0928, Found: 231.0929. 
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 6-(2-fluorophenyl)-6-methyl-5,6-dihydro-7H-pyrrolo[1,2-a]imidazole-7-one 
(3j): Prepared according to general procedure C from 1-(2-(2-fluorophenyl)allyl)-
1H-imidazole-2-carbaldehyde 1j (0.046 g, 0.20 mmol), triazolium 2 (6 mg, 0.02 
mmol) and DBU (6 L, 0.04 mmol).  The crude reaction mixture was purified by flash column 
chromatography with (90:10 hexanes:EtOAc) to afford 3j in 99% yield (0.046 g, 0.20 mmol) as 
an off-white solid. 1H NMR (600 MHz, CDCl3)  1.74 (s, 3H), 4.39 (d, J = 12.0 Hz, 1H), 4.53 (d, 
J = 12.0 Hz, 1H), 7.03 (dd, J = 12.0, 7.8 Hz, 1H), 7.15 (t, J = 7.8 Hz, 1H), 7.25 (app s, 1H), 7.29 
(m, 1H), 7.48 (t, J = 7.8 Hz, 1H), 7.64 (s, 1H).  13C NMR (151 MHz, CDCl3)  23.2, 54.1, 56.2 
(d, J = 4.6 Hz, 1C), 116.2 (d, J = 21.6 Hz, 1C), 119.9, 124.5 (d, J = 3.2 Hz, 1C), 128.1 (d, J = 12.8 
Hz, 1C), 128.2 (d, J = 4.0 Hz, 1C), 129.9 (d, J = 8.8 Hz, 1C), 139.6, 145.5, 160.7 (d, J = 246.8 Hz, 
1C), 189.9. 19F NMR (CDCl3, 565 MHz):  -113.05 (s, 1F). HRMS (ESI): Calcd. for C13H12FN2O+ 
([M+H]+): 231.0928, Found: 231.0928. 
 2-methyl-1,2-dihydro-3H-benzo[d]pyrrolo[1,2-a]imidazol-3-one (6a): 
Prepared according to general procedure C from 1-allyl-1H-benzo[d]-imidazole-
2-carbaldehyde 5a (0.037 g, 0.20 mmol), triazolium 2 (6 mg, 0.02 mmol) and DBU (6 L, 0.04 
mmol). The crude reaction mixture was purified by flash column chromatography (90:10 
hexanes:EtOAc)  to afford 6a in 97% yield (0.036 g, 0.19 mmol) as a white solid. 1H NMR (600 
MHz, CDCl3)  1.47 (d, J = 7.2 Hz, 3H), 3.33 (m, 1H), 4.03 (dd, J = 11.4, 4.2 Hz, 1H), 4.71 (dd, 
J = 11.4, 7.8 Hz, 1H), 7.38 (ddd, J = 7.8, 7.2, 1.2, Hz, 1H), 7.41 (ddd, J = 7.8, 7.2, 1.2 Hz, 1H), 
7.48 (d, J = 7.8 Hz, 1H), 7.92 (d, J = 7.8 Hz, 1H). 13C NMR (151 MHz, CDCl3)  15.4, 45.0, 47.0, 
111.0, 123.21, 124.8, 125.6, 132.8, 149.1, 149.4, 193.7. HRMS (ESI): Calcd. for C11H11N2O
+ 
([M+H]+): 187.0866, Found: 187.0866. 
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 2-benzyl-1,2-dihydro-3H-benzo[d]pyrrolo[1,2-a]imidazol-3-one (6b): 
Prepared according to general procedure C from 1-cinnamyl-1H-
benzo[d]imidazole-2-carbaldehyde 5b (0.052 g, 0.20 mmol), triazolium 2 (6 mg, 
0.02 mmol) and DBU (6 L, 0.04 mmol).  The crude reaction mixture was 
purified by flash column chromatography with (100:0 hexanes:EtOAc to 90:10 hexanes:EtOAc) 
to afford 6b in 87% yield (0.045 g, 0.17 mmol) as a white solid. 1H NMR (400 MHz, CDCl3)  
2.96 (dd, J = 14.0, 10.0 Hz, 1H), 3.51 (dd, J = 14.0, 4.4 Hz, 1H), 3.61-3.70 (m, 1H), 4.18 (dd, J = 
11.6, 4.0 Hz, 1H), 4.51 (dd, J = 11.6, 7.6 Hz, 1H), 7.24-7.30 (m, 3H), 7.31-7.37 (m, 2H), 7.38-
7.49 (m, 3H), 7.94 (dd, J = 6.8, 2.8 Hz, 1H). 13C NMR (101 MHz, CDCl3)  36.1, 44.6, 51.6, 
111.1, 123.4, 125.0, 125.8, 127.3, 128.9, 129.1, 132.9, 137.6, 149.2, 149.5, 192.2. HRMS (ESI): 
Calcd. for C17H15N2O
+ ([M+H]+): 263.1179, Found: 263.1177. 
2-(4-chlorobenzyl)-1,2-dihydro-3H-benzo[d]pyrrolo[1,2-a]imidazol-3-one 
(6c):  Prepared according to general procedure C from (E)-1-(3-(4-
chlorophenyl)allyl)-1H-benzo[d]imidazole-2-carbaldehyde 5c (0.059 g, 0.20 
mmol), triazolium 2 ( 6 mg, 0.02 mmol) and DBU (6 L, 0.04 mmol).  The crude 
reaction mixture was purified by flash column chromatography with (100:0 hexanes:EtOAc to 
90:10 hexanes:EtOAc) as eluent to afford 6c  in 84% yield (0.050 g, 0.17 mmol). 1H NMR (600 
MHz, d6-DMSO)  3.00 (dd, J = 14.4, 10.8 Hz, 1H), 3.28 (dd, J = 14.4, 4.8 Hz, 1H), 3.75-3.82 
(m, 1H), 4.21 (dd, J = 11.4, 4.2 Hz, 1H), 4.56 (dd, J = 11.4, 7.8 Hz, 1H), 7.35-7.41 (m, 5H), 7.42-
7.45 (m, 1H), 7.76 (d, J = 8.4 Hz, 1H), 7.85 (d, J = 8.4 Hz, 1H). 13C NMR (101 MHz, d6-DMSO) 
 34.1, 44.6, 50.8, 112.3, 122.0, 124.3, 124.9, 128.5, 130.8, 131.3, 132.7, 137.6, 148.5, 149.6, 
193.5. HRMS (ESI): Calcd. for C17H14ClN2O
+ ([M+H]+): 297.0789, Found: 297.0789. 
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2-methyl-2-phenyl-1,2-dihydro-3H-benzo[d]pyrrolo[1,2-a]imidazol-3-one 
(6d):  Prepared according to general procedure C from 1-(2-phenylallyl)-1H-
benzo[d]imidazole-2-carbaldehyde 5d (0.052 g, 0.20 mmol), triazolium 2 (6 mg, 
0.02 mmol) and DBU (6 L, 0.04 mmol).  The crude reaction mixture was 
purified by flash column chromatography with (100:0 hexanes:EtOAc to 90:10 hexanes:EtOAc) 
as eluent to afford 6d in 93% yield (0.048 g, 0.19 mmol) as a white solid. 1H NMR (600 MHz, 
CDCl3)  1.86 (s, 3H), 4.57 (d, J = 11.4 Hz, 1H), 4.84 (d, J = 11.4 Hz, 1H), 7.25-7.36 (m, 5H), 
7.45 (ddd, J = 8.4, 7.8, 1.2 Hz, 1H), 7.48 (ddd, J = 8.4, 7.8, 1.2 Hz, 1H), 7.57 (dd, J = 7.8, 1.2 Hz, 
1H), 8.01 (dd, J = 7.8, 1.2 Hz, 1H). 13C NMR (151 MHz, CDCl3)  23.8, 55.5, 56.7, 111.2, 123.4, 
125.0, 125.9, 125.93, 127.9, 129.2, 132.8, 140.9, 148.6, 149.8, 193.8. HRMS (ESI): Calcd. for 
C17H15N2O
+ ([M+H]+): 263.1179, Found: 263.1181. 
2,6,7-trimethyl-1,2-dihydro-3H-benzo[d]pyrrolo[1,2-a]imidazol-3-one 
(6e): Prepared according to general procedure C from 1-allyl-5,6-dimethyl-1H-
benzo[d]imidazole-2-carbaldehyde 5e (0.021 g, 0.10 mmol), triazolium 2 (3 mg, 0.01 mmol) and 
DBU (2.9 L, 0.020 mmol).  The crude reaction mixture was purified by flash column 
chromatography with (100:0 hexanes:EtOAc to 90:10 hexanes:EtOAc) to afford 6e in 66% yield 
(0.014 g, 0.066 mmol) as a white solid.  1H NMR (600 MHz, CDCl3)  1.48 (d, J = 7.2 Hz, 3H), 
2.39 (s, 3H), 2.41 (s, 3H), 3.29-3.35 (m, 1H), 3.99 (dd, J = 11.4, 4.2 Hz, 1 H), 4.67 (dd, J = 11.4, 
7.8 Hz, 1H), 7.26 (s, 1H), 7.68 (s, 1H).  13C NMR (151 MHz, CDCl3)  1.1, 15.5, 20.7, 20.9, 45.0, 
47.0, 110.7, 122.6, 131.6, 134.6, 135.9, 148.5, 193.4. HRMS (ESI): Calcd. for C13H15N2O
+ 
([M+H]+): 215.1179, Found: 215.1178. 
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2-(4-chlorobenzyl)-6,7-dimethyl-1,2-dihydro-3H-benzo[d]pyrrolo[1,2-
a]imidazol-3-one (6f): Prepared according to general procedure C (E)-1-(3-(4-
chlorophenyl)allyl)-5,6-dimethyl-1H-benzo[d]imidazole-2-carbaldehyde 5f 
(0.032 g, 0.10 mmol), triazolium 2 (3 mg, 0.01 mmol) and DBU (3 L, 0.02 
mmol).  The crude reaction mixture was purified by column chromatography with (100:0 
hexanes:EtOAc to 90:10 hexanes:EtOAc) to afford 6f in 88% yield (0.028 g, 0.088 mmol) as a 
white solid. 1H NMR (600 MHz, CDCl3)  2.38 (app s, 6H), 2.95 (dd, J = 14.4, 10.2 Hz, 1H), 3.41 
(dd, J = 14.4, 4.2 Hz, 1H), 3.54-3.60 (m, 1H), 4.05 (dd, J = 11.4, 3.6 Hz, 1H), 4.44 (dd, J = 11.4, 
7.2 Hz, 1H), 7.18 (d, J = 7.8 Hz, 2H), 7.20 (s, 1H ), 7.28 (d, J = 7.8 Hz, 2H), 7.66 (s, 1H). 13C 
NMR (151 MHz, CDCl3)  20.8, 21.0, 35.5, 44.3, 51.4, 110.7, 122.7, 129.2, 130.3, 130.8, 131.6, 
133.1, 134.9, 136.2, 148.3, 148.4, 191.5. HRMS (ESI): Calcd. for C19H18ClN2O
+ ([M+H]+): 
325.1102, Found: 325.1103. 
General Procedure D: Enantioselective synthesis of 3e-j 
  
In a nitrogen-filled glovebox, to a 1-dram vial was added triazolium 7 (0.010 mmol, 0.10 
equiv), the appropriate N-allyimidazole-2-carboxaldehyde 1e-j (0.10 mmol, 1.0 equiv), DBU (3 
L, 0.02 mmol, 0.2 equiv), and 1,4-dioxane (0.2 mL, 0.5 M).  The vial was sealed with a teflon-
lined septum cap.  The reaction vessel was removed from the glovebox and the reaction mixture 
was stirred at 80 °C for 12 h.  The reaction was cooled to room temperature and filtered through a 
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plug of silica gel with EtOAc as eluent.  The filtrate was concentrated under reduced pressure.  The 
crude product was purified by flash column silica gel chromatography (hexane:EtOAc) to give the 
appropriate dihydropyrroloimidazolones (3e-j). 
(S)-6-methyl-6-phenyl-5,6-dihydro-7H-pyrrolo[1,2-a]imidazole-7-one (3e): 
Prepared according to general procedure D from 1-(2-phenylallyl)-1H-imidazole-
2-carbaldehyde 1e (0.021 g, 0.10 mmol), triazolium 7 (4 mg, 0.01 mmol) and DBU 
(3 L, 0.02 mmol).  The crude reaction mixture was purified by flash column chromatography 
with (90:10 hexanes:EtOAc) to afford 3e in 90% yield (0.019 g, 0.090 mmol) as an off white solid.  
The enantiomeric excess was determined by HPLC analysis (254 nm, 25 °C) tR 27.1 min (major); 
tR 32.4 min (minor) [Chiracel AD-H (0.46 cm x 25 cm)(from Daicel Chemical Ind., hexane/i-
PrOH, 90:10, 1.0 mL/min] to be 71% ee. []D24 = -188.8° (c 0.63, CHCl3). NMR spectra are 
consistent with racemic spectra above. 
(S)-6-(4-methoxyphenyl)-6-methyl-5,6-dihydro-7H-pyrrolo[1,2-
a]imidazole-7-one (3f): Prepared according to general procedure D from 1-(2-
(4-methoxyphenyl)allyl)-1H-imidazole-2-carbaldehyde 1f (0.024 g, 0.10 mmol), 
triazolium 7 (4 mg, 0.01 mmol), and DBU (3 L, 0.02 mmol).  The crude reaction mixture was 
purified by flash column chromatography with (90:10 hexanes:EtOAc) to afford 3f in 98% yield 
(0.024 g, 0.097 mmol) as an off white solid.  The enantiomeric excess was determined by HPLC 
analysis (254 nm, 25 °C) tR 44.3 min (major); 56.9 min (minor) [Chiracel AD-H (0.46 cm x 25 
cm)(from Daicel Chemical Ind., Ltd.) hexane/i-PrOH, 90:10, 1.0 mL/min] to be 79% ee. []D23 = 
-84.9° (c 1.06, CHCl3). NMR spectra are consistent with racemic spectra above. 
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(S)-6-(4-chlorophenyl)-6-methyl-5,6-dihydro-7H-pyrrolo[1,2-a]imidazole-7-
one (3g): Prepared according to general procedure D from 1-(2-(4-
chlorophenyl)allyl)-1H-imidazole-2-carbaldehyde 1g (0.025 g, 0.10 mmol), 
triazolium 7 ( 4 mg, 0.01 mmol) and DBU (3 L, 0.02 mmol).  The crude reaction 
mixture was purified by flash column chromatography with (90:10 hexanes:EtOAc) to afford 3g 
96% yield (0.024 g, 0.096 mmol) as an off white solid.  The enantiomeric excess was determinded 
by HPLC analysis (254 nm, 25 °C) tR 36.1 min (major); 45.7 min (minor) [Chiracel AD-H (0.46 
cm x 25 cm)(from Daicel Chemical Ind., Ltd.) hexane/i-PrOH, 90:10, 1.0 mL/min] to be 67% ee. 
[]D22 = -156.9° (c 1.02, CHCl3). NMR spectra are consistent with racemic spectra above. 
 (S)-6-(4-fluorophenyl)-6-methyl-5,6-dihydro-7H-pyrrolo[1,2-a]imidazole-7-
one (3h): Prepared according to general procedure D from 1-(2-(4-
fluorophenyl)allyl)-1H-imidazole-2-carbaldehyde 1h (0.023 g, 0.10 mmol), 
triazolium 7 (4 mg, 0.01 mmol) and DBU (3 L, 0.02 mmol).  The crude reaction mixture was 
purified by flash column chromatography with (90:10 hexanes:EtOAc) to afford 3h in 81% yield 
(0.019 g, 0.083 mmol) as an orange oil. The enantiomeric excess was determined by HPLC 
analysis (254 nm, 25 °C) tR 33.3 min (major); tR 39.8 min (minor) [Chiracel AD-H (0.46 cm x 25 
cm)(from Daicel Chemical Ind., Ltd.) hexane/i-PrOH, 90:10, 1.0 mL/min] to be 75% ee. []D23 = 
-40.5° (c 0.84, CHCl3). NMR spectra are consistent with racemic spectra above. 
 (S)-6-(3-fluorophenyl)-6-methyl-5,6-dihydro-7H-pyrrolo[1,2-a]imidazole-
7-one (3i): Prepared according to general procedure D from 1-(2-(3-
fluorophenyl)allyl)-1H-imidazole-2-carbaldehyde 1i (0.023 g, 0.10 mmol), 
triazolium 7 (4 mg, 0.01 mmol) and DBU (3 L, 0.02 mmol).  The crude reaction mixture was 
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purified by flash column chromatography with (90:10 hexanes:EtOAc) to afford 3i in 93% yield 
(0.021 g, 0.093 mmol) as an orange oil. The enantiomeric excess was determined by HPLC 
analysis (254 nm, 25 °C) tR 29.2 min (major); tR 33.5 min (minor) [Chiracel AD-H (0.46 cm x 25 
cm)(from Daicel Chemical Ind., Ltd.) hexane/i-PrOH, 90:10, 1.0 mL/min] to be 67% ee. []D23 = 
-51.2° (c 1.01, CHCl3). NMR spectra are consistent with racemic spectra above. 
 (S)-6-(2-fluorophenyl)-6-methyl-5,6-dihydro-7H-pyrrolo[1,2-a]imidazole-7-
one (3j): Prepared according to general procedure D from 1-(2-(2-
fluorophenyl)allyl)-1H-imidazole-2-carbaldehyde 1j (0.023 g, 0.10 mmol), 
triazolium 7 (4 mg, 0.01 mmol) and DBU (3 L, 0.02 mmol).  The crude reaction mixture was 
purified by flash column chromatography with (90:10 hexanes:EtOAc) to afford 3j in 39% yield 
(0.089 g, 0.038 mmol) as an off-white solid.   The enantiomeric excess was determined by HPLC 
analysis (254 nm, 25 °C) tR 29.0 min (major); tR 35.4 min (minor) [Chiracel AD-H (0.46 cm x 25 
cm)(from Daicel Chemical Ind., Ltd.) hexaes/i-PrOH, 90:10, 1.0 mL/min] to be 56% ee. []D23 = 
+28.6° (c 0.35, CHCl3). NMR spectra are consistent with racemic spectra above. 
Representative Procedure for Rhodium-Catalysed Hydroacylation of 1a 
 
In a nitrogen-filed glovebox, 1-allyl-1H-imidazole-2-carboxaldehyde (13.6 mg, 0.100 
mmol, 1.00 equiv), [Rh(COD)Cl]2 (1.2 mg, 0.0025 mmol, 0.025 equiv), racemic-BINAP (3.1 mg, 
0.0050 mmol, 0.050 equiv), AgBF4 (1.0 mg, 0.0050 mmol, 0.050 equiv) and 1,4-dioxane (0.25 
mL, 0.40M) were added to 1-dram vial.  The vial was sealed with a Teflon-lined septum cap and 
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removed from the glovebox.  The reaction mixture was stirred at 100 °C in an oil bath for 16 h.  
The vial was removed from the oil bath and allowed to cool to room temperature.  The reaction 
mixture was filtered through a short plug of silica gel with 100% EtOAc as eluent.  The crude 
reaction mixture was concentrated under reduced pressure.  The crude residue was analyzed by 1H 
NMR spectroscopy with dibromomethane as the internal standard.  Only unreacted starting 
material was observed by 1H NMR spectroscopy. 
Evaluation of Rhodium-Catalysed Hydroacylation of 1a by 31P NMR Spectroscopy 
 In a nitrogen-filled glovebox, rac-BINAP (6.2 mg, 0.010 mmol, 0.050 equiv) and CDCl3 
(0.5 mL) was added to 1-dram vial and stirred until rac-BINAP fully dissolved.  The reaction 
mixture was then transferred to an NMR tube and sealed.  A 31P spectrum was obtained to give 
spectrum A in Figure S1.  The sealed NMR tube was returned to the glovebox.  To a 1-dram vial 
was added Rh(COD)2BF4 (4.1 mg, 0.010 mmol, 0.050 equiv) and the solution containing rac-
BINAP in CDCl3, and the resulting  solution was stirred for 15 minutes at room temperature.  After 
stirring, the solution was returned to the NMR tube, sealed, and spectrum B in Figure S1 was 
obtained, showing that the formation of [Rh(COD)(rac-BINAP)]+BF4
-.  The NMR tube was 
returned to the nitrogen-filled glovebox. To a 1-dram vial containing 1-allyl-1H-imidazole-2-
carboxaldehyde 1a (27.2 mg, 0.200 mmol, 1.00 equiv) was added the solution containing 
[Rh(COD)(rac-BINAP)]+BF4
-, and the resulting solution was stirred for 15 minutes.  After  
stirring, the solution was returned to the NMR tube, sealed, and spectrum C in Figure S1 was 
obtained, showing the displacement of rac-BINAP from the rhodium. 
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Figure S1 
 
Synthesis of Diketone S1 
  
1,2-Bis(1-allyl-1H-imidazol-2-yl)ethane-1,2-dione was prepared according to the 
following procedure from carboxaldehyde 1a. In a nitrogen-filled glovebox, to a 1-dram vial was 
added triazolium 2 (9.0 mg, 0.030 mmol, 0.10 equiv), 1-allyl-1H-imidazole-2-carboxaldehyde 1a 
(0.041 g, 0.30 mmol, 1.0 equiv), DBU (9 L, 0.06 mmol, 0.2 equiv), and 1,4-dioxane (0.6 mL, 0.5 
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M).  The vial was sealed with a teflon-lined septum cap.  The reaction vessel was removed from 
the glovebox, and the reaction mixture was stirred at rt for 5 minutes.  The reaction was cooled to 
room temperature, exposed to air, and filtered through a plug of silica gel with EtOAc as eluent.  
The filtrate was concentrated under reduced pressure.  The reaction mixture was purified by 
column chromatography (100% DCM) to afford diketone S1 in 90% yield (0.037 g, 0.13 mmol) 
as an off-white solid. 1H NMR (400 MHz, CDCl3)  5.08 (d, J = 6.0 Hz, 4H), 5.17 (dd, J = 17.2, 
1.2 Hz, 2H), 5.24 (dd, J = 10.4, 1.2 Hz, 2H), 5.93-6.04 (m, 2H), 7.14 (d, J = 0.8 Hz, 2H), 7.20 (d, 
J = 0.8 Hz, 2H). 13C NMR (101 MHz, CDCl3)  50.7, 119.5, 126.3, 132.1, 132.2, 140.3, 183.2. 
HRMS (ESI): Calcd. for C14H15N4O2
+ ([M+H]+): 271.1190, Found: 271.1194. 
Evaluation of NHC-Catalysed Hydroacylation of 1a by 1H NMR Spectroscopy 
  
In a nitrogen-filled glovebox, to a 1-dram vial was added triazolium 2 (7.1 mg, 0.025 mmol, 
0.10 equiv), 1-allyl-1H-imidazole-2-carboxaldehyde 1a (34.0 mg, 0.250 mmol, 1.0 equiv), 1,4-
dioxane-d8 (0.5 mL, 0.5 M), and finally DBU (7.5 L, 0.050 mmol, 0.20 equiv). The reaction 
mixture was immediately added to a NMR tube and sealed with a teflon-lined septum cap.  The 
reaction vessel was removed from the glovebox and immediately inserted into the Bruker Avance 
III 600 that was preheated to 60 °C. Spectra were collected every 10 seconds for the first 42 
minutes, every 27 seconds for the following 112 minutes, every 57 seconds for the next 237 
minutes, and every 117 seconds for the remainder of the reaction time. Within the time taken to 
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prepare the sample, 1a is converted to 4a at room temperature.  Upon heating the mixture 
containing 4a at 60 °C in the NMR spectrometer, 4a is converted to hydroacylation product 3a 
over the course of the experiment as shown in Figure S2. Upon completion of the NMR 
experiment, the reaction was cooled to room temperature and filtered through a plug of silica gel 
with EtOAc as eluent.  The filtrate was concentrated under reduced pressure.  The crude product 
was purified by flash column silica gel chromatography (90:10 hexane:EtOAc) to give 3a in 96% 
yield (32 mg, 0.24 mmol). 
Figure S2  
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CHAPTER IV 
 NICKEL-CATALYZED ALKENE CARBOACYLATION VIA ACTIVATION OF 
AMIDE C-N BONDS 
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Abstract 
 We report nickel-catalyzed formal carboacylation of ortho-allylbenzamides with 
arylboronic acid pinacol esters. These carboacylation reactions are triggered by the oxidative 
addition of an activated amide C-N bond to a nickel(0) catalyst and proceed via alkene insertion 
into a nickel(II)-acyl bond. The exo-selective carboacylation reactions generate 2-benzyl-2,3-
dihydro-1H-inden-1-ones in moderate-to-high yields (46-99%) from a variety of arylboronic acid 
pinacol esters and substituted ortho-allylbenzamides. These results demonstrate that amides are 
practical substrates for alkene carboacylation via activation of an amide C-N bond, and this 
approach bypasses challenges associated with alkene carboacylation triggered by C-C bond 
activation. 
Introduction 
 Carboacylation of alkenes in the presence of a transition-metal catalyst is an emerging 
reaction that enables the difunctionalization of an alkene with formation of two C-C σ-bonds.1-16 
Among the most studied and developed approaches to alkene carboacylation are reactions initiated 
by activation of a C-C σ-bond of a ketone. While much progress has been made to understand the 
mechanistic pathways and utility of these carboacylation reactions, the development of alkene 
carboacylation reactions is limited by the requirement for substrates containing either a quinoline 
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directing group2-3, 5, 7, 11 or a strained cyclic ketone.6, 9-10, 12-15 The ability to perform alkene 
carboacylation reactions without a requirement for strained ketone substrates or substrates 
containing directing groups has the potential to expand the utility of these reactions with readily 
accessible substrates.1, 4, 8, 16-21 
Scheme 1. Synthesis of Ketones via Transition Metal-Catalyzed Activation of Amide C-N 
Bonds 
 
 
 Recently, studies by a number of groups have demonstrated Suzuki-Miyaura coupling of 
benzamides with arylboron compounds to generate a variety of aromatic ketones.22-33 The Suzuki-
Miyaura-type coupling reactions involve C-N activation of an activated benzamide via oxidative 
addition and transmetalation with an arylboron compound to generate acyl-metal-aryl intermediate 
A (Scheme 1a). Subsequent reductive elimination forms a diaryl ketone.  The ability to intercept 
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acyl-metal intermediates with an alkene offers the potential to develop a new class of alkene 
functionalization reactions. During the course of our studies, Garg and co-workers reported 
Mizoroki-Heck cyclizations of ortho-allylbenzamides that involve insertion of an alkene into an 
acyl-nickel(II)-amido intermediate B (Scheme 1b).34 Subsequent -hydride elimination forms 2-
vinylindanones containing a quaternary carbon center. 
The potential to develop a new class of alkene carboacylation reactions via activation of 
amide C-N bonds22-33, 35-40 led us to investigate nickel-catalyzed carboacylations of ortho-
allylbenzamides.  We envisioned a process involving activation of the C-N bond of a benzamide 
via oxidative addition and transmetalation with an arylboron compound to generate acyl-nickel(II)-
aryl intermediate C (Scheme 1c). Migratory insertion of the tethered alkene and reductive 
elimination would generate 2-benzylindanones, the product of a formal alkene carboacylation 
reaction.  In contrast to the recently reported Mizoroki-Heck cyclization reactions which involve 
the formation of a single C-C σ-bond, the proposed formal carboacylation reactions involve 
difunctionalization of an alkene with the formation of two C-C σ-bonds.   The development of this 
approach to alkene carboacylation offers the potential to expand these reactions beyond strained 
cyclic ketones and ketones containing a quinoline directing group. We now report the first nickel-
catalyzed carboacylations triggered by C-N bond activation of ortho-allylbenzamides to form a 
variety of 2-benzyl-2,3-dihydro-1H-inden-1-ones in up to 99% yield. 
Results & Discussion 
 To identify reaction conditions for the nickel-catalyzed carboacylation of ortho-
allylbenazamides, we evaluated the model reaction of tert-butyl(2-allylbenzoyl)(benzyl)carbamate 
(1a) with phenylboronic acid pinacol ester (PhBpin) in the presence of a catalyst generated from 
Ni(cod)2 and 1,3-bis(2,6-diisopropylphenyl)-4,5-dihydroimidazol-2-ylidine (SIPr) (Table 1).  The 
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nickel carbene complex catalyzed the model reaction to form indanone 2a in 20% yield when the 
reaction was conducted in toluene at 90 °C with 1.2 equiv of PhBpin (entry 1). The yield of 
indanone 2a increased to 30% when the reaction was run with 3.0 equiv of PhBpin (entry 3). 
However, the major product of these reactions is generated from isomerization of the ortho-
allylbenzamide starting material. To further improve the yield of the model reaction and minimize 
alkene isomerization, we investigated the impact of the identity of the solvent (entries 3-7). When 
the model reaction was carried out in THF, indanone 2a was generated in 75% yield with the 
formation of 24% yield of the isomerized starting material (entry 7). 
Table 1. Identification of Reaction Conditions for Ni-Catalyzed Carboacylation of 1a with 
PhBpina 
 
entry temp (°C) solvent conv. (%)b yield (%)b,c 
1d 90 toluene 67 20(35) 
2e 90 toluene 49 21(27) 
3 90 toluene 100 30(43) 
4 90 benzene 70 27(45) 
5 90 dioxane 84 26(46) 
6f 90 DME 82 46(9) 
7f 90 THF 99 75(24) 
8f 80 THF 100 78(9) 
9f 70 THF 100 83(4) 
10f 60 THF 100 97(0) 
11 40 THF 48 39(0) 
12e 60 THF 65 55(0) 
13d 60 THF 39 39(0) 
14f,g 60 THF 100 95(0) 
15h 60 THF 40 38(0) 
16i 60 THF 100 88(11) 
aReaction conditions: 1a (0.100 mmol), Ni(cod)2 (0.010 mmol), SIPr = 1,3-bis-(2,6-
diisopropylphenyl)imidazolidin-2-ylidene (0.010 mmol), K3PO4 (0.200 mmol), solvent (1.0 M), 
12 h. bDeterminded by 1H NMR spectroscopy of the crude reaction mixture using dibromomethane 
as an internal standard. cYields of alkene isomerization product tert-butyl benzyl(2-(prop-1-en-1-
yl)benzoyl)carbamate determined by 1H NMR spectroscopy are shown in parentheses. dPhBpin 
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(1.2 equiv). ePhBpin (2 equiv). fisolated yields of 3a. g5 mol % Ni(cod)2 and 5 mol % SIPr. 
h2.5 
mol % Ni(cod)2 and 2.5 mol % SIPr. 
iReaction run with SIPr·HCl (0.010 mmol) in place of SIPr 
 
  To further increase the ratio of indanone 2a relative to the isomerized starting material, 
we investigated the impact of reaction temperature (entries 7-11). Lowering the reaction 
temperature to 60 °C led to the formation of indanone 2a in 97% yield without observable 
isomerization of the ortho-allylbenzamide (entry 10). Consistent with our observations of reactions 
run in toluene (entries 1-3), the yield of indanone 2a decreases upon lowering the nymber of 
equivalents of PhBpin when the reaction is run in THF at 60 °C (compare entry 10 with entries 12 
and 13). The model reaction catalyzed by 5 mol % of the nickel catalyst formed 2a in 95% yield 
(entry 14).  However, decreasing the catalyst loading to 2.5 mol % led incomplete conversion and 
formation of 2a in only 38% yield (entry 15).   The model reaction occurs to form 2a in 88% yield 
with 11% isomerization of 1a when the nickel carbene catalyst is generated in situ from Ni(cod)2 
and SIPr·HCl (entry 16). 
 With a practical catalyst system identified for the model reaction of 1a with PhBpin, we 
next evaluated carboacylation reactions of 1a with a broad range of arylboronic acid pinacol esters 
(ArBpin) (Scheme 2). The carboacylation of 1a with a range of para-substituted, electron-rich 
ArBpin reagents generated ketones 2b-e in good-to-excellent yields (78-99%). The reaction of 1a 
with para-substituted electron-deficient ArBpin reagents formed indanones 2f-2j in moderate-to-
high yields (54-85%). The carboacylation of 1a with ArBpin compounds containing electron-
donating groups at the meta-position formed ketones 2k-2l in 85-99% yield, while meta-
halogenated ArBpin compunds reacted with 1a to form 2m-2n in 54-67% yield. Reactions of 
ArBpin reagents containing electron-donating groups at the ortho-position with 1a were also 
possible and generated the carboacylation products 2o and 2p in 50% and 90% yield.  However, 
reactions of 1a with ortho-halogenated ArBpin reagents did not occur under our reaction 
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conditions. The scope of alkene carboacylation is not limited to substituted ArBpin compounds 
but also includes boronic acid pinacol esters of polycyclic arenes and heteroarenes. The 
carboacylation reactions of 1a with heteroarylboronic acid pinacol esters formed ketone products 
2r-2s in 63-88% yields. Reactions of 1a with arylboronic acids and alkylboronic acid pinacol esters 
did not occur under our standard reaction conditions. 
 With the scope of arylboronic acid pinacol esters established, we sought to evaluate nickel-
catalyzed carboacylations of a variety of substituted ortho-allylbenzamides 3a-j (Scheme 3). 
Reactions of PhBpin with 3a-3c containing electron-donating and electron-withdrawing groups at 
the 5-position occur to form indanones 4a-4c in moderate-to-excellent yields (51-99%). 
Carboacylations of 4-substituted ortho-allylbenzamides containing either electron-donating or 
electron-withdrawing groups occur to generate ketones 4d-4g in 80-99% yield. Carboacylations 
of 3- and 6-fluorinated ortho-allylbenzamides generated indanones 4h-4i in excellent yields (84-
95%), while the reaction of a 4,5-difluorinated ortho-allylbenzamide formed indanone 4j in 46% 
yield. ortho-Allylbenzamides containing substituted allyl units were unreactive under our standard 
reaction conditions, and reactions conducted at elevated temperatures led exclusively to 
isomerization of the alkene. The carboacylation of the acyclic 5-hexenamide derivative, tert-butyl 
benzyl(hex-5-enoyl)carbamate, with PhBpin did not form the corresponding cyclic ketone. 
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Scheme 2. Scope of Arylboronic Acid Pinacol Estersa 
 
aReaction conditions: 1a (0.100 mmol), Ni(cod)2 (0.010 mmol), SIPr (0.010 mmol), K3PO4 (0.200 
mmol), H2O (0.200 mmol), ArBpin (0.300 mmol), THF (0.100 mL), 16 h. Yields of 2b-t are 
isolated yields after column chromatography.  Yields of alkene isomerization product tert-butyl 
benzyl(2-(prop-1-en-1-yl)benzoyl)carbamate determined by 1H NMR spectroscopy are shown in 
parnetheses. b20 mol % Ni(cod)2, 20 mol %, SIPr, and 0.20 mL THF. 
 
 To highlight the utility of our alkene carboacylation reaction, we conducted a series of 
experiments to show that the carboacylation reaction 1) can be conducted on the gram scale, 2) 
encompasses an ortho-allylbenzoate ester, and 3) can be sequenced with nickel-catalyzed, 
enantioselective -arylation to form an indanone derivative containing a quaternary stereogenic 
center. The reaction of 4-fluorinated ortho-allylbenzamide 3f with PhBpin can be conducted on a 
gram scale to form the product 4f in nearly quantitative yield (eq 1). In addition, the carboacylation 
of methyl 2-allylbenzoate 5 with PhBpin forms indanone 2a in 50% yield (eq 2).41-47  The modest 
yield of 2a can be attributed to alkene isomerization of 5 to form methyl 2-(prop-1-en-1-
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yl)benzoate in 25% yield.  Highly enantioenriched indanone derivatives containing a quaternary 
stereogenic center are readily prepared by nickel-catalyzed -arylation of the racemic 2-
benzylindanones generated from our carboacylation reactions.48  For example, the -arylation of 
2a occurs in the presence of a catalyst generated from Ni(cod)2 and (S)-BINAP to form indanone 
6 in 65% yield and 98% ee (eq 3). 
Scheme 3. Carboacylation of Benzamides 3a-ja 
 
aReaction conditions: 3a-j (0.100 mmol), Ni(cod)2, SIPr (0.010 mmol), K3PO4 (0.200 mmol), H2O 
(0.200 mmol), PhBpin (0.300 mmol), THF (0.100 mL), 12 h. Yields of 4a-j are isolated yields 
after column chromatography. 
 
 Two potential mechanistic pathways for the carboacylation of 1a with ArBpin are 
presented in Scheme 4. After coordination of the NHC-Ni(0) catalyst to 1a to form complex I, 
oxidative addition of the amide C-N bond to the Ni(0) center is likely to form the acyl-nickel(II)-
amido complex II.  At this stage, the mechanism of the formal carboacylation may diverge based 
on the ordering of the subsequent transmetalation and migratory insertion events.  If 
transmetalation of ArBpin with complex II occurs first, acyl-nickel(II)-aryl complex III would be 
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generated.  Subsequent migratory insertion of the tethered alkene into the Ni-C(acyl) bond would 
form alkyl-nickel(II)-aryl complex V.  Reductive elimination of the indanone product 2 from V 
and coordination of another molecule of 1a would close the catalytic cycle.  Alternatively, if 
migratory insertion precedes transmetallation, alkyl-nickel(II)-amido complex IV would be 
formed by insertion of the tethered alkene into the Ni-C(acyl) bond of complex II.34  Subsequent 
transmetalation of ArBpin with complex IV would form complex V and the indanone 2 upon 
reductive elimination.   
 
 Our working hypothesis is that transmetalation of ArBpin with complex II precedes 
migratory insertion of the tethered alkene based on two observations. First, the identity of the 
ArBpin significantly impacts the amount of alkene isomerization observed under our reaction 
conditions (see Scheme 2). Second, alkene isomerization is not observed in the absence of ArBpin.  
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Taken together, these results are consistent with transmetalation of ArBpin with complex II 
occurring first to form complex III followed by migratory insertion to generate complex V. 
Scheme 4. Potential Mechanistic Pathways for Ni-Catalyzed Carboacylation via Amide C-N 
Activation 
 
 
 To gain additional insight into the mechanism of the formal carboacylation reaction, we 
conducted a series of competition experiments (Scheme 5). The competition experiment between 
4-(trifluoromethyl)- and 4-methylbenzamides 3k and 3b formed ketones 4k and 4b in a 6.8:1 ratio 
favoring the trifluoromethyl-substituted ketone 4k. Although this result is consistent with the 
relative reactivity of electron-deficient and electron-rich benzamides in the context of Suzuki-
Miyaura and Negishi coupling,23, 49 it contrasts the more facile nature of oxidative addition into 
electron-rich benzamide 3b versus electron-deficient benzamide 3k due to the increased amidic 
resonance that would be expected for 3k versus 3b.50 In addition, this result suggests that the ratio 
of products observed is not determined by the relative rates of oxidative addition of 3k and 3b. 
Competition experiments between the pinacol ester of 4-tolylboronic acid with the pinacol esters 
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of 2-tolylboronic acid or 4-(trifluoromethyl)pheylboronic acid formed ketones 2p and 2c in an 
8.3:1 ratio and ketones 2j and 2c in a 10.5:1 ratio.  The observation that ketones derived from 
reactions with sterically hindered and electron-deficient arylboron nucleophiles are favored 
suggests that transmetalation is fast relative to reductive elimination and the ratio of products is 
determined by the relative rates of either reductive elimination or migratory insertion into the Ni-
C(acyl) bond of complex III. Given that a nearly equimolar ratio of 4k and 4b would be expected 
from the competition between 3k and 3b if reductive elimination was turnover-limiting, we 
propose that migratory insertion of the alkene into the Ni-C(acyl) bond is the elementary step 
critical to determining product ratios. 
Scheme 5. Competition Experiments between Substituted Benzamides or ArBpin 
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Conclusion 
 In summary, we have developed the first nickel-catalyzed alkene carboacylation reactions 
initiated by activation of amide C-N bonds.  These processes enable coupling of a variety of ortho-
allylbenzamides and arylboronic acid pinacol esters to form two new C-C bonds and the indanone 
products in up to 99% yield.  Moreover, the development of this approach to alkene carboacylation 
bypasses challenges associated with related alkene carboacylation reactions that rely on C-C bond 
activation and further demonstrates the utility of amides as powerful building blocks in organic 
synthesis. Studies are ongoing in our laboratory to further leverage the synthetic potential of this 
transformation and to gain additional mechanistic understanding of the nickel-catalyzed alkene 
carboacylation reaction.      
 
Experimental  
 General Experimental. All air-sensitive procedures were conducted under inert 
atmosphere in a nitrogen-filled dry box or by standard Schlenk techniques.  All reactions were 
performed under an atmosphere of nitrogen unless otherwise stated.  All glassware for moisture 
sensitive reactions were dried at 140 °C in an oven.  Tetrahydrofuran, methylene chloride and N,N-
dimethylformamide were degassed by purging with argon for 45 minutes and dried with a solvent 
purification system by passing through a one-meter column of activated alumina.  Anhydrous 1,4-
dioxane was purchased from Sigma Aldrich. Flash column chromatography was performed on 
SiliFlash® P60 silica gel (40-63 m, 60Å) or using a Teledyne Isco Combiflash® Rf system with 
RediSep GoldTM columns using hexanes/ethyl acetate, dichloromethane/methanol, or 
pentane/ether mixtures as eluents.  Reactions products were visualized on TLC by UV light or by 
staining with KMnO4. 
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 Instrumentation. HRMS (ESI) analysis was performed at the Iowa State University 
Chemical Instrumentation Facility on an Agilent 6540 QTOF spectrometer.  NMR spectra were 
acquired on Varian MR-400 and Bruker Avance III 600 spectrometers at the Iowa State University 
Chemical Instrumentation Facility. Chemical shifts are reported in ppm relative to a residual 
solvent peak (CDCl3 = 7.26 ppm for 
1H and 77.16 ppm for 13C).  19F NMR shifts are reported 
based on indirect reference to CDCl3.
51 
Materials. 2-iodobenzoic acid (S1a) was purchased from Sigma Aldrich. 2-Iodo-5-
methylbenzoic acid (S1b), 2-bromo-4-methylbenzoic acid (S1c), 2-iodo-5-methoxybenzoic acid 
(S1d), 2-bromo-4-methoxybenzoic acid (S1e), 2-bromo-6-fluorobenzoic acid (S1f), 2-bromo-4-
fluorobenzoic acid (S1g), 2-bromo-3-fluorobenzoic acid (S1h), 2-bromo-5-
(trifluoromethyl)benzoic acid (S1i), 2-iodo-4-(trifluoromethyl)benzoic acid (S1j), and 2-bromo-
4,5-difluorobenzoic acid (S1k) were purchased from Combi-Blocks. Arylboronic acid pinacol 
esters were synthesized according to known a literature procedure.52 Tetrakis(triphenylphosphine), 
cesium fluoride, and di-tert-butyl dicarbonate were purchased from Ak Scientific. Tribasic 
potassium phosphate was purchased from Sigma Aldrich.  Bis(1,5-cyclooctadiene)nickel(0), and 
1,3-bis(2,6-di-i-propylphenyl)-4,5-dihydroimidazol-2-ylidine were purchased from Strem 
Chemicals. 
 
 
 
 
 
 
150 
 
 
General Procedure A: Synthesis of o-Halobenzamides S2a-S2k: 
 
     o-Halobenzamides (S2a-S2k) were prepared from the appropriate o-halobenzoic acid (S1a-
S1k).  To the appropriate o-halobenzoic acid (S1a-S1k) in anhydrous DCM (0.3 M) at 0 °C under 
N2 was added 2M oxalyl chloride (1.20 equiv) dropwise and a catalytic amount of DMF (1-2 
drops).  The reaction was allowed to warm to room temperature and stirred for 1 h. The solvent 
was removed under reduced pressure to afford the corresponding crude acid chloride.  To the crude 
acid chloride was added DCM (0.9 M) and triethylamine (1.25 equiv).  Next, a solution of 
benzylamine (1.10 equiv) in DCM (0.5 M) was added dropwise.  The reaction mixture was stirred 
at room temperature for 1 h, then diluted with ethyl acetate, and washed successively with 1M HCl 
and brine.  The organic layer was dried over anhydrous sodium sulfate, and concentrated under 
reduced pressure.  The resulting crude material was used directly in the next step.  To the round-
bottom flask containing the crude benzamide was added DMAP (0.10 equiv), acetonitrile (0.2 M) 
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and Boc2O (1.30 equiv).  The reaction flask was then flushed with N2 and allowed to stir at room 
temperature for 16 h.  The reaction was quenched by addition of water, and extracted with ethyl 
acetate (3x).  The organic layers were combined, dried over Na2SO4, filtered, and evaporated under 
reduced pressure.  The resulting crude o-halobenzamides (S2a-S2k) were used directly in the next 
step without further purification. 
tert-butyl benzyl(2-iodobenzoyl)carbamate (S2a):  Prepared according to 
general procedure A from o-iodobenzoic acid  S1a (7.61 g, 30.7 mmol).  The 
reactions afforded crude product S2a as white solid in 80% yield (10.7 g, 24.7 
mmol). 1H NMR (400 MHz, CDCl3)  1.14 (s, 9H), 5.05 (s, 2H), 7.07 (td, J = 
7.1, 1.5 Hz, 1H), 7.17 (dd, J = 7.6, 1.2 Hz, 1H), 7.29 (d, J = 7.2 Hz, 1H), 7.31-7.38 (m, 3H), 7.47 
(d, J = 8.0 Hz, 2H), 7.80 (d, J = 8.0 Hz, 1H). 13C NMR (101 MHz, CDCl3)  27.5, 47.6, 83.9, 
91.7, 127.0, 127.6, 127.9, 128.5, 128.6, 130.3, 137.5, 139.2, 144.6, 15.1, 171.6. HRMS (ESI): 
Calcd. for C19H21INO3
+ ([M+H]+): 438.0561, Found: 438.0556. 
tert-butyl benzyl(2-iodo-5-methylbenzoyl)carbamate (S2b): Prepared 
according to general procedure A from 2-iodo-5-methylbenzoic acid S1b 
(2.62 g, 10.0 mmol). The reactions afforded crude product S2b as a colorless 
oil in 91% yield (4.01 g, 9.10 mmol). 1H NMR  (400 MHz, CDCl3) δ 1.16 (s, 9H), 2.30 (s, 3H), 
5.05 (s, 2H), 6.90 (dd, J = 8.1, 1.5 Hz, 1H), 7.01 (d, J = 1.5 Hz, 1H), 7.28 (t, J = 7.2 Hz, 1H), 7.32-
7.38 (m, 2H), 7.48 (d, J = 7.2 Hz, 2H), 7.66 (d, J = 8.1 Hz, 1H). 13C NMR (101 MHz, CDCl3) δ 
21.0, 27.5, 48.0, 83.7, 87.5, 127.5, 127.9, 128.5, 128.6, 131.3, 137.5, 138.1, 138.9, 144.3, 152.1, 
171.8. HRMS (ESI): Calcd. for C20H23INO3
+ ([M+H]+): 452.0717, Found: 452.0720. 
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tert-butyl benzyl(2-bromo-4-methylbenzoyl)carbamate (S2c): Prepared 
according to general procedure A from 2-bromo-4-methylbenzoic acid S1c 
(2.15 g, 10.0 mmol). The reactions afforded crude product S2c as a colorless 
oil in 83% yield (3.36 g, 8.32 mmol).   1H NMR (400 MHz, CDCl3)  1.17 (s, 
9H), 2.35 (s, 3H), 5.05 (s, 2H), 7.12-7.18 (m, 2H), 7.26-7.30 (m, 1H), 7.32-7.37 (m, 3H), 7.45-
7.47 (m, 2H).  13C NMR (101 MHz, CDCl3)  27.5, 48.0, 83.6, 118.5, 127.4, 127.7, 128.0, 128.4, 
128.5, 133.0, 133.1, 137.5, 137.6, 140.9, 152.3, 170.5. HRMS (ESI): Calcd. for C20H23BrNO3
+ 
([M+H]+): 404.0856, Found: 404.0828. 
tert-butyl benzyl(2-iodo-5-methoxybenzoyl)carbamate (S2d): Prepared 
according to general procedure A from 2-iodo-5-methoxybenzoic acid 
S1d (2.78 g, 10.0 mmol). The reactions afforded crude product S2d as a 
colorless oil in 81% yield (3.79 g, 8.10 mmol). 1H NMR (400 MHz, CDCl3) δ 1.17 (s, 9H), 3.75 
(s, 3H), 5.04 (s, 2H), 6.67 (dd, J = 8.7, 3.0 Hz, 1H) 6.74 (d, J = 3.0 Hz, 1H), 7.28 (d, J = 7.3 Hz, 
1H), 7.31-7.37 (m, 2H), 7.47 (d, J = 7.3 Hz, 2H), 7.63 (d, J = 8.7 Hz, 1H). 13C NMR (101 MHz, 
CDCl3) δ 27.5, 48.0, 55.6, 80.1, 83.8, 112.9, 116.9, 127.5, 128.5, 128.6, 137.4, 139.8, 145.2, 152.0, 
159.7, 171.3. HRMS (ESI): Calcd. for C20H23INO4
+ ([M+H]+): 468.0666, Found: 468.0665. 
tert-butyl benzyl(2-bromo-4-methoxybenzoyl)carbamate (S2e): 
Prepared according to general procedure A from 2-bromo-4-
methoxybenzoic acid S1e (2.31 g, 10.0 mmol). The reactions afforded 
crude product S2e as a yellow oil in 90% yield (3.80 g, 9.00 mmol). 1H NMR (400 MHz, CDCl3) 
 1.19 (s, 9H), 3.81 (s, 3H), 5.03 (s, 2H), 6.86 (dd, J = 8.6, 2.4 Hz, 1H), 7.07 (d, J = 2.4 Hz, 1H), 
7.21 (d, J = 8.6 Hz, 1H), 7.26-7.29 (m, 1H), 7.31-7.35 (m, 2H), 7.42-7.46 (m, 2H). 13C NMR (101 
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MHz, CDCl3)  27.6, 48.2, 53.6, 55.8, 83.5, 113.2, 118.1, 119.7, 127.5, 128.5, 129.2, 132.6, 137.7, 
152.4, 160.7, 170.5. HRMS (ESI): Calcd. for C20H22BrNO4
+Na ([M+Na]+): 442.0624, Found: 
442.0587. 
tert-butyl benzyl(2-bromo-6-fluorobenzoyl)carbamate (S2f): Prepared 
according to general procedure A from 2-bromo-6-fluorobenzoic acid S1f (2.19 
g, 10.0 mmol). The reactions afforded crude product S2f as a white solid in 75% 
yield (3.05 g, 7.50 mmol). 1H NMR (400 MHz, CDCl3)  1.18 (s, 9H), 5.10 (s, 2H), 7.04-7.08 (m, 
1H), 7.21 (m, 1H), 7.24-7.30 (m, 1H), 7.31-7.37 (m, 3H), 7.41-7.45 (m, 2H). 13C NMR (101 MHz, 
CDCl3)  27.5, 47.6, 84.2, 114.6 (d, J = 21.2 Hz, 1C), 119.2 (d, J = 5.05 Hz, 1C), 127.5, 128.1, 
128.3 (d, J = 4.04 Hz, 1C), 128.5, 129.7, (d, J = 21.2 Hz, 1C), 130.6 (d, J = 8.08 Hz, 1C), 137.2, 
151.6, 158.4 (d J = 252.5 Hz, 1C), 165.4. 19F NMR (CDCl3, 376 MHz):  -114.1 (m, 1F). HRMS 
(ESI): Calcd. for C19H19BrFNO3
+Na ([M+Na]+): 430.0425, Found: 430.0387. 
tert-butyl benzyl(2-bromo-4-fluorobenzoyl)carbamate (S2g): Prepared 
according to general procedure A from 2-bromo-4-fluorobenzoic acid S1g 
(2.19 g, 10.0 mmol). The reactions afforded crude product S2g as a white 
solid in 85% yield (3.47 g, 8.50 mmol). 1H NMR (400 MHz, CDCl3)  1.20 (s, 9H), 5.04 (s, 2H), 
7.06 (td, J = 8.0, 2.5 Hz, 1H), 7.24-7.36 (m, 5H), 7.43-7.45 (m, 2H). 13C NMR (101 MHz, CDCl3) 
 27.6, 48.1, 84.0. 114.7 (d, J = 21.2, 1C), 119.3 (d, J = 9.09 Hz, 1C), 120.0 (d, J = 13.1 Hz, 1C), 
120.2 (d, J = 14.1 Hz, 1C), 127.6, 128.5, 129.2, 136.7 (d, J = 4.04 Hz, 1C), 137.4, 152.1, 162.5 (d, 
J = 254.5 Hz, 1C), 169.6. 19F NMR (CDCl3, 376 MHz):  -109.4 (m, 1F). HRMS (ESI): Calcd. 
for C19H19BrFNO3
+Na ([M+Na]+): 430.0425, Found: 430.0384. 
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tert-butyl benzyl(2-bromo-3-fluorobenzoyl)carbamate (S2h): Prepared 
according to general procedure A from 2-bromo-3-fluorobenzoic acid S1h (2.19 
g, 10.0 mmol). The reactions afforded crude product S2h as a white solid in 84% 
yield (3.43 g, 8.40 mmol). 1H NMR (400 MHz, CDCl3)  1.17 (s, 9H), 5.06 (s, 
2H), 7.04 (dt, J = 7.6, 1.0 Hz, 1H), 7.14 (td, J = 8.4, 1.4 Hz, 1H), 7.27-7.37 (m, 4H), 7.42-7.47 (m, 
2H). 13C NMR (101 MHz, CDCl3)  27.5, 47.9, 84.1, 106.4 (d, J = 23.2 Hz, 1C), 116.7 (d, J = 
22.2 Hz, 1C), 122.8 (d, J = 3.0 Hz, 1C), 127.7, 128.5, 128.6, 128.9 (d, J = 8.1 Hz, 1C), 137.3, 
142.6, 151.9, 159.0 (d, J = 248.5 Hz, 1C), 169.1. 19F NMR (CDCl3, 376 MHz):  -106.1 (m, 1F). 
HRMS (ESI): Calcd. for C19H19BrFNO3
+Na ([M+Na]+): 430.0425, Found: 430.0393. 
tert-butyl benzyl(2-bromo-5-(trifluoromethyl)benzoyl)carbamate 
(S2i): Prepared according to general procedure A from 2-bromo-5-
(trifluoromethyl)benzoic acid S1i (2.69 g, 10.0 mmol). The reactions 
afforded crude product S2i as a white solid in 88% yield (4.03 g, 8.80 mmol). 1H NMR (400 MHz, 
CDCl3)  1.16 (s, 9H), 5.07 (s, 2H), 7.28-7.38 (m, 3H), 7.45-7.51 (m, 4H), 7.67 (d, J = 8.2 Hz, 
1H). 13C NMR (101 MHz, CDCl3)  27.5, 48.0, 84.4, 122.5, 124.7 (q, J = 3.8 Hz, 1C), 126.1 (q, 
J = 274.0 Hz, 1C), 126.8 (q, J = 3.7 Hz, 1C), 127.7, 128.6, 128.6, 130.3, 133.3, 137.1, 141.4, 151.7, 
168.9. 19F NMR (CDCl3, 376 MHz):  -62.9 (s, 3F). HRMS (ESI): Calcd. for C20H19BrF3NO3+Na 
([M+Na]+): 480.0393, Found: 480.0344. 
tert-butyl benzyl(2-iodo-4-(trifluoromethyl)benzoyl)carbamate (S2j): 
Prepared according to general procedure A from 2-iodo-4-
(trifluoromethyl)benzoic acid S1j (3.16 g, 10.0 mmol). The reactions 
afforded crude product S2j as a colorless oil in 91% yield (4.60 g, 9.10 mmol). 1H NMR (400 
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MHz, CDCl3)  1.19 (s, 9H), 5.08 (s, 2H), 7.27-7.38 (m, 4H), 7.49 (d, J = 8.0 Hz, 2H), 7.64 (dd, J 
= 8.0, 0.9 Hz, 1H), 8.06 (s, 1H). 13C NMR (101 MHz, CDCl3)  27.6, 47.8, 84.5, 91.1, 122.7 (q, 
J = 274.7, 1C), 124.5 (d, J = 22.2 Hz, 1C), 126.9 (d, J = 11.1 Hz, 1C), 127.7 (q, J = 6.1 Hz, 1C), 
128.6 (m, 1C), 128.7 (d, J = 9.1 Hz, 1C), 132.0 (q, J = 33.3 Hz, 1C), 135.9 (dd, J = 15.2, 4.0 Hz, 
1C), 137.1, 148.1, 151.6, 170.5. 19F NMR (CDCl3, 376 MHz):  -62.8 (s, 3F). HRMS (ESI): 
Calcd. for C20H20F3INO3
+ ([M+H]+): 506.0434, Found: 506.0450. 
tert-butyl benzyl(2-bromo-4,5-difluorobenzoyl)carbamate (S2k): 
Prepared according to general procedure A from 2-bromo-4,5-
difluorobenzoic acid S1k (2.37 g, 10.0 mmol). The reactions afforded crude 
product S2k as a white solid in 74% yield (3.16 g, 7.40 mmol). 1H NMR (400 MHz, CDCl3)  
1.24 (s, 9H), 5.03 (s, 2H), 7.14 (dd, J = 9.8, 7.9 Hz, 1H), 7.27-7.43 (m, 6H). 13C NMR (101 MHz, 
CDCl3)  27.6, 48.1, 84.4, 112.6 (dd, J = 7.4, 4.1 Hz, 1C), 116.9, 117.1 (d, J = 2.0 Hz, 1C), 127.7, 
128.5, 128.6 (d, J = 2.0 Hz, 1C), 137.0 (dd, J = 6.1, 5.1 Hz, 1C), 137.1, 149.7 (dd, J = 252.5, 13.1 
Hz, 1C), 150.4 (dd, J = 257.6, 14.1 Hz, 1C), 151.9, 168.4. 19F NMR (CDCl3, 376 MHz):  -137.8 
(m, 1F), -133.4 (m, 1F). HRMS (ESI): Calcd. for C19H19BrF2NO3
+ ([M+H]+): 426.0511, Found: 
426.0502. 
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General Procedure B: Synthesis of o-Allylbenzamides 1a, 3a-j  
 
   o-Allylbenzamides (1a, 3a-j) were prepared according to the following procedure. A 
round-bottom flask was charged with 3.00 mmol of o-iodobenzamide (S2a-S2k), CsF (1.77 g, 11.6 
mmol), Pd(PPh3)4 (0.347 g, 0.300 mmol), and THF (37.5 mL).  The resulting solution was stirred 
at room temperature for 30 minutes.  Then 2-allyl-4,4,5,5-tetramethyl-1,3,2-dioxaborolane 
(allylBpin) (0.907 g, 5.40 mmol) in THF (37.5 mL) was added.  The resulting solution was stirred 
at reflux for 24 hours. The reaction mixture was diluted with hexanes (100 mL) followed by water 
(100 mL).  The layers were separated, and the organic layer extracted with hexanes (2 x 100 mL).  
The combined organic layers were washed with water (200 mL) and brine (200 mL), dried over 
Na2SO4, filtered, and concentrated under reduced pressure. Purifications of the crude products 
were carried out by flash column chromatography to give o-allylbenzamides 1a, 3a-j.  
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tert-butyl (2-allylbenzoyl)(benzyl)carbamate (1a): Prepared according to 
general procedure B from tert-butyl benzyl(2-iodobenzoyl)carbamate S2a (1.31 
g, 3.00 mmol).  The crude reaction mixture was purified by flash column 
chromatography (100:0 hexanes:EtOAc to 90:10 hexanes EtOAc) to give 1a as 
a colorless oil in 79% yield (0.830 g, 2.37 mmol).  1H NMR (400 MHz, CDCl3)  1.08 (s, 9H), 
3.45 (d, J = 6.8 Hz, 1H), 5.03 (s, 2H), 5.03-5.10 (m, 2H), 5.92 (ddt, J = 17.0, 10.0, 6.8 Hz, 1H), 
7.12 (d, J = 7.6 Hz, 1H), 7.19 (t, J = 7.6 Hz, 1H), 7.22-7.37 (m, 5H), 7.45 (d, J = 7.4 Hz, 2H).  13C 
NMR (101 MHz, CDCl3)  27.5, 37.6, 48.1, 83.4, 116.6, 125.9, 126.1, 127.5, 128.4, 128.6, 129.6, 
129.8, 136.6, 137.3, 137.9, 138.2, 153.0, 172.4. HRMS (ESI): Calcd. for C22H26NO3
+ ([M+H]+): 
352.1907, Found: 352.1883. 
tert-butyl (2-allyl-5-methylbenzoyl)(benzyl)carbamate (3a): Prepared 
according to general procedure B from tert-butyl (2-iodo-5-
methylbenzoyl)(benzyl)carbamate S2b (1.35 g, 3.00 mmol). The crude 
reaction mixture was purified by flash column chromatography (100:0 hexanes:EtOAc to 90:10 
Hexanes:EtOAc) to give 3a as a colorless oil in 78% yield (0.856 g, 2.34 mmol).  1H NMR (400 
MHz, CDCl3)  1.09 (s, 9H), 2.30 (s, 3H), 3.41 (d, J = 8.0 Hz, 2H), 5.03 (s, 2H), 5.01-5.08 (m, 
2H), 5.91 (ddt, J = 17.0, 10.0, 8.0 Hz, 1H), 6.96 (s, 1H), 7.11-7.16 (m, 2H), 7.26-7.30 (m, 1H), 
7.33-7.37 (m, 2H), 7.45-7.47 (m, 2H).  13C NMR (101 MHz, CDCl3)  20.9, 27.4, 37.2, 48.1, 83.3, 
116.2, 126.7, 127.5, 128.4, 128.5, 129.8, 130.3, 134.3, 135.4, 136.81, 137.9, 137.9, 153.1, 172.5. 
HRMS (ESI): Calcd. for C23H28NO3
+ ([M+H]+): 366.2064, Found: 366.2024. 
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tert-butyl (2-allyl-5methoxybenzoyl)(benzyl)carbamate (3b): Prepared 
according to general procedure B from tert-butyl benzyl(2-iodo-5-
methoxybenzoyl)carbamate S2d (1.40 g, 3.00 mmol). The crude reaction 
mixture was purified by flash column chromatography (100:0 
hexanes:EtOAc to 90:10 hexanes:EtOAc) to give 3b as a dark-green oil in 61% yield (0.698 g, 
1.83 mmol).  1H NMR (400 MHz, CDCl3)  1.14 (s, 9H), 3.38 (d, J = 6.8 Hz, 2H), 3.76 (s, 3H), 
5.02-5.08 (m, 2H), 5.04 (s, 2H), 5.91 (ddt, J = 17.0, 10.1, 6.8 Hz, 1H), 6.69 (d, J = 2.8 Hz, 1H), 
6.89 (dd, J = 8.5, 2.8 Hz, 1H), 7.16 (d, J = 8.5 Hz, 1H), 7.28-7.31 (m, 1H), 7.34-7.38 (m, 2H), 
7.46-7.48 (m, 2H). 13C NMR (101 MHz, CDCl3)  27.5, 36.7, 48.1, 55.5, 83.4, 111.5, 115.4, 116.1, 
127.5, 128.4, 128.5, 129.2, 130.9, 136.9, 137.8, 138.9, 152.9, 157.6, 172.1. HRMS (ESI): Calcd. 
for C23H27NO4
+Na ([M+Na]+): 404.1832, Found: 404.1786. 
tert-butyl (2-allyl-5-(trifluoromethyl)benzoyl)(benzyl)carbamate (3c): 
Prepared according to general procedure B from tert-butyl benzyl(2-
bromo-5-(trifluoromethyl)benzoyl)carbamate S2i (1.37 g, 3.00 mmol). The 
crude reaction mixture was purified by flash column chromatography (100:0 hexanes:EtOAc to 
95:5 hexanes:EtOAc) to give 3c as a colorless oil as an 84:16 mixture of 3c and the olefin 
isomerization product in 70% yield  (0.879 g, 2.10 mmol). 1H NMR (400 MHz, CDCl3)  1.10 (s, 
9H), 3.46 (d, J = 6.8 Hz, 2H), 5.05 (s, 2H), 5.06-5.11 (m, 2H), 5.81-5.93 (m, 1H), 7.27-7.40 (m, 
5H), 7.45 (d, J = 7.2 Hz, 2H) 7.58 (dd, J = 7.9, 3.1 Hz, 1H). 13C NMR (101 MHz, CDCl3)  27.3, 
37.3, 48.0, 83.9, 117.4, 122.9 (q, J = 3.7 Hz, 1C), 125.9 (q, J = 3.8 Hz, 1C), 127.0 (q, J = 273.4 
Hz, 1C), 127.6, 128.3, 128.5, 128.7, 130.2, 131.5, 135.2, 137.3, 138.7, 141.0, 152.3, 170.8,. 19F 
NMR (376 MHz, CDCl3)  -62.6 (m, 1F).   HRMS (ESI): Calcd. for C23H25F3NO3+ ([M+H]+): 
420.1781, Found: 420.1720. 
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tert-butyl benzyl(2-allyl-4-methoxybenzoyl)carbamate (3d): Prepared 
according to general procedure B from tert-butyl benzyl(2-bromo-4-
methoxybenzoyl)carbamate S2e (1.26 g, 3.00 mmol). The crude reaction 
mixture was purified by flash column chromatography (100:0 
hexanes:EtOAc to 90:10 hexanes:EtOAc) to give 3d as a colorless oil in 34% yield (0.386 g, 1.01 
mmol). 1H NMR (400 MHz, CDCl3)  1.13 (s, 9H), 3.48 (d, J = 6.8 Hz, 2H), 3.80 (s, 3H), 4.99 (s, 
2H), 5.04-5.12 (m, 2H), 5.92 (ddt, J = 17.2, 10.0, 6.8 Hz, 1H), 6.70 (dd, J = 8.5, 2.4 Hz, 1H), 6.78 
(d, J = 2.4 Hz, 1H), 7.12 (d, J = 8.5 Hz, 1H), 7.24-7.29 (m, 1H), 7.31-7.35 (m, 2H), 7.42-7.44 (m, 
2H). 13C NMR (101 MHz, CDCl3)  27.6, 37.7, 48.4, 55.4, 83.1, 110.9, 115.5, 116.6, 127.5, 128.3, 
128.4, 128.5, 130.5, 136.5, 138.0, 140.2, 153.3, 160.8, 172.4. HRMS (ESI): Calcd. for 
C23H27NO4
+Na ([M+Na]+): 404.1832, Found: 404.1782. 
 tert-butyl (2-allyl-4-methylbenzoyl)(benzyl)carbamate (3e): Prepared 
according to general procedure B from tert-butyl benzyl(2-bromo-4-
methylbenzoyl)carbamate S2c (1.21 g, 3.00 mmol). The crude reaction 
mixture was purified by flash column chromatography (100:0 hexanes:EtOAc to 90:10 
hexanes:EtOAc) to give 3e as a colorless oil in 28% yield (0.310 g, 0.848 mmol). 1H NMR (400 
MHz, CDCl3)  1.11 (s, 9H), 2.34 (s, 3H), 3.44 (d, J = 8.0 Hz, 2H), 5.01 (s, 2H), 5.05-5.10 (m, 
2H), 5.93 (ddt, J = 17.0, 10.0, 6.9 Hz, 1H), 6.99 (d, J = 8.0 Hz, 1H), 7.05 (d, J = 8.0 Hz, 1H), 7.05-
7.07 (m, 1H), 7.24-7.30 (m, 1H), 7.30-7.37 (m, 2H), 7.44 (d, J = 8.0 Hz, 2H). 13C NMR (101 
MHz, CDCl3)  21.5, 27.5, 37.6, 48.2, 83.2, 116.3, 126.4, 126.5, 127.5, 128.3, 128.5, 130.6, 135.3, 
136.8 137.5, 138.0, 139.8, 153.1, 172.6.  HRMS (ESI): Calcd. for C23H28NO3
+ ([M+H]+): 
366.2064, Found: 366.2027. 
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tert-butyl (2-allyl-4-fluorobenzoyl)(benzyl)carbamate (3f): Prepared 
according to general procedure B from tert-butyl benzyl(2-bromo-4-
fluorobenzoyl)carbamate S2g (1.22 g, 3.00 mmol). The crude reaction 
mixture was purified by flash column chromatography (100:0 
hexanes:EtOAc to 90:10 hexanes:EtOAc) to give 3f as a colorless oil in 51% yield (0.568 g, 1.54 
mmol). 1H NMR (400 MHz, CDCl3)  1.14 (s, 9H), 3.44 (d, J = 6.9 Hz, 2H), 5.01 (s, 2H), 5.06-
5.12 (m, 2H), 5.89 (ddt, J = 17.4, 9.6, 6.9 Hz, 1H), 6.89 (td, J = 8.5, 2.4 Hz, 1H), 6.97 (dd, J = 9.8, 
2.4 Hz, 1H), 7.12 (dd, J = 8.5, 5.7 Hz, 1H), 7.26-7.30 (m, 1H), 7.32-7.36 (m, 2H), 7.42-7.44 (m, 
2H). 13C NMR (101 MHz, CDCl3)  27.6, 37.4, 48.2, 83.6, 112.8 (d, J = 21.2 Hz, 1C), 116.7 (d, 
J = 22.2 Hz, 1C), 117.4, 127.61, 128.1 (d, J = 9.1 Hz, 1C), 128.4, 128.6, 134.3 (d, J = 3.0 Hz, 1C), 
135.6, 137.7 140.6 (d, J = 7.1 Hz, 1C), 152.9, 163.3 (d, J = 250.5 Hz, 1C), 171.6. 19F NMR (376 
MHz, CDCl3)  -110.9 (m, 1F). HRMS (ESI): Calcd. for C22H24FNO3+Na ([M+Na]+): 392.1632, 
Found: 392.1596. 
tert-butyl (2-allyl-4-(trifluoromethyl)benzoyl)(benzyl)carbamate (3g): 
Prepared according to general procedure B from tert-butyl benzyl(2-iodo-
4-(trifluoromethyl)benzoyl)carbamate S2j (1.52 g, 3.00 mmol). The crude 
reaction mixture was purified by flash column chromatography (100:0 hexnaes:EtOAc to 90:10 
hexanes:EtOAc) to give 3g as a colorless oil in 81% yield (1.02 g, 2.43 mmol). 1H NMR (400 
MHz, CDCl3)  1.12 (s, 9H), 3.45 (d, J = 6.8 Hz, 2H), 5.05 (s, 2H), 5.06-5.12 (m, 2H), 5.89 (ddt, 
J = 16.8, 10.3, 6.8 Hz, 1H), 7.23 (d, J = 8.0 Hz, 1H), 7.27-7.32 (m, 1H), 7.34-7.38 (m, 2H), 7.43-
7.51 (m, 4H).  13C NMR (101 MHz, CDCl3)  22.5, 37.4, 47.9, 84.1, 117.7, 122.9 (q, J = 3.75 Hz, 
1C), 126.1, 126.5 (q, J = 4.0 Hz, 1C), 127.0 (q, J = 274.1 Hz, 1C), 127.7, 128.5, 128.6, 131.2, 
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135.2, 137.5, 137.9, 141.8, 152.4, 171.1. 19F NMR (376 MHz, CDCl3)  -62.6 (s, 3F).    HRMS 
(ESI): Calcd. for C23H24F3NO3
+Na ([M+Na]+): 442.1600, Found: 442.1550. 
tert-butyl (2-allyl-3-fluorobenzoyl)(benzyl)carbamate (3h): Prepared 
according to general procedure B from tert-butyl benzyl(3-fluoro-2-
bromobenzoyl)carbamate S2h (1.22 g, 3.00 mmol). The crude reaction mixture 
was purified by flash column chromatography (100:0 hexanes:EtOAc to 90:10 hexanes:EtOAc) to 
give 3h as a colorless oil in 71% yield (0.787 g, 2.13 mmol). 1H NMR (400 MHz, CDCl3)  1.12, 
(s, 9H), 3.43 (d, J = 6.0 Hz, 2H), 4.97-5.05 (m, 2H), 5.03 (s, 2H), 5.89 (ddt, J = 17.1, 10.0, 6.6 Hz, 
1H), 6.93 (dd, J = 7.6, 0.6 Hz, 1H), 7.05-7.09 (m, 1H), 7.18 (m, 1H), 7.27-7.30 (m, 1H), 7.33-7.37 
(m, 2H), 7.43-7.45 (m, 2H). 13C NMR (101 MHz, CDCl3)  27.5, 30.7, 48.0, 83.8, 116.27, 116.3, 
116.5, 121.7 (d, J = 3.0 Hz, 1C), 124.6 (d, J = 17.2 Hz, 1C), 127.4 (d, J = 9.1 Hz, 1C), 127.6, 128.5 
(d, J = 15.2 Hz, 1C), 135.2, 137.7, 140.4 (d, J = 5.1 Hz, 1C), 152.7, 161.4 (d, J = 248.5 Hz, 1C), 
170.9 (d, J = 3.0 Hz, 1C). 19F NMR (376 MHz, CDCl3)  -116.6 (m, 1F).  HRMS (ESI): Calcd. 
for C22H24FNO3
+Na ([M+Na]+): 392.1632, Found: 392.1587. 
tert-butyl (2-allyl-6-fluorobenzoyl)(benzyl)carbamate (3i): Prepared 
according to general procedure B from tert-butyl benzyl(2-bromo-6-
fluorobenzoyl)carbamate S2f (1.22 g, 3.00 mmol). The crude reaction mixture 
was purified by flash column chromatography (100:0 hexanes:EtOAc to 90:10 hexanes:EtOAc) to 
give 3i as a colorless oil in 89% yield (0.984 g, 2.66 mmol). 1H NMR (400 MHz, CDCl3)  1.16 
(s, 9H), 3.37 (dd, J = 22.6, 7.2 Hz, 2H), 4.99-5.05 (m, 2H), 5.09 (d, J = 4.6 Hz, 2H), 5.86 (ddt, J = 
17.6, 9.6, 6.8 Hz, 1H), 6.91 (t, J = 9.6 Hz, 1H), 7.03 (d, J = 7.6 Hz, 1H), 7.24-7.30 (m, 2H), 7.32-
7.36 (m, 2H), 7.42-7.44 (m, 2H).  13C NMR (101 MHz, CDCl3)  27.4 (d, J = 4.0 Hz, 1C), 37.4, 
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47.6, 83.7, 112.9, 113.1, 116.9, 125.3 (d, J = 2.0 Hz, 1C), 126.9 (d, J = 17.2 Hz, 1C), 127.8 (d, J 
= 74.7 Hz, 1C), 128.5, 130.1 (d, J = 8.1 Hz, 1C), 135.8 (d, J = 6.1 Hz, 1C), 137.6, 139.1 (d, J = 
3.0 Hz, 1C), 152.1, 158.3 (d, J = 247.5 Hz, 1C), 167.25. 19F NMR (376 MHz, CDCl3)  -117.7 
(m, 1F). HRMS (ESI): Calcd. for C22H24FNO3
+Na ([M+Na]+): 392.1632, Found: 392.1598.  
tert-butyl (2-allyl-4,5-difluorobenzoyl)(benzyl)carbamate (3j): Prepared 
according to general procedure B from tert-butyl benzyl(4,5-difluoro-2-
bromobenzoyl)carbamate S2k (1.28 g, 3.00 mmol). The crude reaction 
mixture was purified by flash column chromatography (100:0 DCM:EtOAc to 90:10 
DCM:EtOAc) to give 3j as a colorless oil in 61% yield (0.709 g, 1.83 mmol). 1H NMR (400 MHz, 
CDCl3)  1.19 (s, 9H), 3.36 (d, J = 6.8 Hz, 2H), 5.00 (s, 2H), 5.03-5.10 (m, 2H), 5.84 (ddt, J = 
16.9, 10.2, 6.8 Hz, 1H), 6.97 (dd, J = 10.2, 7.8 Hz, 1H), 7.06 (dd, J = 11.2, 7.6 Hz, 1H), 7.27-7.31 
(m, 1H), 7.33-7.38 (m, 2H), 7.39-7.43 (m, 2H).  13C NMR (101 MHz, CDCl3)  27.5, 36.6, 48.1, 
83.9, 115.3 (d, J = 19.2 Hz, 1C), 117.4, 118.5 (d, J = 18.2 Hz, 1C), 127.6, 128.36 (d, J = 29.3 Hz, 
1C), 128.37 (d, J = 10.1 Hz, 1C), 134.2 (dd, J = 5.1 Hz, 1C), 134.5 (dd, J = 5.1 Hz, 1C), 135.3, 
137.3, 148.2 (dd, J = 249.6, 13.2 Hz, 1C), 150.5 (dd, J = 248.2, 12.6 Hz, 1C), 152.4, 170.1. 19F 
NMR (376 MHz, CDCl3)  -141.3 (m, 1F) -135.8 (m, 1F).    HRMS (ESI): Calcd. for 
C22H23F2NO3
+Na ([M+Na]+): 410.1538, Found: 410.1492. 
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General Procedure C: Synthesis of 2-Benzyl-2,3-dihydro-1H-inden-1-ones 2a-2t, 4a-4j 
 
 
2-benzyl-2,3-dihydro-1H-inden-1-ones 2a-2t, 4a-4j were prepared by the following 
procedure. A 1-dram vial was charged with 0.100 mmol of the appropriate o-allylbenzamide 1a, 
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3a-3j, Ni(cod)2 (2.8 mg, 0.010 mmol ), SIPr (3.9 mg, 0.010 mmol), K3PO4 (42.5 mg, 0.200 mmol), 
H2O (3.6 µL, 0.20 mmol), the appropriate ArBpin (0.300 mmol), and THF (0.10-0.20 mL, 0.50-
1.0 M).   The resulting solution stirred at 60 °C for 12-16 hours.  Upon completion of the reaction, 
the reaction mixture was filtered through a short plug of silica gel eluting with 70:30 
hexanes:EtOAc and concentrated under reduced pressure. The crude product was purified by 
column chromatography with a gradient of 100:0 hexanes:EtOAc to 90:10 hexanes:EtOAc over a 
25 minute period on a Combiflash system. 
2-benzyl-2,3-dihydro-1H-inden-1-one (2a): Prepared according to general 
procedure C from tert-butyl (2-allylbenzoyl)(benzyl)carbamate 1a (35.1 mg, 
0.100 mmol) and phenylboronic acid pinacol ester (61.2 mg, 0.300 mmol).  
The crude reaction mixture was purified by flash column chromatography (100:0 hexanes:EtOAc 
to 90:10 hexanes:EtOAc) to give 2a as a colorless oil in 97% yield (21.6 mg, 0.097 mmol). 1H 
NMR (400 MHz, CDCl3)  2.68 (dd, J = 14.0, 10.4 Hz, 1H), 2.88 (dd, J = 17.2, 4.0 Hz, 1H), 2.97-
3.06 (m, 1H), 3.18 (dd, J = 17.2, 7.8 Hz, 1H), 3.42 (dd, J = 14.0, 4.2 Hz, 1H), 7.20-7.34 (m, 5H), 
7.35-7.43 (m, 2H), 7.58 (t, J = 7.6 Hz, 1H), 7.80 (d, J = 7.6 Hz, 1H). 13C NMR (101 MHz, CDCl3) 
 32.3, 37.1, 49.1, 124.1, 126.5, 126.7, 127.5, 128.6, 129.0, 134.9, 136.7, 139.8, 153.7, 207.9. 
HRMS (ESI): Calcd. for C16H14O
+Na ([M+Na]+): 245.0937, Found: 245.0902. 
2-(4-methoxybenzyl)-2,3-dihydro-1H-inden-1-one (2b): Prepared 
according to general procedure C from tert-butyl (2-
allylbenzoyl)(benzyl)carbamate 1a (35.1 mg, 0.100 mmol) and 4-
methoxyphenylboronic acid pinacol ester (70.2 mg, 0.300 mmol).  The 
crude reaction mixture was purified by flash column chromatography (100:0 hexanes:EtOAC to 
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90:10 hexanes:EtOAc) to give 2b as a colorless oil in 98% yield (24.8 mg, 0.098 mmol).  1H NMR 
(400 MHz, CDCl3)  2.65 (dd, J = 14.0, 10.1 Hz, 1H), 2.86 (dd, J = 17.2, 4.0 Hz, 1H), 2.93-3.00 
(m, 1H), 3.17 (dd, J = 17.2, 7.7 Hz, 1H), 3.31 (dd, J = 14.0, 4.3 Hz, 1H), 3.79 (s, 3H), 6.84 (ddd, 
J = 8.7, 3.0, 2.1 Hz, 2H), 7.16 (ddd, J = 8.7, 3.0, 2.0 Hz, 2H), 7.35-7.41 (m, 2H), 7.57 (ddd, J = 
7.6, 7.6, 1.2 Hz, 1H), 7.78 (d, J = 8.0 Hz, 1H). 13C NMR (101 MHz, CDCl3)  32.2, 36.2, 49.3, 
55.4, 114.0, 124.1, 126.7, 127.5, 130.0, 131.7, 134.9, 136.7, 153.8, 158.3, 208.1. HRMS (ESI): 
Calcd. for C17H17O2
+ ([M+H]+): 253.1223, Found: 253.1225. 
2-(4-methylbenzyl)-2,3-dihydro-1H-inden-1-one (2c): Prepared 
according to general procedure C from tert-butyl (2-
allylbenzoyl)(benzyl)carbamate 1a (35.1 mg, 0.100 mmol) and 4-
tolylboronic acid pinacol ester (65.4 mg, 0.300 mmol).  The crude reaction 
mixture was purified by flash column chromatography (100:0 hexanes:EtOAc to 90:10 
hexanes:EtOAc) to give 2c as a colorless oil in 99% yield (23.4 mg, 0.099 mmol). 1H NMR (400 
MHz, CDCl3)  2.33 (s, 3H), 2.64 (dd, J = 14.0, 10.4 Hz, 1H), 2.86 (dd, J = 17.2, 3.9 Hz, 1H), 
2.95-3.02 (m, 1H), 3.17 (dd, J = 17.2, 7.8 Hz, 1H), 3.36 (dd, J = 14.0, 4.2 Hz, 1H), 7.10-7.15 (m, 
4H), 7.35-7.41 (m, 2H), 7.57 (ddd, J = 7.6, 7.6, 1.1 Hz, 1H), 7.78 (d, J = 7.7 Hz, 1H). 13C NMR 
(101 MHz, CDCl3)  21.3, 32.3, 36.7, 49.2, 124.1, 126.6, 127.5, 128.9, 129.3, 134.8, 136.0, 136.66, 
136.73, 153.8, 208.1. HRMS (ESI): Calcd. for C17H17O
+ ([M+H]+): 237.1274, Found: 237.1272. 
2-([1,1’-biphenyl]-4-ylmethyl)-2,3-dihydro-1H-inden-1-one (2d): 
Prepared according to general procedure C from tert-butyl (2-
allylbenzoyl)(benzyl)carbamate 1a (35.1 mg, 0.100 mmol) and 4-
biphenylboronic acid pinacol ester (84.1 mg, 0.300 mmol).  The crude 
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reaction mixture was purified by flash column chromatography (100:0 hexanes:EtOAc to 90:10 
hexanes:EtOAc) to give 2d as a colorless oil in 94% yield (27.9 mg, 0.094 mmol). 1H NMR (400 
MHz, CDCl3)  2.73 (dd, J = 14.0, 10.4 Hz, 1H), 2.91 (dd, J = 17.2, 4.0 Hz, 1H), 3.02-3.08 (m, 
1H), 3.23 (dd, J = 17.2, 7.8 Hz, 1H), 3.44 (dd, J = 14.0, 4.3 Hz, 1H), 7.32-7.46 (m, 7H), 7.53-7.60 
(m, 5H), 7.81 (d, J = 7.5 Hz, 1H). 13C NMR (101 MHz, CDCl3)  32.4, 36.8, 49.0, 124.2, 126.7, 
127.1, 127.3, 127.4, 127.6, 128.9, 129.5, 135.0, 136.7, 138.9, 139.4, 141.0, 153.8, 207.9. HRMS 
(ESI): Calcd. for C22H19O
+ ([M+H]+): 299.1430, Found: 299.1433. 
2-(4-(methoxymethyl)benzyl)-2,3-dihydro-1H-inden-1-one (2e): 
Prepared according to general procedure C from tert-butyl (2-
allylbenzoyl)(benzyl)carbamate 1a (35.1 mg, 0.100 mmol) and 4-
(methoxymethyl)phenylboronic acid pinacol ester (74.4 mg, 0.300 
mmol).  The crude reaction mixture was purified by flash column chromatography (100:0 
hexanes:EtOAc to 90:10 hexanes:EtOAc) to give 2e as a colorless oil in 78% yield (20.7 mg, 0.078 
mmol). 1H NMR (400 MHz, CDCl3)  2.68 (dd, J = 13.8, 11.0 Hz, 1H), 2.84 (dd, J = 17.2, 3.8 
Hz, 1H), 2.96-3.03 (m, 1H), 3.16 (dd, J = 17.1, 7.8 Hz, 1H), 3.36-3.40 (m, 4H), 4.42 (s, 2H), 7.22-
7.28 (m, 4H), 7.34-7.40 (m, 2H), 7.56 (dd, J = 7.5, 7.5 Hz, 1H), 7.78 (d, J = 7.7 Hz, 1H). 13C NMR 
(101 MHz, CDCl3)  32.3, 36.8, 49.0, 58.3, 74.6, 124.2, 126.7, 127.6, 128.2, 129.1, 134.9, 136.4, 
136.8, 138.2, 153.8, 207.91. HRMS (ESI): Calcd. for C18H19O2
+ ([M+H]+): 267.1380, Found: 
267.1383. 
2-(4-fluorobenzyl)-2,3-dihydro-1H-inden-1-one (2f): Prepared according 
to general procedure C from tert-butyl (2-allylbenzoyl)(benzyl)carbamate 
1a  (35.1 mg, 0.100 mmol) and 4-fluorophenylboronic acid pinacol ester 
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(66.7 mg, 0.300 mmol).  The crude reaction mixture was purified by flash column chromatography 
(100:0 hexanes:EtOAc to 90:10 hexanes:EtOAc) to give 2f as a colorless oil in 98% yield (23.6 
mg, 0.098 mmol). 1H NMR (400 MHz, CDCl3)  2.70 (dd, J = 14.0, 10.0 Hz, 1H), 2.83 (dd, J = 
17.1, 4.0 Hz, 1H), 2.93-3.00 (m, 1H), 3.18 (dd, J = 17.1, 7.8 Hz, 1H), 3.33 (dd, J = 14.0, 4.3 Hz, 
1H), 6.95-7.00 (m, 2H), 7.18-7.21 (m, 2H), 7.35-7.41 (m, 2H), 7.57 (ddd, J = 7.7, 7.7, 1.0 Hz, 1H), 
7.77 (d, J = 7.6 Hz, 1H). 13C NMR (101 MHz, CDCl3)  32.2, 36.2, 49.0, 115.4 (d, J = 21.0 Hz), 
124.2, 126.7, 127.6, 130.5 (d, J = 7.8 Hz), 135.0, 135.3 (d, J = 3.2 Hz), 136.6, 153.6, 161.6 (d, J = 
243 Hz), 207.7. 19F NMR (376 MHz, CDCl3)  -116.9 (m, 1F). HRMS (ESI): Calcd. for 
C16H14FO
+ ([M+H]+): 241.1023, Found: 241.1023. 
2-(4-chlorobenzyl)-2,3-dihydro-1H-inden-1-one (2g): Prepared 
according to general procedure C from tert-butyl (2-
allylbenzoyl)(benzyl)carbamate 1a  (35.1 mg, 0.100 mmol) and 4-
chlorophenylboronic acid pinacol ester (71.5 mg, 0.300 mmol). The crude 
reaction mixture was purified by flash column chromatography (100:0 hexanes:EtOAc to 90:10 
hexanes:EtOAc) to give 2g as a colorless oil in 85% yield (21.8 mg, 0.085 mmol). 1H NMR (400 
MHz, CDCl3)  2.70 (dd, J = 14.0, 10.0 Hz, 1H), 2.83 (dd, J = 17.2, 4.2 Hz, 1H), 2.94-3.00 (m, 
1H), 3.18 (dd, J = 17.1, 7.8 Hz, 1H), 3.34 (dd, J = 14.0, 4.4 Hz, 1H), 7.18 (d, J = 8.5, 2H), 7.26 (d, 
J = 8.5 Hz, 2H), 7.36-7.42 (m, 2H), 7.58 (td, J = 7.6, 1.2 Hz, 1H), 7.78 (d, J = 7.7 Hz, 1H).   13C 
NMR (101 MHz, CDCl3)  32.2, 36.4, 48.8, 124.3, 126.7, 127.7, 128.8, 130.4, 132.3, 135.1, 136.6, 
138.1, 153.6, 207.6. HRMS (ESI): Calcd. for C16H14ClO
+ ([M+H]+): 257.0728, Found: 257.0726. 
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2-(4-acetylbenzyl)-2,3-dihydro-1H-inden-1-one (2h): Prepared 
according to general procedure C from tert-butyl (2-
allylbenzoyl)(benzyl)carbamate 1a  (35.1 mg, 0.100 mmol) and 4-
acetylboronic acid pinacol ester (73.8 mg, 0.300 mmol).  The crude 
reaction mixture was purified by flash column chromatography (100:0 hexanes:EtOAc to 90:10 
hexanes:EtOAc) to give 2h as a white solid in 76 % yield (20.1 mg, 0.076 mmol). 1H NMR (400 
MHz, CDCl3)  2.58 (s, 3H), 2.75-2.85 (m, 2H), 2.98-3.05 (m, 1H), 3.18 (dd, J = 17.1, 7.9 Hz, 
1H), 3.42 (dd, J = 14.0, 4.4 Hz, 1H), 7.34 (d, J = 8.1 Hz, 2H), 7.39 (dd, J = 7.5., 7.5 Hz, 2H), 7.58 
(dd, J = 7.5, 7.5 Hz, 1H), 7.78 (d, J = 7.6 Hz, 1H), 7.90 (d, J = 7.7 Hz, 1H). 13C NMR (101 MHz, 
CDCl3)  23.7, 32.2, 37.0, 48.6, 124.2, 126.7, 127.7, 128.8, 129.3, 135.1, 135.7, 136.5, 145.5, 
153.5, 197.9, 207.4. HRMS (ESI): Calcd. for C18H17O2
+ ([M+H]+): 265.1223, Found: 265.1226. 
2-(4-benzoylbenzyl)-2,3-dihydro-1H-inden-1-one (2i): Prepared 
according to general procedure C from tert-butyl (2-
allylbenzoyl)(benzyl)carbamate 1a (35.1 mg, 0.100 mmol) and 4-
benzoylphenylboronic acid pinacol ester (92.5 mg, 0.300 mmol).  The 
crude reaction mixture was purified by flash column chromatography (100:0 hexanes:EtOAc to 
80:20 hexanes:EtOAc) to give 2i as a white solid in 54% yield (17.5 mg, 0.054 mmol). 1H NMR 
(400 MHz, CDCl3)  2.80 (dd, J = 14.0, 10.2 Hz, 1H), 2.87 (dd, J = 17.1, 3.9 Hz, 1H), 3.02-3.08 
(m, 1H), 3.22 (dd, J = 17.0, 7.8 Hz, 1H), 3.47 (dd, J = 17.0, 4.3 Hz, 1H), 7.36-7.43 (m, 4H), 7.47-
7.50 (m, 2H), 7.57-7.61 (m, 2H), 7.75-7.80 (m, 5H). 13C NMR (101 MHz, CDCl3)  32.3, 37.1, 
48.7, 124.2, 126.7, 127.7, 128.4, 129.0, 130.1, 130.6, 132.4, 135.1, 135.9, 136.5, 137.8, 144.9, 
153.5, 196.5, 207.4. HRMS (ESI): Calcd. for C23H19O2
+ ([M+H]+): 327.1380, Found: 327.1382. 
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2-(4-(trifluoromethyl)benzyl)-2,3-dihydro-1H-inden-1-one (2j): 
Prepared according to general procedure C from tert-butyl (2-
allylbenzoyl)(benzyl)carbamate 1a (35.1 mg, 0.100 mmol) and 4-
(trifluoromethyl)phenylboronic acid pinacol ester (81.6 mg, 0.300 mmol).  
The crude reaction mixture was purified by flash column chromatography (100:0 hexanes:EtOAc 
to 90:10 hexanes:EtOAc) to give 2j as colorless oil in 69% yield (19.9 mg, 0.069 mmol). 1H NMR 
(400 MHz, CDCl3)  2.74-2.85 (m, 2H), 2.93-3.00 (m, 1H), 3.20 (dd, J = 17.0, 7.8 Hz, 1H), 3.43 
(dd, J = 14.0, 4.3 Hz, 1H), 7.35-7.42 (m, 4H), 7.55-7.61 (m, 3H), 7.79 (d, J = 7.7 Hz, 1H). 13C 
NMR (101 MHz, CDCl3)  32.3, 36.9, 48.7, 110.2, 124.3, 125.6 (q, J = 3.8 Hz), 126.7, 127.8, 
129.1 (q, J = 235 Hz), 129.4, 132.6, 135.2, 136.5, 143.9, 207.31. 19F NMR (376 MHz, CDCl3)  
-62.4 (s, 1F). HRMS (ESI): Calcd. for C17H14F3O
+ ([M+H]+): 291.0991, Found: 291.0992. 
2-(3-methoxybenzyl)-2,3-dihydro-1H-inden-1-one (2k):  Prepared 
according to general procedure C from tert-butyl (2-
allylbenzoyl)(benzyl)carbamate 1a (35.1 mg, 0.100 mmol) and 3-
methoxyphenylboronic acid pinacol ester (70.2 mg, 0.300 mmol).  The crude 
reaction mixture was purified by flash column chromatography (100:0 hexanes:EtOAc to 90:10 
hexanes:EtOAc) to give 2k as a colorless oil in 96% yield (24.3 mg, 0.096 mmol). 1H NMR (400 
MHz, CDCl3)  2.64 (dd, J = 13.9, 10.5 Hz, 1H), 2.87 (dd, J = 17.2, 4.0 Hz, 1H), 2.96-3.03 (m, 
1H), 3.18 (dd, J = 17.2, 7.8 Hz, 1H), 3.38 (dd, J = 14.0, 4.2 Hz, 1H), 3.79 (s, 3H), 6.75-6.85 (m, 
3H), 7.22 (dd, J = 7.9, 7.9 Hz, 1H), 7.35-7.42 (m, 2H), 7.57 (ddd, J = 7.6, 7.6, 1.2 Hz, 1H), 7.78 
(d, J = 7.7 Hz, 1H). 13C NMR (101 MHz, CDCl3)  32.4, 37.2, 49.0, 55.3, 111.8, 114.7, 121.4, 
124.2, 126.7, 127.6, 129.6, 135.0, 136.7, 141.4, 153.8, 160.0, 207.9. HRMS (ESI): Calcd. for 
C17H17O2
+ ([M+H]+): 253.1223, Found: 253.1227. 
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2-(3-methylbenzyl)-2,3-dihydro-1H-inden-1-one (2l): Prepared according 
to general procedure C from tert-butyl (2-allylbenzoyl)(benzyl)carbamate 1a 
(35.1 mg, 0.100 mmol) and 3-tolylboronic acid pinacol ester (65.4 mg, 0.300 
mmol).  The crude reaction mixture was purified by flash column 
chromatography (100:0 hexanes:EtOAc to 90:10 hexanes:EtOAc) to give 2l as a white solid in 
85% yield (20.0 mg, 0.085 mmol). 1H NMR (400 MHz, CDCl3)  2.34 (s, 3), 2.61 (dd, J = 13.9, 
10.6 Hz, 1H), 2.86 (dd, J = 17.2, 3.9 Hz, 1H), 2.96-3.03 (m, 1H), 3.17 (dd, J = 17.2, 7.7 Hz, 1H), 
3.38 (dd, J = 13.9, 4.1 Hz, 1H), 7.03-7.07 (m, 3H), 7.19 (dd, J = 7.5 Hz, 1H), 7.36-7.42 (m, 2H), 
7.58 (d, J = 7.7 Hz, 1H) 7.79 (d, J = 7.6 Hz, 1H). 13C NMR (101 MHz, CDCl3)  21.5, 32.4, 37.1, 
49.1, 124.1, 126.0, 126.8, 127.2, 127.6, 128.6, 129.8, 134.8, 136.7, 138.3, 139.8, 153.8, 208.0. 
HRMS (ESI): Calcd. for C17H17O
+ ([M+H]+): 237.1274, Found: 237.1276. 
2-(3-fluorobenzyl)-2,3-dihydro-1H-inden-1-one (2m): Prepared 
according to general procedure C from tert-butyl (2-
allylbenzoyl)(benzyl)carbamate 1a (35.1 mg, 0.100 mmol) and 3-
fluorophenylboronic acid pinacol ester (66.7 mg, 0.300 mmol).  The crude 
reaction mixture was purified by flash column chromatography (100:0 hexanes:EtOAc to 90:10 
hexanes:EtOAc) to give 2m as a colorless oil in 67% yield (16.1 mg, 0.067 mmol). 1H NMR (400 
MHz, CDCl3)  2.68 (dd, J = 14.0, 10.3 Hz, 1H), 2.84 (dd, J = 17.1, 4.1 Hz, 1H), 2.95-3.02 (m, 
1H), 3.20 (dd, J = 17.2, 7.8 Hz, 1H), 3.38 (dd, J = 14.0, 4.3 Hz, 1H), 6.89-6.97 (m, 2H), 7.02 (d, J 
= 7.6 Hz, 1H), 7.23-7.28 (m, 1H), 7.36-7.42 (m, 2H), 7.58 (ddd, J = 7.7, 7.7, 1.1 Hz, 1H), 7.78 (d, 
J = 7.7 Hz, 1H). 13C NMR (101 MHz, CDCl3)  32.3, 36.8, 48.8, 113.4 (d, J = 21.0 Hz), 115.9 (d, 
J = 21.0 Hz), 124.2, 124.7 (d, J = 2.8 Hz), 126.7, 127.7, 130.1 (d, J = 8.3 Hz), 135.6, 136.6, 142.3 
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(d, J = 7.2 Hz), 153.6, 163.0 (d, J = 245 Hz), 207.5. 19F NMR (376 MHz, CDCl3)  -113.3 (m, 
1F). HRMS (ESI): Calcd. for C16H14FO
+ ([M+H]+): 241.1023, Found: 241.1023. 
2-(3-chlorobenzyl)-2,3-dihydro-1H-inden-1-one (2n): Prepared according 
to general procedure C from tert-butyl (2-allylbenzoyl)(benzyl)carbamate 1a 
(35.1 mg, 0.100 mmol) and 3-chlorophenylboronic acid pinacol ester (71.6 
mg, 0.300 mmol).   The crude reaction mixture was purified by flash column 
chromatography (100:0 hexanes:EtOAc to 90:10 hexanes:EtOAc) to give 2n as a colorless oil in 
54% yield (13.9 mg, 0.054 mmol). 1H NMR (400 MHz, CDCl3)  2.65 (dd, J = 14.0, 10.4 Hz, 
1H), 2.84 (dd, J = 17.0, 4.1 Hz, 1H), 2.95-3.01 (m, 1H), 3.20 (dd, J = 17.2, 7.7 Hz, 1H), 3.37 (dd, 
J = 14.1, 4.2 Hz, 1H), 7.13 (ddd, J = 7.0, 1.7, 1.7 Hz, 1H), 7.18-7.25 (m, 3H), 7.36-7.43 (m, 2H), 
7.58 (ddd, J = 7.6, 7.6, 1.2 Hz, 1H), 7.78 (d, J = 7.7 Hz, 1H). 13C NMR (101 MHz, CDCl3)  32.3, 
36.8, 48.8, 124.2, 126.74, 126.75, 127.2, 127.7, 129.1, 130.0, 134.4, 135.1, 136.6, 141.9, 153.5, 
207.4. HRMS (ESI): Calcd. for C16H14ClO
+ ([M+H]+): 257.0728, Found: 257.0725. 
2-(2-methoxybenzyl)-2,3-dihydro-1H-inden-1-one (2o): Prepared 
according to general procedure C from tert-butyl (2-
allylbenzoyl)(benzyl)carbamate 1a (35.1 mg, 0.100 mmol) and 2-
methoxyphenylboronic acid pinacol ester (70.2 mg, 0.300 mmol).   The crude reaction mixture 
was purified by flash column chromatography (100:0 hexanes:EtOAc to 90:10 hexanes:EtOAc) to 
give 2o as a colorless oil in 50% yield (12.6 mg, 0.050 mmol). 1H NMR (400 MHz, CDCl3)  2.63 
(dd, J = 13.6, 9.9 Hz, 1H), 2.86 (dd, J = 20.5, 7.2 Hz, 1H), 3.07-3.16 (m, 2H), 3.42 (dd, J = 13.6, 
4.2 Hz, 1H), 3.82 (s, 3H), 6.86-6.92 (m, 2H), 7.17-7.24 (m, 2H), 7.34-7.40 (m, 2H), 7.56 (ddd, J 
= 7.6, 7.6, 1.2 Hz, 1H) 7.78 (d, J = 7.9 Hz, 1H). 13C NMR (101 MHz, CDCl3)  31.9, 32.5, 47.7, 
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55.3, 110.4, 120.6, 124.1, 126.7, 127.4, 127.8, 128.3, 130.6, 134.7, 136.9, 154.0, 157.9, 208.5. 
HRMS (ESI): Calcd. for C17H17O2
+ ([M+H]+): 253.1223, Found: 253.1221. 
2-(2-methylbenzyl)-2,3-dihydro-1H-inden-1-one (2p): Prepared 
according to general procedure C from tert-butyl (2-
allylbenzoyl)(benzyl)carbamate 1a (35.1 mg, 0.100 mmol) and 2-
tolylboronic acid pinacol ester (65.4 mg, 0.300 mmol).   The crude reaction mixture was purified 
by flash column chromatography (100:0 hexanes:EtOAc to 90:10 hexanes:EtOAc) to give 2p as a 
colorless oil in 90% yield (21.3 mg, 0.090 mmol). 1H NMR (400 MHz, CDCl3)  2.38 (s, 3H), 
2.59 (dd, J = 14.5, 11.1 Hz, 1H), 2.87 (dd, J = 17.2, 4.0 Hz, 1H), 2.99-3.06 (m, 1H), 3.21 (dd, J = 
17.2, 7.8 Hz, 1H), 3.49 (dd, J = 14.5, 4.1 Hz, 1H), 7.14-7.21 (m, 4H), 7.37-7.44 (m, 2 H), 7.59 
(ddd, J = 7.6, 7.6, 1.1 Hz, 1H) 7.81 (d, J = 7.6 Hz, 1H). 13C NMR (101 MHz, CDCl3)  19.6, 32.8, 
34.6, 47.7, 124.1, 124.3, 126.1, 126.6, 126.8, 127.5, 129.1, 130.6, 135.0, 136.6, 138.1, 153.7, 
208.1. HRMS (ESI): Calcd. for C17H17O
+ ([M+H]+): 237.1274, Found: 237.1273. 
2-(naphthalen-2-ylmethyl)-2,3-dihydro-1H-inden-1-one (2q): 
Prepared according to general procedure C from tert-butyl (2-
allylbenzoyl)(benzyl)carbamate 1a (35.1 mg, 0.100 mmol) and 2-
naphthylboronic acid pinacol ester (76.2 mg, 0.300 mmol). The crude 
reaction mixture was purified by flash column chromatography (100:0 DCM:EtOAc to 90:10 
DCM:EtOAc) to give 2q as a white solid in 99% (27.0 mg, 0.099 mmol). 1H NMR (400 MHz, 
CDCl3)  2.84 (dd, J = 14.1, 10.0 Hz, 1H), 2.92 (dd, J = 16.5, 3.2 Hz, 1H), 3.06-3.23 (m, 2H), 3.57 
(dd, J = 14.1, 4.1 Hz, 1H), 7.34-7.50 (m, 5H), 7.57 (dt, J = 7.7, 1.2 Hz, 1H), 7.68 (broad s, 1H), 
7.76-7.84 (m, 4H). 13C NMR (101 MHz, CDCl3)  32.3, 37.3, 49.0, 124.2, 125.6, 126.2, 126.7, 
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127.4, 127.5, 127.6, 127.61, 127.8, 128.4, 132.3, 133.7, 135.0, 136.7, 137.3, 153.8, 208.0. HRMS 
(ESI): Calcd. for C20H16O
+Na ([M+Na]+): 295.1093, Found: 295.1057. 
2-(furan-3-ylmethyl)-2,3-dihydro-1H-inden-1-one (2s): Prepared 
according to general procedure C from tert-butyl (2-
allylbenzoyl)(benzyl)carbamate 1a (35.1 mg, 0.100 mmol) and 3-
furanylboronic acid pinacol ester (58.2 mg, 0.300 mmol). The crude reaction mixture was purified 
by flash column chromatography (100:0 hexanes:EtOAc to 90:10 hexanes:EtOAc) to give 2s as a 
colorless oil in 63% yield (13.4 mg, 0.063 mmol). 1H NMR (400 MHz, CDCl3)  2.67 (dd, J = 
14.2, 8.8 Hz, 1H), 2.89 (dd, J = 16.6, 4.2 Hz, 1H), 2.87-2.95 (m, 2H),  3.08 (dd, J = 14.2, 3.7 Hz, 
1H), 3.26 (dd, J = 16.6, 7.2 Hz, 1H), 6.27 (s, 1H), 7.32 (t, J = 1.6 Hz, 1H), 7.36 (t, J = 7.8 Hz, 1H), 
7.42 (d, J = 7.7 Hz, 1H), 7.57 (td, J = 7.6, 1.2 Hz, 1H), 7.76 (d, J = 8.0 Hz, 1H).  13C NMR (101 
MHz, CDCl3)  26.2, 32.4, 47.8, 111.3, 122.3, 124.1, 126.7, 127.6, 135.0, 136.8, 139.8, 143.1, 
153.8, 208.0. HRMS (ESI): Calcd. for C14H13O2
+ ([M+H]+): 213.0910, Found: 213.0916. 
2-(thiophen-3-ylmethyl)-2,3-dihydro-1H-inden-1-one (2t): Prepared 
according to general procedure C from tert-butyl (2-
allylbenzoyl)(benzyl)carbamate 1a (35.1 mg, 0.100 mmol) and 3-
thienylboronic acid pinacol ester (63.0 mg, 0.300 mmol). The crude reaction mixture was purified 
by flash column chromatography (100:0 hexanes:EtOAc to 90:10 hexanes:EtOAc) to give 2t as a 
white solid in 88% yield (20.1 g, 0.088 mmol). 1H NMR (400 MHz, CDCl3)  2.82 (dd, J = 14.4, 
9.8 Hz, 1H), 2.88 (dd, J = 17.2, 4.0 Hz, 1H), 2.96-3.02 (m, 1H), 3.25 (dd, J = 17.2, 7.7 Hz, 1H), 
3.33 (dd, J = 14.4, 4.1 Hz, 1H), 6.98 (dd, J = 4.9, 1.2 Hz, 1H), 7.00-7.02 (m, 1H), 7.25 (dd, J = 
4.9, 3.0 Hz, 1H), 7.37 (t, J = 7.8 Hz, 1H), 7.41 (d, J = 7.7 Hz, 1H), 7.57 (td, J = 7.6, 1.2 Hz, 1H), 
7.77 (d, J = 7.7 Hz, 1H). 13C NMR (101 MHz, CDCl3)  31.5, 32.5, 48.3, 121.5, 124.1, 125.8, 
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126.7, 127.5, 128.4, 134.9, 136.7, 139.8, 153.8, 207.9. HRMS (ESI): Calcd. for C14H13OS
+ 
([M+H]+): 229.0682, Found: 222.0684. 
2-benzyl-6-methyl-2,3-dihydro-1H-inden-1-one (4a): Prepared 
according to general procedure C from tert-butyl (2-allyl-5-
methyl)(benzyl)carbamate 3a (36.5 mg, 0.100 mmol) and phenylboronic 
acid pinacol ester (61.2 mg, 0.300 mmol).  The crude reaction mixture was purified by flash 
column chromatography (100:0 hexanes:EtOAc to 90:10 hexanes:EtOAc) to give 4a as a colorless 
oil in 92% yield (21.7 mg, 0.092 mmol). 1H NMR (400 MHz, CDCl3)  2.41 (s, 3H), 2.66 (dd, J 
= 14.0, 10.4 Hz, 1H), 2.81 (dd, J = 17.0, 3.8 Hz, 1H), 2.97-3.04 (m, 1H), 3.13 (dd, J = 17.0, 7.8 
Hz, 1H), 3.40 (dd, J = 14.0, 4.2 Hz, 1H), 7.21-7.36 (m, 6H), 7.40 (dd, J = 7.8. 1.1 Hz, 1H), 7.59 
(s, 1H). 13C NMR (101 MHz, CDCl3)  21.2, 32.0, 37.2, 49.4, 124.1, 126.4, 126.4, 128.6, 129.0, 
136.2, 136.8, 137.5, 139.9, 151.1, 208.1. HRMS (ESI): Calcd. for C17H17O
+ ([M+H]+): 237.1274, 
Found: 237.1270. 
2-benzyl-6-methoxy-2,3-dihydro-1H-inden-1-one (4b): Prepared 
according to a modified version of general procedure C from tert-butyl 
(2-allyl-5-methoxy)(benzyl)carbamate 3b (38.1 mg, 0.100 mmol) and 
phenylboronic acid pinacol ester (61.2 mg, 0.300 mmol). Upon completion of the reaction,  the 
reaction mixture was filtered through a short plug of silica gel.  The filtrate was concentrated under 
reduced pressure.  To the crude product was dissolved in DCM (2.0 mL).  The resulting solution 
was cooled to 0 °C, and TFA (0.400 mL) was added slowly.  The mixture was allowed to warm to 
room temperature and stirred for 1 h. The reaction was concentrated under reduced pressure. The 
crude reaction mixture was purified by flash column chromatography (100:0 hexanes:EtOAc to 
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90:10 hexanes:EtOAc) to give 4b as a white solid in 96% yield (24.0 mg, 0.096 mmol). 1H NMR 
(400 MHz, CDCl3)  2.66 (dd, J = 14.0, 10.2 Hz, 1H), 2.78 (dd, J = 16.4, 3.2 Hz, 1H), 2.97-3.07 
(m, 1H), 3.09 (dd, J = 16.4, 7.6 Hz, 1H), 3.39 (dd, J = 14.0, 4.2 Hz, 1H), 3.84 (s, 3H), 7.17 (dd, J 
= 8.3, 2.5 Hz, 1H), 7.19-7.33 (m, 6H) 13C NMR (101 MHz, CDCl3)  31.6, 37.2, 49.8, 55.7, 105.2, 
124.4, 126.5, 127.4, 128.6, 129.0, 137.8, 139.8, 146.6, 159.5, 208.0 HRMS (ESI): Calcd. for 
C17H17O2
+ ([M+H]+): 253.1223, Found: 253.1226. 
2-benzyl-6-(trifuoromethyl)-2,3-dihydro-1H-inden-1-one (4c): 
Prepared according to general procedure C from tert-butyl (2-allyl-5-
(trifluoromethyl)benzoyl)(benzyl)carbamate 3c (41.9 mg, 0.100 
mmol) and phenylboronic acid pinacol ester (61.2 mg, 0.300 mmol). The crude reaction mixture 
was purified by flash column chromatography (100:0 hexanes:EtOAc to 90:10 hexanes:EtOAc) to 
give 4c as a white solid in 51% yield (14.8 mg, 0.051 mmol). 1H NMR (400 MHz, CDCl3)  2.73 
(dd, J = 14.0, 10.1 Hz, 1H), 2.93 (dd, J = 17.6, 4.0 Hz, 1H), 3.05-3.12 (m, 1H), 3.24 (dd, J = 17.6, 
7.9 Hz, 1H), 3.40 (dd, J = 14.0, 4.4 Hz, 1H), 7.21-7.25(m, 3H), 7.28-7.34 (m, 2H), 7.52 (d, J = 8.0 
Hz, 1H), 7.81 (dd, J = 8.0, 1.3 Hz, 1H), 8.04 (s, 1H). 13C NMR (101 MHz, CDCl3)  32.3, 36.9, 
49.4, 121.4 (q, J = 4.0 Hz, 1H), 126.6 (q, J = 274 Hz, 1C), 126.7, 127.5, 128.8, 129.0. 130.5 (q, J 
= 33.3 Hz, 1C), 131.4 (q, J = 3.0 Hz, 1C), 137.1, 139.2, 156.9, 206.6. 19F NMR (CDCl3, 376 
MHz):  -62.5 (s, 1F). HRMS (ESI): Calcd. for C17H14F3O+ ([M+H]+): 291.0991, Found: 
291.0995. 
2-benzyl-5-methoxy-2,3-dihydro-1H-inden-1-one (4d): Prepared 
according to general procedure C from tert-butyl (2-
allylbenzoyl)(benzyl)carbamate 3d (38.1 mg, 0.100 mmol) and 
phenylboronic acid pinacol ester (61.2 mg, 0.300 mmol). The crude reaction mixture was purified 
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by flash column chromatography (100:0 hexanes:EtOAc to 90:10 hexanes:EtOAc) to give 4d as a 
white solid in 88% yield (22.2 mg, 0.088 mmol). 1H NMR (400 MHz, CDCl3)  2.65 (dd, J = 14.0, 
10.4 Hz, 1H), 2.80 (dd, J = 17.2, 3.8 Hz, 1H), 2.96-3.02 (m, 1H), 3.11 (dd, J = 17.2, 7.8 Hz, 1H), 
3.39 (dd, J = 14.0, 4.2 Hz, 1H), 3.86 (s, 3H), 6.82 (s, 1H), 6.90 (dd, J = 8.5, 2.2 Hz, 1H), 7.19-7.32 
(m, 5H), 7.72 (d, J = 8.5 Hz, 1H). 13C NMR (101 MHz, CDCl3)  32.3, 37.3, 49.2, 55.7, 109.8, 
115.5, 125.8, 126.4, 128.6, 129.0, 129.9, 139.9, 156.7, 165.5, 206.1. HRMS (ESI): Calcd. for 
C17H17O2
+ ([M+H]+): 253.1223, Found: 253.1226. 
2-benzyl-5-methyl-2,3-dihydro-1H-inden-1-one (4e): Prepared 
according to general procedure C from tert-butyl (2-allyl-4-
methylbenzoyl)(benzyl)carbamate 3e (36.5 mg, 0.100 mmol) and 
phenylboronic acid pinacol ester (61.2 mg, 0.300 mmol).  The crude reaction mixture was purified 
by flash column chromatography (100:0 hexanes:EtOAc to 90:10 hexanes:EtOAc) to give 4e as a 
colorless oil in 97% yield (22.9 mg, 0.097 mmol). 1H NMR (400 MHz, CDCl3)  2.42 (s, 3H), 
2.65 (dd, J = 14.0, 10.5 Hz, 1H), 2.81 (dd, J = 17.1, 3.7 Hz, 1H), 2.95-3.02 (m, 1H), 3.11 (dd, J = 
17.1, 7.7 Hz, 1H), 3.39 (dd, J = 13.9, 4.1 Hz, 1H), 7.17-7.32 (m, 7H), 7.68 (d, J = 7.8 Hz, 1H). 13C 
NMR (101 MHz, CDCl3)  22.2, 32.1, 37.3, 49.2, 123.9, 126.4, 127.0, 128.6, 128.8, 129.1, 134.4, 
139.9, 146.1, 154.3, 207.4. HRMS (ESI): Calcd. for C17H17O
+ ([M+H]+): 237.1274, Found: 
237.1276. 
2-benzyl-5-fluoro-2,3-dihydro-1H-inden-1-one (4f): Prepared 
according to general procedure C from tert-butyl (2-allyl-4-
fluorobenzoyl)(benzyl)carbamate 3f (36.9 mg, 0.100 mmol) and 
phenylboronic acid pinacol ester (61.2 mg, 0.300 mmol). The crude reaction mixture was purified 
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by flash column chromatography (100:0 hexanes:EtOAc to 90:10 hexanes:EtOAc) to give 4f as a 
yellow oil in 99% yield (23.8 mg, 0.099 mmol). 1H NMR (400 MHz, CDCl3)  2.69 (dd, J = 14.0, 
10.2 Hz, 1H), 2.85 (dd, J = 17.3, 3.8 Hz, 1H), 2.98-3.07 (m, 1H), 3.15 (dd, J = 17.3, 7.8 Hz, 1H), 
3.38 (dd, J = 14.0, 4.3 Hz, 1H), 7.02-7.95 (m, 2H), 7.19-7.25 (m, 3H), 7.27-7.33 (m, 2H), 7.78 
(dd, J = 8.2, 5.3 Hz, 1H). 13C NMR (101 MHz, CDCl3)  32.2 (d, J = 2.0 Hz, 1C), 37.1, 49.3, 
113.3 (d, J = 22.2 Hz, 1C), 115.9 (d, J = 24.2 Hz, 1C), 126.4 (d, J = 11.1 Hz, 1C), 126.6, 128.7, 
129.0, 133.1 (d, J = 2.0 Hz, 1C), 139.4, 156.6 (d, J = 10.1 Hz, 1C), 167.3 (d, J = 257.6 Hz, 1C), 
206.0. 19F NMR (CDCl3, 376 MHz):  -102.7 (m, 1F). HRMS (ESI): Calcd. for C16H14FO+ 
([M+H]+): 241.1023, Found: 241.1027. 
2-benzyl-5-(trifluoromethyl)-2,3-dihydro-1H-inden-1-one (4g): 
Prepared according to general procedure C from tert-butyl(2-allyl-4-
(trifluoromethyl)(benzyl)carbamate 3g (41.9 mg, 0.100 mmol) and 
phenylboronic acid pinacol ester (61.2 mg, 0.300 mmol).  The crude reaction mixture was purified 
by flash column chromatography (100:0 hexanes:EtOAc to 90:10 hexanes:EtOAc) to give 4g as a 
white solid in 85% yield (24.7 mg, 0.085 mmol). 1H NMR (400 MHz, CDCl3)  2.73 (dd, J = 14.0, 
10.1 Hz, 1H), 2.93 (dd, J = 17.4, 4.0 Hz, 1H), 3.03-3.11 (m, 1H), 3.24 (dd, J = 17.4, 7.8 Hz, 1H), 
3.39 (dd, J = 14.0, 4.4 Hz, 1H), 7.20-7.25 (m, 3H), 7.28-7.34 (m, 2H), 7.63 (d, J = 8.0 Hz, 1H), 
7.67 (s, 1H), 7.88 (d, J = 8.0 Hz, 1H) 13C NMR (101 MHz, CDCl3)  32.2, 36.9, 49.4, 123.9 (q, J 
= 4.0 Hz, 1C), 124.7, 125.2 (q, J = 4.0 Hz, 1C), 126.5 (q, J = 274.7 Hz, 1C), 126.7, 128.8, 129.0, 
136.2 (q, J = 31.3 Hz, 1C), 139.2, 139.31-139.35 (m, 1C), 153.8, 206.9. 19F NMR (CDCl3, 376 
MHz):  -62.9 (s, 3F). HRMS (ESI): Calcd. for C17H14F3O+ ([M+H]+): 291.0991, Found: 
291.0978. 
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2-benzyl-4-fluoro-2,3-dihydro-1H-inden-1-one (4h): Prepared according 
to general procedure C from tert-butyl(2-allyl-3-
fluorobenzoyl)(benzyl)carbamate 3h (36.9 mg, 0.100 mmol) and 
phenylboronic acid pinacol ester (61.2 mg, 0.300 mmol). The crude reaction 
mixture was purified by flash column chromatography (100:0 hexanes:EtOAc to 90:10 
hexanes:EtOAc) to give 4h as a yellow oil in 95% yield (22.8 mg, 0.095 mmol). 1H NMR (400 
MHz, CDCl3)  2.71 (dd, J = 14.0, 10.2 Hz, 1H), 2.85 (dd, J = 17.5, 4.0 Hz, 1H), 3.00-3.06 (m, 
1H), 3.20 (dd, J = 17.5, 7.8 Hz, 1H), 3.39 (dd, J = 14.0, 4.3 Hz, 1H), 7.21-7.27 (m, 4H), 7.29-7.33 
(m, 2H), 7.34-7.39 (m, 1H), 7.58 (d, J = 7.5 Hz, 1H). 13C NMR (101 MHz, CDCl3)  28.0, 37.0, 
49.0, 119.9, 121.0 (d, J = 20.2 Hz, 1C), 126.6, 128.7, 129.0, 129.5 (d, J = 6.1 Hz, 1C), 139.3, 139.5 
(d, J = 8.1 Hz, 1C), 139.6 (d, J = 8.1 Hz, 1C), 160.2 (d, J = 251.5 Hz, 1C), 206.6. 19F NMR (376 
MHz, CDCl3)  -118.9 (m, 1F). HRMS (ESI): Calcd. for C16H14FO+ ([M+H]+): 241.1023, Found: 
241.1019. 
2-benzyl-4-fluoro-2,3-dihydro-1H-inden-1-one (4i): Prepared according 
to general procedure C from tert-butyl(2-allyl-6-
fluorobenzoyl)(benyl)carbamate 3i (36.9 mg, 0.100 mmol) and 
phenylboronic acid pinacol ester (61.2 mg, 0.300 mmol). The crude reaction mixture was purified 
by flash column chromatography (100:0 hexanes:EtOAc to 90:10 hexanes:EtOAc) to give 4i as a 
yellow oil in 84% yield (20.2  mg, 0.084 mmol). 1H NMR (400 MHz, CDCl3)  2.70 (dd, J = 14.0, 
10.2 Hz, 1H), 2.87 (dd, J = 17.3, 4.2 Hz, 1H), 3.00-3.06 (m, 1H), 3.17 (dd, J = 17.3, 7.9 Hz, 1H), 
3.39 (dd, J = 14.0, 4.3 Hz, 1H), 6.97 (t, J = 9.0 Hz, 1H), 7.16 (d, J = 7.3 Hz, 1H), 7.19-7.33 (m, 
5H), 7.54 (m, 1H) 13C NMR (101 MHz, CDCl3)  32.2, 37.0, 49.6, 114.4 (d, J = 19.2 Hz, 1C), 
122.5 (d, J = 5.1 Hz, 1C), 124.5 (d, J = 13.1 Hz, 1C), 126.6, 128.7, 129.1, 136.7-136.9 (m, 1C), 
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139.4, 155.8 (d, J = 2.0 Hz, 1C), 159.2 (d, J = 265.6 Hz, 1C), 204.1 (d, J = 1.0 Hz, 1C). 19F NMR 
(376 MHz, CDCl3)  -114.4 (m, 1F). HRMS (ESI): Calcd. for C16H14FO+ ([M+H]+): 241.1023, 
Found: 241.1018. 
2-benzyl-5,6-difluoro-2,3-dihydro-1H-inden-1-one (4j): Prepared 
according to general procedure C from tert-butyl(2-allyl-4,5-
difluorobenzoyl)(benyl)carbamate 3j (38.7 mg, 0.100 mmol) and 
phenylboronic acid pinacol ester (61.2 mg, 0.300 mmol). The crude reaction mixture was purified 
by flash column chromatography (100:0 hexanes:EtOAc to 90:10 hexanes:EtOAc) to give 4j as a 
off-white solid in 46% yield (11.9  mg, 0.046 mmol). 1H NMR (400 MHz, CDCl3)  2.70 (dd, J = 
14.0, 10.0 Hz, 1H), 2.82 (dd, J = 17.0, 1.2 Hz, 1H), 2.99-3.08 (m, 1H), 3.13 (ddd, J = 17.0, 7.7, 
0.6 Hz, 1H), 3.36 (dd, J = 14.0, 4.3 Hz, 1H), 7.17 (dd, J = 9.4, 6.7 Hz, 1H), 7.20-7.24 (m, 3H), 
7.27-7.33 (m, 2H), 7.54 (dd, J = 8.2, 0.4 Hz, 1H). 13C NMR (101 MHz, CDCl3)  31.8 (d, J = 1.0 
Hz, 1C), 40.0, 49.4 (d, J = 1.0 Hz, 1C), 112.2 (dd, J = 17.2, 2.0 Hz, 1C), 114.9 (d, J = 18.2 Hz, 
1C), 126.7, 128.7, 129.0, 133.0 (dd, J = 6.1, 3.0 Hz, 1C), 139.1, 150.3 (dd, J = 8.1, 3.0 Hz, 1C), 
150.8 (dd, J = 252.5, 14.1 Hz, 1C), 155.4 (dd, J = 260.6, 14.1 Hz, 1C), 205.7 (d, J = 2.0 Hz, 1C). 
19F NMR (376 MHz, CDCl3)  -136.8 (m, 1F), -125.2 (m, 1F). HRMS (ESI): Calcd. for 
C16H13F2O
+ ([M+H]+): 259.0929, Found: 259.0918. 
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Nickel-Catalyzed Carboacylation of Methyl-2-Allylbenzoate 5  
 
A 1-dram vial was charged with 0.100 mmol of methyl 2-allylbenzoate 5 (17.6 mg, 0.100 
mmol), Ni(cod)2 (2.8 mg, 0.010 mmol), SIPr (3.9 mg, 0.010 mmol), K3PO4 (42.5 mg, 0.200 mmol), 
H2O (3.6 L, 0.20 mmol), phenylboronic acid pinacol ester (61.2 mg, 0.300 mmol), and THF 
(0.100 mL).   The resulting solution stirred at 60 °C for 12 hours.  Upon completion of the reaction, 
the reaction mixture was filtered through a plug of silica with 70:30 hexanes:EtOAc. The crude 
product was purified by column chromatography with a gradient of 100:0 hexanes:EtOAc to 90:10 
hexanes:EtOAc over a 25 minute period on a Combiflash system to 2a as colorless oil in 50% 
yield (11.0 mg, 0.049 mmol).  NMR data match those reported for synthesis of 2a from benzamide 
1a. 
Enantioselective α-Arylation of 2a to Form (S)-2-Benzyl-2-phenyl-2,3-dihydro-1H-inden-1-
one 6 
 
2-Benzyl-2-phenyl-2,3-dihydro-1H-inden-1-one 6 was prepared according to a known 
literature procedure.48  Inside of a glovebox, to a 1-dram vial containing a magnetic stir bar was 
added Ni(cod)2 (5.5 mg, 0.020 mmol), (S)-BINAP (14.9 mg, 0.024 mmol), NaOtBu (38.4 mg, 
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0.400 mmol), chlorobenzene (40.5 L, 0.400 mmol), 2a (44.5 mg, 0.200 mmol), and toluene (1.00 
mL).  The vial was sealed with a cap containing a PTFE septum and removed from the glovebox. 
The reaction was stirred at 80 °C for 36 h.  Upon completion, the reaction was cooled to room 
temperature.  The reaction was quenched with a saturated aqueous NH4Cl solution and extracted 
with Et2O (2 x 10 mL).  The combined organic layers were dried over Na2SO4, filtered, and 
concentrated under reduced pressure.  The crude product was purified by flash column 
chromatography (98:2, hexanes:EtOAc) to give 6 as a white solid in 65% yield (39.0 mg, 0.130 
mmol). The enantiomeric excess was determined by HPLC analysis (254 nm, 25 °C) tR 27.2 min 
(minor); tR 36.0 min (major) [Chiracel AD-H (0.46 cm x 25 cm)(from Daicel Chemical Ind., Ltd.) 
hexane/i-PrOH, 98:2, 1.0 mL/min] to be 98% ee. NMR data are consistent with known literature 
values.48 
 
 
 
182 
 
 
Experimental Procedures for Competition Experiments: 
 
A competition experiment generating 2-benzyl-2,3-dihydro-1H-inden-1-ones 4b and 4k was 
carried out by the following procedure. A 1-dram vial was charged with o-allylbenzamides 3b 
(36.5 mg, 0.100 mmol) and 3k (41.9 mg, 0.100 mmol), Ni(cod)2 (2.8 mg, 0.010 mmol), SIPr (3.9 
mg, 0.010 mmol), K3PO4 (42.4 mg, 0.200 mmol), H2O (3.6 L, 0.20 mmol), phenylboronic acid 
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pinacol ester (102 mg, 0.500 mmol), and THF (0.10 mL).   The resulting solution was stirred at 60 
°C for 12 hours.  Upon completion of the reaction, the reaction mixture was filtered through a plug 
of silica with hexanes:EtOAc (70:30), and concentrated under reduced pressure. The crude mixture 
was dissolved in CDCl3 with CH2Br2 as internal standard. The ratio of products 4k:4b was 
determined to be 6.8:1 by 1H NMR spectroscopy.  The NMR yields of 4k and 4b were determined 
to be 75% and 11%, respectively. 
 
A competition experiment generating 2-benzyl-2,3-dihydro-1H-inden-1-ones 2p and 2c was 
carried out by the following procedure. A 1-dram vial was charged with o-allylbenzamide 1a (35.1 
mg, 0.100 mmol), Ni(cod)2 (2.8 mg, 0.010 mmol), SIPr (3.9 mg, 0.010 mmol), K3PO4 (42.5 mg, 
0.200 mmol), H2O (3.6 L, 0.20 mmol), 4-tolylboronic acid pinacol ester (109 mg, 0.500 mmol), 
2-tolylboronic acid pinacol ester (109 mg, 0.500 mmol), and THF (0.10 mL).   The resulting 
solution was stirred at 60 °C for 12 hours.  Upon completion of the reaction, the reaction mixture 
was filtered through a plug of silica with hexanes:EtOAc (70:30), and concentrated under reduced 
pressure. The crude mixture was dissolved in CDCl3 with CH2Br2 as internal standard. The ratio 
of products 2p:2c was determined to be 8.3:1 by 1H NMR spectroscopy.  The NMR yields of 2p 
and 2c were determined to be 58% and 7%, respectively. 
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A competition experiment generating 2-benzyl-2,3-dihydro-1H-inden-1-ones 2j and 2c was 
carried out by the following procedure. A 1-dram vial was charged with o-allylbenzamide 1a (35.1 
mg, 0.100 mmol), Ni(cod)2 (2.8 mg, 0.010 mmol), SIPr (3.9 mg, 0.010 mmol), K3PO4 (42.5 mg, 
0.200 mmol), H2O (3.6 L, 0.20 mmol), 4-tolylboronic acid pinacol ester (109 mg, 0.500 mmol), 
4-(trifluoromethyl)phenylboronic acid pinacol ester (136 mg, 0.500 mmol), and THF (0.10 mL).   
The resulting solution was stirred at 60 °C for 12 hours.  Upon completion of the reaction, the 
reaction mixture was filtered through a plug of silica with hexanes:EtOAc (70:30), and 
concentrated under reduced pressure. The crude mixture was dissolved in CDCl3 with CH2Br2 as 
internal standard. The ratio of products 2j:2c was determined to be 10.5:1 by 1H NMR 
spectroscopy.  The NMR yields of 2j and 2c were determined to be 84% and 8%, respectively. 
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CHAPTER V 
CONCLUSION 
Summary 
 This thesis describes the development of new transition metal- and NHC-catalyzed alkene 
hydroacylation and enantioselective α-arylation reactions.  Additionally, the development of a new 
nickel-catalyzed formal alkene carboacylation is discussed.  The catalytic methods discussed 
enabled access to a wide variety of carbocyclic and heterocyclic molecular scaffolds, and in some 
cases access to all-carbon quarternary stereocenters.  The experimental work detailed contributes 
to the fundamental understanding of the mechanistic principles that control these reactions and 
opens the door for many new developments. 
 This thesis presents the first nickel-catalyzed alkene carboacylation reactions initiated by 
activation of amide C-N bonds.  These processes enable coupling of a wide variety of o-
allylbenzmides with arylboronic acid pinacol esters to form two new C-C bonds and the indanone 
products in up to 99% yield. Additionally, experimental results have given insight into the 
mechanism of this new reaction.  The development of this approach to alkene carboacylation 
bypasses the challenges associated with related alkene carboacylation reactions that rely on the 
use of non-removable directing groups or ring-strain release to facilitate the C-C bond activation.  
This method also demonstrates the utility of amides as powerful building blocks in organic 
synthesis and is an early example of the potential of activation of amide C-N bonds in the 
development of new classes of reactions. 
 The utilization of amide C-N bond activation has the potential to allow innovation of 
existing and development of new reactions. Currently, developments to further expand the utility 
of this process have led to the studies of intramolecular boroacylation to form a new carbon-carbon 
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and carbon-boron bond in a single transformation that could later be used for further 
functionalization for more complex molecular scaffolds.  Additionally, the investigation of a 
transition-metal catalyzed system that will catalyze the asymmetric intramolecular carboacylation 
of ortho-allylbenzaldehyde and ortho-vinylbenzaldehyde is ongoing in our lab. The development 
of the racemic, three-component, intermolecular carboacylation of benzamides with norbornene 
has shown early promise and further being leveraged as a preliminary result to the study and 
develop intermolecular carboacylation of simple alkenes via amide C-N bond activation. 
Conclusion 
 In conclusion, the synthetic methods detailed in this thesis demonstrates a variety of 
methods to functionalize alkenes to generate a wide variety of products with excellent yields, 
enantio- and regioselectivities. These new catalytic methods represent substantial advancement in 
terms of alkene hydroacylation, and a new class of reaction for the formal alkene carboacylation 
triggered by amide C-N bond activation.  Additionally, the utilization of amide C-N bond 
activation has led to a variety of new developments in the areas of boroacylation and the 
development of asymmetric intra- and intermolecular carboacylation reactions. 
 
